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SUMMARY
i Protein-chemical and immunological studies were carried out on 
three mitochondrial proteins: the phosphate and adenine nucleotide inner membrane 
carriers (PTP and ANT), and the pyruvate dehydrogenase multienzyme complex 
(PDC).
PTP was purified to homogeneity from both mammalian (rat liver and bovine 
heart) and yeast (S.cerevisiae) mitochondria. Antisera were
raised against the rat liver and yeast carriers. It was observed that, by pre-incubating 
freshly-isolated mitochondria with the potent ANT inhibitor, carboxyatractyloside 
(CAT), it was possible to co-purify PTP and ANT from both mammalian and yeast 
sources. However, it was not possible to purify ANT to homogeneity by adopting the 
procedure outlined in the literature. The petite (rho-) S.cerevisiae mutant strain 
D273-10B-1 was employed to investigate the biosynthesis of the putative yeast PTP. In 
agreement with Wohlrab's group (Phelps et al., 1991), the yeast carrier was observed 
to lack an N-terminal-extended signal sequence.
Various chromatographic techniques were employed in an attempt to separate 
the co-purified mitochondrial carriers. It was observed that, after application to the 
Matrex gel Procion Red A at pH 8 .8 , mammalian PTP and ANT were differentially 
eluted with a salt (NaCl) gradient. Following separation, the identities of the bovine 
heart carriers were confirmed by N-terminal protein sequencing. Procion Red A column 
chromatography was also found to represent an assay for native mammalian PTP 
conformation, an important pre-requisite for physical analyses of the carrier and 
crystallisation trials. This Matrex gel was further employed to transfer bovine heart PTP 
from solution in Triton X-100 to detergents suitable for analysis by circular dichroism 
(CD). In this manner, the secondary structure of the carrier was analysed and found
to contain 85-95% a-helix. Although possibly rather high, this value may reflect the 
6-7 transmembrane domains of PTP and the carrier's resistance to proteolysis in the
membrane. In one of the detergents tested, PTP was also found to contain ~5% p-sheet 
structure, which may correspond to the putative 7th transmembrane domain proposed 
for the 'tripartite' family of membrane carriers. However, no further evidence was
XV
found for the presence of this secondary structure in PTP. CD spectra were also 
obtained for bovine PTP in the presence of increasing concentrations of the denaturing 
reagent guanidine-HCl (GdnHCl).
The putative phosphate carrier isolated from yeast mitochondria was identified 
on the bases of its purification characteristics and immunological properties. 
Characterisation of yeast ANT was based on the protein's purification properties and its 
stabilisation with CAT. Although it was not possible to separate the yeast co-isolate 
with Procion Red A, the binding and elution characteristics of the proteins further 
suggested that they represent yeast PTP and ANT. Preliminary results also indicated 
that Procion Red A represents an assay for native PTP conformation. Further to this, 
chromatographic analysis revealed the presence of an unbound mitochondrial 
polypeptide with a near-identical Mr value to the putative yeast PTP. Subsequent 
research identified this contaminant as the outer membrane protein, porin.
The SERC-funded amino acid sequencing facility at the University of 
Aberdeen was employed to determine the N-terminus of the putative yeast PTP. This 
initially indicated that the protein isolated in this study was distinct from that encoded 
by the putative yeast PTP gene cloned and sequenced by Phelps et al. (1991).
However, it was subsequently demonstrated that the amino acid sequence obtained was 
the N-terminus of contaminating porin in the PTP preparation. The N-terminal of PTP 
was shown to be blocked, confirming prior observations (A. Phelps, personal 
communication). Another group had previously isolated and characterised the putative 
yeast PTP gene (Murakami et al., 1990), but claimed that it encodes a yeast 
mitochondrial import receptor. The possible in vivo function(s) of both this protein and 
the polypeptide isolated in this study are speculated upon, although further research is 
clearly required to fully characterise them and confirm that they are identical.
In addition to studying the mitochondrial carriers PTP and ANT, a specific 
problem relating to the control of yeast PDC activity was addressed. Whereas PDC
activity is regulated by a phosphorylation/dephosphorylation cycle on the E l a  subunit 
in all other eukaryotic organisms, no equivalent mechanism has ever been detected in 
yeast. In this project, in situ ATP-radiolabelling studies with freshly-prepared yeast 
mitochondria were employed to provide strong evidence for the presence of PDC
kinase activity in this microorganism. Further to this, immune precipitation studies with 
yeast PDC E l antiserum illustrated that the 32p-phosphoprotein in yeast mitochondria
corresponds to PDC E l a.
CHAPTER 1: INTRODUCTION
1.1 THE MITOCHONDRION
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1.1.1 Introduction
The average mammalian mitochondrion has similar dimensions to the bacterium
Escherichia coli. It exists commonly as an oval particle l-2jim long and 0.5-lfim 
wide. Mitochondria can thus be observed in the light microscope, and the earliest 
descriptions of this organelle were based on the analysis of fixed and stained tissue. 
Although initially observed microscopically towards the end of the last century, it was 
not until the late 1940’s that intact mitochondria were successfully isolated (Hogeboom 
et al., 1948).
Electron micrographs of negatively stained mitochondria in transverse section 
clearly show two membranes: a limiting outer membrane and a highly invaginated inner 
membrane. These membranes divide the mitochondrion into two distinct compartments 
creating a total of four locations; outer membrane, inner membrane, matrix and 
intermembrane space, where a protein can be situated in the organelle. The enzymes 
involved in oxidative phosphorylation are located in the inner membrane, and thus 
those tissues, such as muscle, that require the greatest output of oxidatively derived 
ATP have mitochondria suited for this purpose, expressed morphologically as a highly 
invaginated inner membrane.
1.1.2 Composition of the inner and outer membranes
The outer membrane is 6-7nm thick, smooth and unfolded. In addition to being 
rich in phosphatidyl choline (see Table 1.1.1), this membrane contains relatively high 
amounts of cholesterol (Parsons and Yano, 1967; Levy etal., 1969). Structurally, the 
membrane is relatively inelastic but freely permeable to molecules of Mr value below 
10,000. Further analysis indicates that this membrane contains a heterogeneous group 
of enzymes involved in lipid metabolism and hydroxylation reactions. However, as 
these enzymes do not constitute an integrated pathway, the function of this membrane is 
^  not clear. Monoamine oxidase is the marker enzyme most commonly used for the outer
Tahle 1.1.1: Lipid composition of mitochondrial membranes (Adapted 
from Parsons et al.. 1967)
Lipid Mitochondria Inner membrane Outer membrane Microsomes
Phospholipids 
(mg/mg protein) 0.16 0.30 0.88 0.30
Cholesterol
(|ig/mg protein) 2.28 5.26 30.1 30.2
(Percentage of total phospholipid)
Phosphatidyl
choline 40.0 44.5 55.2 62.8
Phosphatidyl
ethanolamine 28.4 27.7 25.3 18.6
Cardiolipin 22.5 21.5 3.2 0.5
Phosphatidyl
inositol 7.0 4.2 13.5 13.4
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membrane.
In contrast, the inner mitochondrial membrane shows evidence of substructure 
on its matrix-facing surface and exhibits differential solute permeabilities. This 6 -8nm 
thick membrane thus represents the major permeability barrier between the cytoplasm 
and the matrix. Small uncharged molecules (eg KtyD, O2, CO2, NH3 and ethanol) are 
freely permeable but specific transport systems (see Section 1.1.4) control the influx 
and/or efflux of hydrophilic ions (eg H+, Pj and adenine nucleotides). This membrane 
has a low phospholipid to protein ratio and its highly invaginated nature offers a very 
large surface area. Characteristic features of the inner membrane include its high content 
of the phospholipid cardiolipin, and low levels of cholesterol which render it relatively 
resistant to the detergent digitonin (see Table 1.1.1). In addition to a variety of solute 
carriers, this membrane also contains the respiratory chain enzymes and 
ATP-synthesising machinery.
The intermembrane space is generally 6-8nm wide except at translocation 
contact sites where the two membranes meet to facilitate protein import (see Section 
1.1.6.4). Relatively few enzymes are housed in this space, and most catalyse the 
interconversion of adenine nucleotides. In contrast, the matrix is extremely viscous and 
contains the vast array of enzymes that compose the tricarboxylic acid cycle (except 
succinate dehydrogenase, which is a component of the inner membrane) and fatty acid 
oxidation. These catabolic pathways provide the respiratory chain with NADH, its 
major oxidisable substrate. The matrix also houses the enzymes which catalyse the 
synthesis of mitochondrial DNA and RNA, together with part of the urea cycle in some 
tissues. The ribosomes and enzymes involved in the synthesis of 
mitochondrially-encoded proteins are also situated in the matrix.
1.1.3 The electron transfer chain and oxidative phosphorylation
The primary function of mitochondria is to carry out oxidative phosphorylation. 
In this process, the electrons generated by the oxidation of the reduced coenzymes 
NADH and FADH2 are ultimately transferred to molecular oxygen with the concomitant 
production of ATP.
While the protons generated during this process are readily soluble in aqueous
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solution, the free electrons are passed from NADH or FADH2 to oxygen along a chain 
of electron carriers which are components of the inner mitochondrial membrane. A 
series of electron carriers are grouped into four multiprotein intramembranous 
complexes, all of which exhibit lateral mobility in the plane of the membrane. As no 
stable contacts have been detected between these enzymes, transport of electrons from 
one complex to another may simply involve random collisions of the two. Figure 1.1.1 
outlines the mitochondrial electron transfer chain. The lipid-soluble coenzyme Q 
shuttles electrons from the NADH-Q reductase and succinate dehydrogenase complexes 
to QH2-cytochrome c reductase. Cytochrome c interacts with specific sites on both 
QH2-cytochrome c reductase and cytochrome c oxidase and acts as a mobile carrier, 
transferring electrons from one complex to the other. Each of these complexes contains 
a variety of subunits and prosthetic groups. NADH-Q reductase consists of 
approximately 25 subunits with 8-9 FeS centres and a FMN group. Succinate 
dehydrogenase, which has 4 subunits, also contains 3 FeS centres as well as a FAD 
group and cytochrome b 553. QH2-cytochrome c reductase, also known as the be 1 
complex, contains 11 subunits, cytochromes b 555 and b 552, cytochrome c 1 and the 
Rieske FeS centre. Cytochrome c oxidase, which reduces molecular oxygen, consists 
of 13 subunits and contains cytochromes a and a 3 and 2-3 copper atoms.
Oxidation and ATP production are believed to be coupled by a proton motive 
force generated across the inner mitochondrial membrane during electron transport. 
First postulated by Mitchell (1961), the Chemiosmotic Hypothesis is now generally 
accepted as the model for oxidative phosphorylation. Protons are pumped out of the 
matrix at three of the electron transport complexes (NADH-Q reductase, 
QH2~cytochrome c reductase and cytochrome c oxidase) creating a pH gradient and 
electrochemical potential across the membrane. The exact number of electrons 
transferred and protons pumped per complex is the source of much debate. When 
protons are shuttled back into the matrix through the transmembranous FjFoATPase, 
ATP is synthesised from ADP and Pp
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1.1.4 Mitochondrial transport systems
The specialised role of mitochondria in intermediary metabolism requires that 
only certain substrates, cofactors and ions are accessible to the inner compartment. Of 
the molecules which must enter the matrix, the most important are the substrates for 
oxidation and phosphorylation, namely ADP, Pj, O2, pyruvate and fatty acids. Equally 
important, the products of mitochondrial oxidation, including citrate, CO2 and ATP, 
must have means of exiting the matrix. While mitochondria are freely permeable to CO2 
and O2, the inner membrane, which represents the major permeability barrier between 
the cytoplasm and matrix, contains specific transport systems which accommodate the 
efficient influx or efflux of the remainder of these metabolites (see Table 1.1.2).
From Table 1.1.2, it is apparent that mitochondria possess a wide spectrum of 
transport systems, the majority of which are electroneutral exchange diffusion carriers. 
This movement of certain metabolites between the cytoplasm and matrix influences and 
regulates the overall metabolic balance of the cell (see Section 1.2; for review see 
Chappell, 1968).
1.1.5 The mitochondrial genome
Mitochondria contain their own genome which is responsible for the synthesis 
of about 5% of the organelle's proteins in addition to all the ribosomal and transfer 
RNAs of its separate transcription/translation system. The mitochondrial genome is 
autonomously replicated and is expressed within the confines of the organelle. Within a 
cell, each mitochondrion contains several copies of the closed circular DNA genome. 
The Mr value of the DNA varies between species, from approx. 107 in animal tissues to 
7xl07 in higher plants.
The complete sequence and organisation of three mammalian mitochondrial 
genomes have been elucidated (Bibb et a l, 1981; Anderson et al., 1981; Anderson et 
al., 1982), and all demonstrate extreme economy in organisation with very few or no 
non-coding bases between adjacent genes (Figure 1.1.2). There are genes for two 
ribosomal RNAs (12S and 16S), 22 tRNAs and 13 proteins. Encoded on the heavy 
strand of the genome (H-strand) are the two ribosomal RNA genes, 14 tRNA genes 
and 12 proteins. The remainder of the tRNA and protein-coding genes are expressed on
Table 1.1.2: Specific transport systems of the inner mitochondrial 
membrane
Transporter in vivo function 
(IN/OUT)
Inhibitors Biological importance
Phosphate
Adenine
nucleotide
Pi/OH-
ADP37ATP4'
N-ethylmaleimide
atractyloside 
carboxyatractyloside 
bongkrekic acid
1)Mitochondrial ATP synthesis
2)Allows flux of dicarboxylates 
and tricarboxylates
Mitochondrial ATP synthesis
Pyruvate pyruvate/OH' 
Dicarboxylate malate/Pj
a-cyano (4, OH) cinnamate Link between glycolysis
and the TCA cycle
n -butyl malonate 
2 -phenyl succinate
1)Transfer of reducing 
equivalents into and out of 
the matrix
2)Provides carbon skeleton 
for PEP
Malate/succinate malate/succinate
Tricarboxylate citrate/malate or
isomalate 
(citrate/isocitrate)
citrate analogues l)Transfer of acetyl CoA into 
cytosol
2)Control of PFK
3)Provision of NADPH to 
cytosol
Oxoglutarate oxoglutarate/malate or aspartate
malonate
Glutamate
Glu/Asp
Glu/Gln
glutamate/OH* N-ethylmaleimide 
glutamate+H+/aspartate
glutamine/glutamate
ornithine/citrateOrnithine/citrate 
(liver only)
Acyl camitine/camitine acyl /  carnitine
carnitine
1)Transfer of reducing 
equivalents across the 
membrane
2)Transport of amino groups 
into the matrix
Urea formation in the matrix
1)Transfer of reducing 
equivalents
2)Urea synthesis in the cytosol
3)In gluconeogenesis
NH3 production in the kidney 
Urea cycle
carnitine
derivatives
Movement of fatty 
acids across the 
membrane
Ca2+ Ca2+ (in) ruthenium red Ca2+ storage in the matrix
Ca2+/Na+ Ca2+/2Na+
Figure 1.1.2: Genomic map of mammalian mitochondrial DNA (Reproduction from 
Clavton. 19841
The stippled areas represent tRNA genes designated by the single-letter amino 
acid code, with polarity indicated by the arrows. All protein-encoding genes are on the 
H-strand (with counterclockwise polarity), with the exception of URF6 , which is on 
the L-strand. COI, II and El: cytochrome oxidase subunits I, E and IE; Cyt. b: 
cytochrome b; URF: unassigned reading frame; Ojj and O l: the origins of H- and 
L-strand replication respectively. URF's have now been assigned (Chomyn et al.,
1986) as encoding seven subunits of NADH-Q reductase and a further ATPase subunit.
Figure 1.1.2: Genomic mao of mammalian mitochondrial DNA
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the light strand (L-strand). The 13 reading frames have been assigned protein products 
of known function, all involved in oxidative phosphorylation. They were identified 
from the amino acid sequence of purified protein and by homology with the DNA 
sequence of known genes in other mitochondrial systems (Thalenfeld and Tzagaloff, 
1980; Bibb e ta l., 1981; Anderson e ta l., 1981; Chomyn e ta l., 1986). Theonly 
significant non-coding region of mammalian mitochondrial DNA is the displacement 
loop (D-loop). This region contains the origin of H-strand replication and sequences 
relevant to the promotion of transcription from each template strand (Montoya et al., 
1982; Montoya et al., 1983).
In contrast, the yeast mitochondrial genome is approximately five times the size 
of mammalian mitochondrial DNA and appears to be less economically organised. It 
encodes two ribosomal RNAs, 25 tRNAs and 16 proteins. In addition, several yeast 
genes have been shown to contain intervening sequences (introns) in their structure, a 
phenomenon absent from mammalian mitochondrial genes.
Although there are marked differences in the overall organisation of genes in 
various eukaryotic mitochondria, the information available does suggest that the 
mitochondrial genome has been stripped of those elements that could be moved to the 
nucleus or dispensed with completely. This lends support to the popular hypothesis that 
these organelles have arisen as symbiotic prokaryotes providing oxidative metabolism 
to their pre-eukaryotic hosts. Southern Blotting has been employed as a technique to 
identify regions of mitochondrial-like DNA within the nuclear genomes of organisms as 
diverse as yeast (Farelly and Butow, 1983), insects (Gellisen et al., 1983) and rat 
(Hadles et al., 1983). A striking example of gene transfer between the mitochondrion 
and nucleus has been identified in Neurospora crassa (Van den Boogart et al., 1982). 
The gene for mitochondrial ATPase subunit IX  is nuclear-encoded though a copy is 
found within the mitochondrial DNA. This copy is apparently dormant and neither its 
origin nor physiological significance is known. However, in S.cerevisiae and plants, 
this protein is encoded by the mitochondrial genome and synthesised without a 
presequence (Viebrock et al., 1982). Considerable evidence thus exists for a 
mechanism of gene transfer from the prokaryotic invader to the nucleus of the 
proto-eukaryotic host during the endosymbiotic process.
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1.1.6 Mitochondrial Biogenesis
As previously discussed (Section 1.1.1), the mitochondrion possesses a double 
membrane system which divides the organelle into two compartments: the 
intermembrane space and matrix, bounded by the outer and inner membranes 
respectively. These compartments each have a special set of proteins, necessary for 
normal mitochondrial function.
Although the mitochondrion has its own genetic material (Section 1.1.5), this 
has a very limited coding potential. Most mitochondrial proteins (about 95%) are 
nuclear-encoded and synthesised on cytoplasmic ribosomes prior to transport to the 
organelle (For reviews, see Reid, 1985 and Hard et al., 1989). However, polypeptides 
destined for the inner mitochondrial compartments must translocate across one or both 
of the organelle's membranous barriers. In addition, some polypeptides must be 
targeted to positions within one of the mitochondrial membranes. Therefore, as four 
potential locations exist for each targeted polypeptide, the import process must be 
highly specific.
1.1.6.1 Mitochondrial protein import
Incorporation of nuclear-encoded proteins into mitochondria can be divided 
conceptually into five steps (shown schematically in Figure 1.1.3):-
1) synthesis of the polypeptide, usually as a larger Mr precursor;
2) recognition and binding of the precursor to the cytoplasmic surface of the 
mitochondrion;
3) translocation of the precursor across or into one or both mitochondrial membranes, 
depending on the final subcellular location of the protein;
4) processing of the polypeptide chain to generate the mature protein (may involve 
cleavage and/or other covalent modifications);
5) assembly of subunits into functional proteins (may involve association with 
mitochondrially-encoded proteins).
Two principal mechanisms exist for the translocation of proteins across 
biological membranes. In both cases, protein synthesis starts on free cytoplasmic 
polysomes. During cotranslational transport, the nascent polypeptide chain is directed
Figure 1.1.3: Biogenesis of an imported mitochondrial protein 
The steps in biogenesis are indicated as follows:-
1) Precursor synthesis
2) Delivery and binding of precursors to the mitochondrial surface
3) Translocation across membrane(s)
4) Processing of precursor polypeptides
5) Refolding and assembly into functional units
Figure 1.1.3: Biogenesis of an imported mitochondrial protein
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to the target membrane as it emerges from the ribosome. Translocation is then initiated 
on resumption of protein synthesis after a temporary pause during initial membrane 
transfer. Translocation across the endoplasmic reticulum (ER) membrane of proteins 
which associate with the signal receptor particle (SRP) occurs in this fashion.
However, the transport of some precursors across the ER membrane is stimulated by
70,000-Mr heat shock proteins (hsps; see Section 1.1.6.7) and occurs 
post-translationally. In post-translational transport, proteins bind to and are inserted 
into the target membrane after their synthesis is completed and the polypeptide has been 
released from the polysome. This type of membrane insertion is predominant in 
chloroplasts, peroxisomes, glyoxisomes and possibly mitochondria. The first evidence 
for a mitochondrial post-translational import mechanism came from in vivo 
experiments with intact cells. At various times after a pulse with radioactive amino 
acids, cells were fractionated and specific labelled precursor proteins analysed by 
immune precipitation. It was observed that labelled proteins first appeared in a cytosolic 
pool, in soluble form, and were detected in mitochondria only after a certain lag period, 
which varied for different precursors. In addition, mitochondrial import continued 
during chase periods after the inhibition of protein synthesis with cycloheximide.
These findings have been substantiated by similar studies with pulse-labelled 
yeast spheroplasts (Mori etal., 1981; Reid and Schatz, 1982; Janussi etal., 1982). The 
post-translational uptake of specific mitochondrial precursor polypeptides has also been 
demonstrated initially using in vitro translation assays. Precursors were synthesised in 
a cell-free translation system, derived from Neurospora crassa or rabbit reticulocytes, 
in the presence of radioactive amino acids. It was found that isolated mitochondria were 
capable of importing these radiolabelled, ribosome-free polypeptides (Harmey et al., 
1977; Korb andNeupert, 1978; Maccecchini etal., 1979; Zimmerman andNeupert,
1980).
There is evidence that, in some cases, translocation may follow a cotranslational 
mechanism in vivo . The existence of mitochondrially-bound polysomes has been 
demonstrated in yeast cells (Ades and Butow, 1980), but their role in protein import 
does not appear to be obligatory for this process (Suissa and Schatz, 1982). In 
summary, it is generally believed that mitochondrial proteins are synthesised on free
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cytoplasmic ribosomes as precursor molecules, which are post-translationally taken up 
by the organelle. However, although most of the evidence points to this, it may be 
strictly a kinetic phenomenon and it cannot be ruled out that a cotranslational import 
process also occurs under some physiological conditions.
1.1.6.2 Mitochondrial precursor proteins
Precursor polypeptides targeted to the mitochondria possess critical differences 
to their mature counterparts. These can be categorised as follows:-
1) precursors must be soluble in the cytosol;
2) they have to be specifically recognised by mitochondria;
3) they must assume a conformation which is competent for translocation into or across 
membranes.
Most mitochondrial precursors contain cleavable N-terminal peptide extensions 
(presequences), which direct them to the organelle. Specific proteolytic processing 
enzymes exist within mitochondria for the maturation of delivered precursors (Bohni et 
al., 1980). There are however, several precursor proteins which are targeted to each of 
the mitochondrial compartments without exhibiting transient signal sequences. For such 
proteins, it has been proposed that an internal targeting sequence directs mitochondrial 
import (Gasser and Schatz, 1983). The absence of a cleavable presequence has been 
documented for, among others, the ADP/ATP carrier of the inner membrane 
(Zimmerman and Neupert, 1980) and the closely associated brown fat uncoupling 
protein (Freeman et al., 1983). These will be discussed more fully in Section 1.2.
In some cases, these N-terminal presequences might serve to maintain the 
precursor in a conformation that prevents premature assembly outside the 
mitochondrion. There is also evidence that precursors which lack a transient N-terminal 
extension still differ from the mature protein in conformation. The extramitochondrial 
form of the ADP/ATP carrier binds to hydroxylapatite while the mature form does not 
(Schleyer and Neupert, 1984). The precursor to the ADP/ATP carrier also occurs in the 
cytoplasm in higher molecular weight complexes of 120 and 500 kDa (Zimmerman and 
Neupert, 1980). It has been proposed that these aggregates may protect the precursors 
from proteolysis in the cytosol, ensure they remain in a soluble state or be involved in 
proper presentation to the mitochondrial surface.
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1J  A 3 Mitochondrial receptors, cvtosolic cofactors and protein-lipid interactions
The specificity of mitochondrial import and sorting implies a receptor-mediated 
process. Several lines of evidence suggest that proteinaceous receptors on the 
mitochondrial surface perform the key functions of recognition (Hennig et al., 1983; 
Riezman et al., 1983; Zwizinski et al., 1983). In these studies, isolated mitochondria 
were pre-treated with low concentrations of proteases (insufficient to degrade the outer 
membrane barrier). This inhibited the subsequent import of mitochondrial precursor 
proteins. Although various outer membrane proteins have subsequently been tentatively 
identified as import receptors, the only polypeptide to date which is known to be 
essential for mitochondrial protein import in vivo is the yeast import site protein 42 
(ISP 42; Vestweber et al., 1988). In N.crassa, the equivalent polypeptide, termed 
MOM 38 (Kiebler et al., 1990), is thought to be identical to the previously detected 
'general insertion protein' (GIP, see Section 1.1.6.4; for review, see Glover and 
Lindsay, 1991).
However, the relative scarcity of proteins associated with the outer membrane 
suggests that other factors are involved in the initial binding of precursor molecules to 
the mitochondrial surface. Several studies have suggested a requirement of cytosolic 
cofactors for mitochondrial protein import (Ohta and Schatz, 1984; Chen and Douglas, 
1987). These cofactors have been partially characterised and determined to be of 
proteinaceous structure (Chen and Douglas, 1987) and to possibly contain RNA 
(Firgaira et al., 1984). The exact nature and function of these cytosolic cofactors 
remains elusive thus far. It is possible that they play a role in conferring solubility to 
cytosolic precursors, in keeping precursors in an import competent conformation and/or 
in the initial binding of precursors to the mitochondrial surface. However, it is likely 
that at least some of these cytosolic cofactors represent heat shock proteins (hsps; see 
Section 1.1.6.7), which stimulate the translocation of precursors across the 
mitochondrial and ER membranes.
A further suggestion is that precursor proteins, prior to binding to import 
receptors, interact with low affinity with lipids of the outer membrane. Studies of the 
interaction of chemically synthesised presequences with artificial lipid membranes 
(Espand etal., 1986; Roise et a l, 1986; Tamm, 1986; Skerjank e ta l ,  1987) imply the 
existence of such a pathway.
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1.1.6.4 Membrane contact sites and the role of the 'general insertion protein1
It is now thought that, after the binding of precursors to the mitochondrial 
surface, the next steps in the import pathway are carried out by the protease-protected 
'general insertion protein’ (GIP), located in the outer membrane (For reviews, see Hard 
et al., 1989 and Baker and Schatz, 1991). This protein appears to bind precursors, 
interpret their signal sequences, and specifically target them to the correct mitochondrial 
location (Pfaller et al., 1988). Outer membrane proteins are released into this membrane 
by GIP, while precursors destined for the other mitochondrial locations (inner 
membrane, matrix, intermembrane space) are released at contact sites between the outer 
and inner membranes (see Figure 1.1.4). The one apparent exception to this 
translocation pathway is cytochrome c , the import of which differs from other 
mitochondrial proteins in several respects (see Hard et al., 1989).
In N.crassa, GIP is now thought to be identical to the MOM 38 outer membrane 
polypeptide which has been isolated as a multimeric complex containing several other 
proteins including two import receptors, MOM 19 and MOM 72 (Kiebler et al., 1990).
It has long been accepted that import of precursors occurs at these translocation 
contact sites between the two mitochondrial membranes. From electron microscopic 
studies, points of membrane contact have been known about for many years 
(Hackenbrock, 1968). More recently, import via translocation contact sites has been
demonstrated for the precursors of FjATPase subunit p, cytochrome c i (Schleyer and 
Neupert, 1985), the Rieske Fe/S protein of the bci complex (Hard et al., 1986), the 
ADP/ATP carrier (Pfanner and Neupert, 1987), and cytochrome b 2 (Pfanner et al., 
1987).
1.1.6.5 Energy requirement of mitochondrial import
Early studies on mitochondrial protein import showed that it was an 
energy-requiring process (Hallermayer and Neupert, 1976). Initial experiments 
indicated that ATP, and not the electrochemical potential across the inner membrane, 
was the primary energy source (Nelson and Schatz, 1979). However, later studies 
demonstrated that it was an energised inner membrane which was essential for 
mitochondrial protein import. Specifically, the electrochemical potential is necessary for 
the initial interaction of precursors with the inner membrane, and their subsequent
Figure 1.1.4: Working hypothesis for the binding and membrane translocation of 
mitochondrial precursor proteins
GIP represents the general insertion protein, while R*, R** and R*** represent 
different classes of outer membrane receptors. The model is adapted from Pfaller et al. 
(1988). In N.crassa GIP is now thought to be identical to the MOM 38 protein, which 
may exist as a multimeric outer membrane complex containing several import receptors 
(see Section 1.1.6.4).
Figure 1.1.4: Binding and membrane translocation of mitochondrial 
precursor proteins
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transport into or across this membrane (Schleyer et al., 1982). Those proteins which do 
not interact with the inner mitochondrial membrane do not require the membrane 
potential for import However, several intermembrane space proteins do possess this 
energy requirement since their precursors transiently interact with the inner membrane 
and/or the matrix during distinct phases of their mitochondrial uptake (Gasser et al., 
1982; Reid et al., 1982).
In addition to a membrane potential, mitochondrial protein import requires 
nucleoside triphosphates (NTPs). This was demonstrated by manipulating the levels of 
NTPs and electrochemical potential independently of each other (Pfanner and Neupert, 
1986). Specifically, NTPs are necessary in most cases for both the initial interaction of 
precursors with the mitochondrial surface, and the completion of translocation into the 
organelle. Even protein import which does not require a membrane potential is usually 
dependent on NTPs.
1.1.6.6 Molecular basis of mitochondrial import
In recent years, the highly developed state of classical and molecular genetics in 
yeast has provided the foundation for analysing the molecular aspects of mitochondrial 
import. Gene fusion studies have demonstrated that the information required to direct a 
precursor to the mitochondrion is contained within its primary sequence (Douglas et al., 
1984; Hase et al., 1984). This was established by observing that gene constructs 
encoding a mitochondrial amino terminus could import hybrid polypeptides containing 
a non-mitochondrial protein at the carboxyl terminus. Hurt et al. (1985) extended these 
studies to demonstrate that, in one specific case, the first twelve amino acids were 
sufficient to direct import to the correct mitochondrial compartment. This dodecapeptide 
retained the properties of the complete cleavable presequence in being hydrophilic, rich 
in basic and hydroxylated amino acids and devoid of acidic residues.
Based upon such elegant gene fusion studies, various models have been 
proposed for the targeting and intramitochondrial sorting of imported proteins (Roise et 
al., 1986; Hurt and van Loon, 1986). The common theme running through these
models is of mitochondrial presequences which can form amphiphilic a-helices, 
enabling them to interact directly with energised mitochondrial membranes. The 
ultimate intramitochondrial location of each precursor is determined by the
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matrix-targeting sequence (as described above) and the presence or absence of a
j
stop-transport domain (long interrupted sequence of uncharged amino acids followed 
by charged residues). If such a stop-transfer sequence is present, protein transport 
across the outer or inner membrane is prevented and the precursor molecule becomes an 
outer membrane, inner membrane or intermembrane space protein, depending on the 
disposition of the stop-transfer signal. The absence of such a domain results in the 
protein being targeted to the matrix. Cleavage sites exist for the proteolytic removal of 
presequences.
1.1.6.7 Assembly of imported proteins
The final stage of the import pathway remains the least understood, i.e. the 
assembly of these proteins into oligomeric complexes. The utilisation of genetic 
techniques in yeast as well as other organisms however, has led to a greater 
understanding of this process. A family of stress proteins or heat shock proteins (hsps) 
has been identified and found to be involved in several steps of mitochondrial protein 
import. These hsps have been classified according to similarities in their primary 
structure (For review, see Lindquist and Craig, 1988). The largest hsp family is 
composed of proteins of Mr values -70,000. Cytosolic hsp70s, termed Ssa l-4p in 
yeast (Wemer-Washbume et al., 1987), stimulate translocation of precursor proteins 
into mitochondria and, in some cases, the endoplasmic reticulum (ER), suggesting they 
are involved in conferring transport-competence to precursors. However, a 
mitochondrial hsp70 (Ssc lp) has also been identified in yeast (Kang et al., 1990). 
Located in the matrix, this hsp70 is involved in both translocation of precursors across 
the mitochondrial membranes and folding of imported proteins in the matrix. The
60,000-Mr family of hsps ('chaperonins') also includes a mitochondrial protein factor 
in yeast (Cheng et al.> 1989). Mitochondrial hsp60 is localised in the matrix as a high 
molecular weight complex, and is required for the assembly into oligomeric complexes 
of proteins imported into the matrix. Mitochondrial hsp60 is thought to function as an 
ATP-dependent 'foldase'.
The further application of genetic techniques, particularly in yeast, will fully 
clarify the functions of these hsps, and ultimately elucidate much of the remaining 
mystery of mitochondrial biogenesis.
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1.1.7 Review of mitochondrial research
This introductory section (Section 1.1) illustrates the major advances in 
mitochondrial research over the last thirty years. Initially, mitochondria were thought to 
be self-contained organelles 'fed* by small molecules from the cytoplasm. This classical 
model originated from studies which demonstrated the ability of mitochondria to carry 
out all their major functions in the absence of cytoplasmic proteins and co-factors 
(Hogeboom et al., 1948).
The discovery that mitochondria contain their own genome (Section 1.1.5) 
further supported this idea of autonomy, which was first disputed by Wildman et al. 
(1962) with the observation that these organelles are continually breaking up and fusing 
with each other. More recent observations, including the discovery that the 
overwhelming majority of mitochondrial proteins are nuclear-encoded, suggest that 
mitochondria interact extensively with other structures. Birkby (1978) noted the high 
level of genetic recombination between mitochondrial genome populations in yeast cells 
during somatic growth; Adams (1982) demonstrated that mitochondria exhibit saltatory 
motion; while Ball and Singer (1982) suggested that these organelles are tethered to the 
cytoskeleton, with this association dictating their movement. Previously it was believed 
that mitochondria were static organelles or moved via random diffusion.
Increasingly, a view of the eukaryotic cell is emerging in which mitochondria 
interact structurally, functionally and biosynthetically with other cellular components 
(Figure 1.1.5). This agrees with the endosymbiotic hypothesis of mitochondrial 
evolution, a phenomenon further supported by the ability of these organelles to transfer 
DNA to the host nucleus (see Section 1.1.5). This hypothesis receives further support 
from the hsp60 ’chaperonin' class of protein factors. Structurally related hsp60s have 
been located in organelles of endosymbiotic origin (chloroplasts: Barraclough and Ellis, 
1980; Ellis and van der Vies, 1988, mitochondria: see Section 1.1.6) and also in the 
bacterial cytosol (Georgopoulos et al., 1973; Sternberg, 1973).
Interactions between mitochondria and the nucleus are not limited to the 
occasional exchange of genetic material. Mitochondrial biogenesis requires a 
continuously operating regulatory system between the two organelles. Knowledge of 
this system is still lacking and it represents a major area of future mitochondrial 
research. In addition to this, the further-application of genetic techniques in the highly
Figure 1.1.5: Interactions between mitochondria and other subcellular 
structures
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developed yeast system should answer the remaining questions regarding hsp function 
and mitochondrial biogenesis (see Section 1.1.6.7).
1.2 THE ADENINE NUCLEOTIDE AND PHOSPHATE 
TRANSPORT SYSTEMS
1.2.1 Introduction
In the aerobic cells of eukaryotic organisms, ATP is synthesised via two distinct 
routes, with some being generated via substrate-level phosphorylation reactions which 
occur predominantly in the cytoplasm. However, the vast majority of ATP is 
synthesised in mitochondria during oxidative phosphorylation. Once synthesised, 
mitochondrial ATP must be transported into the cytoplasm to be used in the many 
endergonic reactions of cellular metabolism, generating ADP, AMP and Pj.
Conversely, ADP and Pj require to be transported into the mitochondria for ATP 
synthesis. Thus two mitochondrial transport systems are required which must be 
directly linked to ATP synthesis: specifically those for adenine nucleotides (ADP, ATP) 
and inorganic phosphate (Pj).
The transport of ADP and ATP is catered for by the adenine nucleotide 
translocase (ANT), the existence of which was first proposed by Klingenberg and Pfaff 
(1966). Subsequently, the carrier was defined by the binding of its substrates, ADP 
and ATP, and the highly specific inhibitors, atractyloside (ATR), carboxyatractyloside 
(CAT) and bongkrekic acid (BKA; Klingenberg et al., 1970; Klingenberg et al., 1971; 
Vignais et al., 1973; Klingenberg et al., 1975).
As a consequence of the work of Chappell and Crofts (1965) and Fonyo (1966) 
on phosphate efflux and its inhibition by thiol group reagents, respectively, it is now 
well established that two systems exist in the inner mitochondrial membrane for Pj 
influx:-
' 1) an electroneutral Pj/dicarboxylate antiporter which is principally involved in the 
exchange of substrates between the matrix and cytoplasm (McGivan and Klingenberg, 
1971; Palmieri etal., 1971).
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2) an electroneutral Pi/H+ symporter or Pi/OH" antiporter (For review, see Wohlrab,
1986) which catalyses the influx of 90% of mitochondrial Pj (Coty and Pedersen, 
1975b). This carrier is now commonly referred to as the phosphate transport protein 
(PTP).
The latter system is dependent on the transmembranous pH gradient (see 
Section 1.1.3) and is inhibited by sulphydryl group reagents such as NEM, mersalyl 
andpCMB (Fonyo andBessman, 1968; Tyler, 1969; Coty and Pedersen, 1974,1975a; 
Wohlrab and Flowers, 1982). The Pi/dicarboxylate carrier is insensitive to NEM but is 
inhibited by mersalyl, pCMB or substrate analogues such as n-butyl malonate or 
2-phenylsuccinate (Meyer and Tager, 1969; Meijer et al., 1970; Coty and Pedersen, 
1974).
1.2.2 Importance of adenine nucleotide and phosphate transport in cell physiology
The importance of adenine nucleotide and phosphate transport in cell 
physiology is evident from the various regulatory processes to which they are linked. 
Consequently, ANT and the major phosphate carrier, PTP are assigned as primary 
exchange carriers of the inner mitochondrial membrane
1) they are responsible for maintaining a continuous supply of substrates (ADP and Pj) 
for oxidative phosphorylation in the mitochondrial matrix-inner membrane 
compartment;
2) they are directly linked to the proton motive force generated across the membrane 
during electron transport (see Section 1.2.3);
3) their operation permits the functioning of secondary and tertiary exchange carriers of 
the inner membrane. PTP allows flux of dicarboxylic and tricarboxylic acids via the 
Pi/dicarboxylate (secondary) and dicarboxylate/tricarboxylate (tertiary) exchange 
carriers, thus controlling the distribution of a certain number of Krebs cycle 
intermediates.
1.2.3 Role of ANT and PTP in oxidative phosphorylation
Both ANT and PTP are intimately involved in oxidative phosphorylation (see 
Figure 1.2.1). As well as controlling the influx of ADP and Pj for ATP synthesis, they
Figure 1.2.1: The role of ANT and PTP in oxidative phosphorylation
The diagram summarises the current standing of the Chemiosmotic Hypothesis. 
Four H+ ions are illustrated being pumped out of the matrix at each proton-translocating 
complex although the exact number is the matter of some debate (see Section 1.2.3). 
However, only three protons are required to shuttle back into the matrix for the 
production of an ATP molecule. The resultant discrepancy in the electrochemical 
potential is corrected by the electrogenic ANT, while the extra proton is accounted for 
by the electroneutral PTP. ANT is thus driven by the membrane potential and PTP by 
the pH gradient.
Figure 1.2.1: The role of ANT and PTP in oxidative phosphorylation
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are directly linked to the membrane potential and pH gradient components of the proton 
motive force, respectively.
The current standing of Mitchell's (1961) Chemiosmotic Hypothesis is the 
subject of much debate, and it now appears that the number of protons pumped out of 
the matrix varies for each of the proton-translocating complexes (NADH-Q reductase, 
QH2-cytochrome c reductase and cytochrome c oxidase). Nevertheless, the apparent 
average is 3-4 protons per complex for each molecule of H2O produced. However, 
only three protons are required to shuttle back into the matrix through the F^QATPase 
for the synthesis of one ATP molecule. This causes a discrepancy in both the 
electrochemical potential and the pH gradient. The charge discrepancy is corrected by 
the electrogenic ANT, which exchanges ADP3- for ATP4-, while the extra proton is 
accounted for by the electroneutral PTP (see Figure 1.2.1). ANT is thus driven by the 
membrane potential component of the proton motive force while PTP is driven by the 
pH gradient. The net effect (on the proton motive force) of PTP behaving as a Pj/OH" 
antiporter rather than a Pi/H+ symporter (as shown in Figure 1.2.1) is nil.
1.2.4 Identification and purification of ANT
The earliest evidence for the existence of an adenine nucleotide carrier in the 
inner mitochondrial membrane came from the observation that ADP/ATP transport 
through this membrane was specific (Klingenberg and Pfaff, 1966). As described 
earlier (Section 1.2.1), the carrier was subsequently defined by the binding of its 
substrates, ADP and ATP, and its inhibition by highly specific ligands (ATR, CAT and 
BKA).
The availability of the specific inhibitor, CAT, subsequently shown to be the 
most effective ligand for stabilising the carrier (Aquila et al., 1978), in the 
35S-radiolabelled form has proved to be the key to identifying and purifying the 
translocase. The procedure commonly applied for the isolation of a membrane protein 
consists of solubilisation with a suitable detergent and subsequent identification by its 
capacity to bind specific ligands added to the crude mixture of solubilised proteins. 
Initially however, the identification of ANT by 35S- CAT binding was unsuccessful 
since no specific binding of CAT was found after solubilisation of the membranes with
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a variety of detergents. A breakthrough was achieved by loading the carrier with CAT 
in the parent mitochondria prior to extraction (Klingenberg et al., 1974). It was then 
found that the CAT-protein complex could be solubilised with a variety of detergents 
(Riccio et al., 1975a) and subsequently purified by applying standard fractionation 
procedures (Riccio et al., 1975b).
Various detergents, both ionic and non-ionic, were used to solubilise 
mitochondria pre-loaded with 35S-CAT; with the release of protein, free 35S-CAT and 
protein-bound35S-CAT being assessed (Riccio eta l., 1975a). Detergents were applied 
in amounts giving near maximum solubilisation of total protein. Although ionic 
detergents were quite effective in solubilising CAT, it was found that the released 
ligand was in a free form, unbound to protein. Among the non-ionic detergents of the 
poly-glycol group, only Triton X-100 was found to be effective. However, Triton 
X-100 was unique among all the detergents tested, being the only case where the 
solubilised CAT remained largely bound to protein. In contrast, the ionic detergents 
appeared to denature the CAT-inhibited carrier. Riccio et al. (1975a) also determined 
that solubilisation of the CAT-ANT complex was enhanced by the presence of salt, the 
optimum conditions being 4% (w/v) Triton X-100,0.5M NaCl (or KC1). Furthermore, 
it was established that the CAT-binding protein could be enriched in the mitochondrial 
membrane by extracting the more soluble proteins with 4% (w/v) cholate, 0.1M 
(NH4)2SC>4 or 0.5% (w/v) Triton X-100, 0.4M NaCl (Riccio et al., 1975a).
The solubilisation of the CAT-complexed ANT from mitochondria facilitated the 
purification of this protein to apparent homogeneity, by standard fractionation 
techniques (Riccio et al., 1975b). The Triton X-100 mitochondrial extract was directly 
applied to a hydroxylapatite (HTP) column and eluted with 0.5% (w/v) Triton X-100, 
0.1M NaCl.The major 35S-CAT containing fractions were pooled and tested
electrophoretically. A single polypeptide of estimated Mr value 29,000 was detected
and tentatively identified as the ADP/ATP carrier. Riccio et al. (1975b) also carried out 
a preliminary characterisation of the isolated protein, involving the displacement of 
CAT by ADP or ATP. Subsequently, the transporter has been further characterised by 
reconstitution studies in artificial liposomes (Schertzer and Racker, 1976; Schertzer et 
al., 1977; Kramer et al., 1977; Kramer and Klingenberg, 1977a,b). The subunit Mr
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value of mammalian ANT is approx. 30,000 according to SDS-PAGE, although the 
carrier may exist as a homodimer in its functional state (Kramer and Klingenberg,
1979).
The purification scheme for ANT has remained essentially the same since the 
pioneering work by Klingenberg’s group (Klingenberg et al., 1974; Riccio et al.,
1975a; Riccio et al., 1975b). However, it has been found that the critical purification 
step, adsorption chromatography with HTP, can be performed more quickly and 
efficiently by adopting a batch procedure rather than running a column (Kramer et al., 
1977). Kramer et al. (1977) also report that the carrier can be isolated in an unliganded 
form by replacing Triton X-100 with 3-lauramido-A//-dimethylpropylamine iV-oxide 
(LAPAO), as the extracting detergent. The same group have subsequently claimed that 
unliganded ANT can also be purified in Triton X-100 by application to HTP prepared 
in their own laboratory, rather than material obtained commercially (Kramer and 
Klingenberg, 1979).
1.2.5 Identification and purification of PTP
On the basis of the observations noted in Section 1.2.1, any protein which is 
responsible for the majority of mitochondrial phosphate transport must have an affinity 
for its substrate, Pj; it must react with sulphydryl group reagents which inhibit 
transport; and it must be capable of catalysing phosphate transport when incorporated 
into artificial liposomes in the correct orientation. PTP purification has however, been 
hindered by the lack of a specific inhibitor as exists for ANT (CAT, ATR and BKA).
An affinity for Pj was first observed in chloroform extracts from rat liver 
mitochondria (Kadenbach and Hadvary, 1973). These extracts were also found to 
contain proteins with free sulphydryl groups, with a reduced affinity for Pj being noted 
upon the addition of sulphydryl group reagents. Similarly, a 10,000-Mr 
cardiolipin-associated proteolipid isolated from yeast was found to contain sulphydryl 
groups and exhibit an affinity for [32P]Pj (Guerin and Napias, 1978). However, 
subsequent studies have failed to identify a protein of Mr value 8-10,000 involved in 
phosphate transport.
Coty and Pedersen (1975a) found that if phosphate transport in rat liver
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mitochondria was inhibited by the addition of limiting amounts of [3H]NEM, at least 10 
different radiolabelled polypeptides could be detected by SDS-PAGE, demonstrating 
the non-specific manner by which NEM reacts with proteins of the inner mitochondrial 
membrane. In the same study, Coty and Pedersen (1975a) developed an elegant 
procedure for labelling the sulphydryl groups involved in phosphate transport more 
specifically, the basis for which was their observation that mercurial compounds inhibit 
PTP in a specific and reversible manner. The phosphate transport system (PTS) was 
initially protected by inhibition with the mercurial mersalyl, with all free sulphydryl 
groups not involved in transport then being blocked by the addition of 
non-radiolabelled NEM. Mersalyl inhibition of PTP was reversed by treatment with 
DTT, restoring about 65-75% of original carrier activity. When phosphate transport 
was then inhibited by [3HJNEM, a marked increase in specificity was observed, with 
only five polypeptides in the Mr range 30-32,000 being modified. These prominent 
NEM-modified bands were subsequently localised in the inner membrane of 
mitochondria from various sources (Briand et al., 1976; Hadvary and Kadenbach,
1976; Touraille et al., 1977; Wohlrab and Greaney, 1978; Wohlrab, 1980). Coty and 
Pedersen (1975a) also established that mitochondrial phosphate transport is controlled
by the transmembranous pH gradient, by demonstrating that uptake of [32P]Pj was
strongly stimulated by the ionophore, valinomycin.
PTP was further characterised by studies on the flight muscle of the adult 
blowfly, Sacrophaga bullata, a membrane system well suited to such studies as it is 
highly specialised, containing only the NEM-sensitive transporter and not the 
Pj/dicarboxylate carrier. Only two protein bands of Mr values 32,000 and 45,000 were 
labelled by [3H]NEM in this membrane system (Wohlrab and Greaney, 1978). Since 
no equivalent to the 45,000-Mr band was detected in rat liver mitochondria (Coty and 
Pedersen, 1975a), Wohlrab and Greaney (1978) suggested the 32,000-Mr polypeptide 
as the most likely NEM-binding component of the PTS. Further studies by Wohlrab 
(1980) confirmed this result by identifying an NEM-sensitive 32,000-Mr polypeptide, 
via high resolution SDS-PAGE, in blowfly flight muscle and rat heart submitochondrial 
particles (SMP) as the strongest candidate for PTP.
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F IP  has since been isolated from bovine and pig heart mitochondria and 
reconstituted into artificial liposomes (Kolbe et al., 1981; Touraille et al., 1981). 
Purification involves the solubilisation of isolated mitochondria with the detergent 
Triton X-100 in a phosphate-containing buffer, followed by adsorption 
chromatography with HTP. The protein was identified by conventional SDS-PAGE 
analysis as a single band, Mr value 34,000, which could be labelled with [3H]NEM 
(Wohlrab, 1980; Kolbe e ta i ,  1981; Touraille et al., 1981). Wohlrab (1980) and 
Wohlrab and Flowers (1982) reported co-purification of unliganded ANT in their P IP  
preparations. This can be removed by a further fractionation step, adsorption 
chromatography with Celite (Kolbe et al., 1981) or mersalyl-ultrogel (Touraille et al.,
1981).
One of the main criteria to be fulfilled by a purified component of the PTS is 
that it should catalyse a Pj-Pj exchange when reconstituted into artificial liposomes. The
34,000-Mr polypeptide, as isolated by Kolbe et al. (1981) and Touraille et al. (1981), 
could maintain only 2% of the activity achieved in isolated mitochondria by Coty and 
Pedersen (1975b). This exchange was however, found to be sensitive to NEM and 
mercurials but insensitive to the ANT inhibitors, CAT and n -butyl malonate. 
Nevertheless, these low levels of phosphate exchange observed in vitro may indicate 
that P IP  as isolated merely represents the NEM-sensitive, transmembrane component 
of a more complex PTS as exists in bacteria.
Kolbe et al. (1984) attempted to further characterise PTP by employing a large 
scale purification scheme from bovine heart. After silver-staining of the 
SDS-polyacrylamide gel, two bands were identified in the ratio 1:1, and assigned as the
putative a  and P subunits of PTP. However, peptide maps of the two subunits are 
essentially identical following fragmentation with either CNBr or HCl/dimethyl 
sulphoxide/HBr. In addition to this, carboxymethylation of the sample prior to 
SDS-PAGE resulted in the detection of only a single band (Mr 34,000), suggesting that 
apparent subunit heterogeneity is caused by the formation of transient disulphide bonds 
during electrophoresis (Kolbe and Wohlrab, 1985). More recently, Gibb et al. (1986) 
reported an improved scheme for the purification of PTP from rat liver mitochondria,
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involving a modification of the method of Kolbe et al. (1981). SDS-PAGE revealed a 
single polypeptide, subunit Mr 34,000, after adsorption chromatography on Celite, in 
general agreement with the value quoted from other mammalian sources (Wohlrab, 
1980; Kolbe et al., 1981; Touraille et al., 1981). Gibb et al. (1986) also reported a 
method for characterising the carrier using an antiserum raised against the 34,000-Mr 
protein. Specific partial inhibition of phosphate uptake, as measured by iso-osmotic 
swelling in the presence of (NH^HPC^, was achieved when mitoplasts (mitochondria 
minus outer membrane) were incubated with this antiserum.
1.2.6 Relationship of cardiolipin to PTP activity
Bisaccia and Palmieri (1984) have obtained evidence that cardiolipin can be 
used to improve the purification of PTP to such an extent that only one major protein 
band is detectable by gradient SDS-PAGE. Previous studies have demonstrated that 
both total protein purified and reconstituted transport activity can be significantly 
increased by the inclusion of cardiolipin in the solubilisation buffer (Kadenbach et al., 
1982; Mende et al., 1982). The specific effect of cardiolipin was corroborated by 
results showing a reversal of enhanced PTP activity in the presence of doxorubcin, 
which forms a specific complex with this lipid (Cheneval et al., 1983). This apparent 
affinity for cardiolipin strongly supports the idea of a specific interaction of the carrier 
protein with this lipid which, in reconstitution studies, may maintain PTP in its native 
conformation. This specific effect has not been observed with any other phospholipids 
tested.
1.2.7 Further characterisation of ANT and PTP: structural and functional studies on the 
carriers
Attempts to further understand the modes of action of the primary mitochondrial 
exchange carriers, ANT and PTP, have concentrated on elucidating their 
transmembrane arrangements and identifying their substrate-binding sites. Such studies 
have concentrated principally on the ADP/ATP carrier, the first of the two to be 
successfully purified, which has the added advantage of being susceptible to a range of 
highly specific inhibitors, ATR, CAT and BKA (see Section 1.2.4).
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A greater understanding of how ANT functions at the molecular level has come 
from reconstitution studies with the purified bovine heart carrier (Schertzer and Racker, 
1976; Schertzer et al., 1977; Kramer et al., 1977; Kramer and Klingenberg, 1977a,b; 
Kramer and Klingenberg, 1979). In particular, the ability of Klingenberg's group to 
purify ANT in both the liganded and unliganded forms (Kramer et al., 1977; Kramer 
and Klingenberg, 1979) has facilitated characterisation of the carrier. After addition of 
unliganded ANT to lecithin liposomes, ADP/ATP exchange is activated by sonication. 
By then correlating CAT (or ATR) and BKA binding with adenine nucleotide transport, 
three populations of the inserted protein were identified (see Figure 1.2.2):-
1) a portion (up to 5%) with high exchange activity, comparable to the original 
transport rates, was differentiated. This class of the protein is inhibited by both CAT 
(or ATR) and BKA. Separate binding studies with these ligands indicate that this 
portion is orientated in the same direction as in mitochondria;
2) a population of very weakly exchanging, though still active, carrier molecules (about 
25%), which are inhibited only by BKA and not by CAT (or ATR), was differentiated. 
This portion of transporters appears to be orientated in the opposite direction as in 
mitochondria and reaches only about 0.2% of the activity of the carrier in the first 
population;
3) the remainder of the carrier protein (about 70%) was irreversibly denatured during 
isolation and reconstitution.
Separate binding studies demonstrated that CAT and ATR are unable to permeate the 
mitochondria, and bind exclusively to the cytosolic surface of the inner membrane 
(Klingenberg et al., 1973). In contrast, BKA is a permeant ligand capable of binding to 
the matrix side of the membrane. In addition to this, these ligands appear to 
demonstrate half-site reactivity ie. one molecule of ATR, CAT or BKA binds to two 
ANT subunits. This data justifies the interpretations explained above and illustrated in 
Figure 1.2.2. It thus appears possible that native ANT exists as a homodimer, as 
previously suspected, with matrix ('m') and cytosolic ('c') binding sites. CAT and 
ATR bind at the ’c' site, which is also the location of ADP binding, whereas BKA 
binds at the'm ' site.
These results also support Klingenberg’s (1976) ’gated pore' model for 
membrane carriers (see Figure 1.2.3) which proposes that a single channel is formed
Figure 1.2.2: Binding and exchange properties of three reconstituted ANT populations 
in liposomes
The carrier protein in its functional state is shown as a dimer with the Tc' 
(cytosolic) or'm ' (matrix) binding site exposed to the external ('e') or internal ('i') side 
of the liposomal membrane. The diagram is adapted from Kramer and Klingenberg 
(1979). For further details see Section 1.2.7.
Figure 1.2.2: Binding and exchange properties of three reconstituted 
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Figure 1.2.3: 'Gated Pore1 model of transmembrane carriers
The carrier is shown as a dimer with a central channel in the 'm-state' or 
'c-state'. Substrate-binding (as shown) induces the conformational change necessary 
for translocation (Adapted from Klingenberg, 1976).
Figure 1.2.3: 'Gated Pore1 model of transmemhrane carriers
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from the two subunits, with the carrier capable of existing in either an 'm-state' or 
'c-state'. Binding of the substrate induces a conformational change which opens the 
channel gate to facilitate translocation. The gate can only open to one side of the 
membrane at a time (Klingenberg, 1981). Further studies with CAT, BKA and the 
sulphydryl group reagent NEM appear to offer further support to this model of ANT 
function. NEM binding to ANT in the presence of ADP is inhibited by CAT but not 
BKA (Aquila et al., 1982a). The BKA-ANT complex incorporates about one molecule 
of NEM per subunit more than the CAT-ANT complex. It was concluded that the single 
reactive sulphydryl group is masked in the 'c-state', but unmasked due to re-orientation 
as the 'm-state' is formed upon the addition of ADP. CAT, which binds at the cytosolic 
side of the carrier, inhibits NEM binding by stabilising ANT in the 'c-state'. In 
contrast, BKA binds at the matrix side of the carrier and stabilises ANT in the 
'm-state'.
With the primary structure of bovine ANT being elucidated (Aquila et al., 
1982b), attempts have been made to characterise the exact binding sites of the various 
ligands. Boulay et al. (1983) positioned the CAT/ATR binding site in the centre of the 
molecule between Cys159 and Met200. More recently, photolabelling work by Dalbon et 
al. (1988) using non-permeant derivatives of ADP, in conjunction with Boulay's data, 
indicated that the region Phe153-Met200 represents the common binding centre for 
CAT/ATR and ADP, with Tyr^O-Met281 also being involved.
Bogner et al. (1986) used the lysine reagent pyridoxal 5-phosphate to 
investigate the transmembrane arrangement of the ADP/ATP carrier. The high 
proportion of lysines present in the bovine ANT sequence meant that this residue could
be used to probe the folding, sidedness and distribution of the amino acid chain with 
respect to the membrane. Furthermore, lysine groups were expected to participate in the 
cationic binding areas for the negatively charged substrates, ADP and ATP and for the 
inhibitors, ATR, CAT and BKA. Several lysines possibly involved in the translocation 
pathway were identified (Lys22, Lys42, Lys48, Lys106, Lys162), and a transmembrane 
folding model for the carrier was presented (see Section 1.2.9).
Further characterisation of PTP has proved more difficult owing to the lack of 
equivalent specific inhibitors to this carrier and the low level of phosphate exchange
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observed in reconstitution studies. However, Tommasino et al. (1987) attempted to 
identify the substrate-binding site of PTP by utilising the photoreactive phosphate 
analogue, 4-azido-2-nitrophenyl phosphate (ANPP). They successfully demonstrated 
that [32P] ANPP competitively inhibits phosphate transport in the dark, and that upon 
photoirradiation the probe irreversibly binds to the carrier. Inhibition is dependent on 
both the pH of the medium and the concentration of the probe. ANPP thus appears to 
be a suitable reagent for characterising the phosphate-binding site of PTP, assuming it 
is possible to localise the modified amino acids in the primary structure of the carrier.
Another possible probe which may prove useful in the characterisation of the 
PTP substrate-binding site is A^V'-dicyclohexylcarbodiimide (DCCD), a reagent which 
inhibits proton-translocating carrier proteins by covalently binding to residues in their 
pores (Beechey et al., 1967). Previously, Houstek et al. (1981) proposed that the 
mitochondrial DCCD-reactive 33,000-Mr protein is identical with PTP. However, 
subsequent studies have indicated that this protein may represent porin (De Pinto et al., 
1985).
Topographical studies have been used to elucidate the membrane organisation of 
PTP. Phelps (1987) demonstrated that the bovine carrier's membrane orientation 
rendered it essentially resistant to proteolysis, indicating that no part of PTP is exposed 
on the membrane surface. However, the non-specific protease, proteinase K cleaves the 
carrier into two segments with Mr values 11,000 and 23,000. The potential thus exists 
for further topographical studies involving the analysis of these proteolytic products by 
immune precipitation and N-terminal sequencing, since the primary structure of bovine 
PTP is now known (Runswick et al., 1987).
From the above, it is apparent that the further characterisation of ANT and PTP 
has been facilitated in recent years by the elucidation of their primary structures from 
both amino acid sequencing and nucleotide sequencing of cDNA clones encoding the 
proteins. The complete amino acid sequence of bovine heart ANT was described by 
Aquila et al. (1982b) after liquid-phase sequencing of tryptic peptides. Subsequently, 
the primary structure of ANT from three other sources, Neurospora crassa (Arends 
and Sebald, 1984), Saccharomyces cerevisiae (Adrian et al., 1986) and Zea mays 
(Baker and Leaver, 1985), has been established by cDNA sequencing. In the case of
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PTP, the first information on primary structure came from Kolbe and Wohlrab (1985) 
who purified and sequenced a 47-residue N-terminal formic acid fragment of the bovine 
heart carrier, identifying the NEM-binding site as Cys42 (see Section 1.2.8). 
Subsequently, Aquila et al. (1987) elucidated the full primary structure of bovine PTP, 
bar 28 residues, by sequencing chemically-cleaved peptides. More recently, the amino 
acid sequence of PTP from three sources, bovine heart (Runswick et al., 1987), rat 
liver (Ferreira et al., 1989) and S.cerevisiae (Phelps et al., 1991), has been established 
from isolated cDNA clones. The implications of this primary structural information will 
be discussed in Section 1.2.9.
1.2.8 Relative location of sulphvdrvl groups of ANT and PTP
An important feature of ANT and PTP in mammalian mitochondria is that both 
are sulphydryl-containing proteins with one or more of these sulphydryl groups being 
required for function. The inhibition of PTP by sulphydryl group reagents is well 
established and led to the purification of the carrier (see Section 1.2.5). Phosphate 
transport is inhibited by both permeable inhibitors (NEM and mersalyl) and the inner 
membrane-impermeable sulphydryl group reagent, eosin-5-maleimide (EMA; Houstek 
and Pedersen, 1985), suggesting that the reactive cysteine residue is located on or near 
the cytosolic side of the inner mitochondrial membrane. As previously discussed,
Kolbe and Wohlrab (1985) identified the sole NEM-reactive residue as Cys42, after 
isolating and sequencing a 47-residue N-terminal formic acid fragment of bovine PTP 
(see Section 1.2.7).
The ADP/ATP carrier was originally thought to be insensitive to 
sulphydryl-reactive reagents. However, sensitivity can be demonstrated if mitochondria 
are preincubated with a low concentration of either ADP or ATP. Under these 
conditions, the sulphydryl groups are unmasked and become reactive towards NEM 
(see Section 1.2.7). Houstek and Pedersen (1985) found that in intact mammalian 
mitochondria, the impermeable probe EMA is unreactive with ANT, even under 
conditions which promote maximal labelling by NEM {i.e. ADP present). However, 
EMA labels ANT in 'inverted' inner membrane vesicles, even in the presence of NEM. 
Labelling is prevented if the vesicles are prepared from mitochondria pretreated with 
CAT. It was interpreted from this data that, with respect to EMA, sulphydryl groups of
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the ADP/ATP carrier occur in two distinct classes, both of which are inaccessible in 
intact mitochondria. Only one class, depending on conditions, can be exposed in SMP. 
Houstek and Pedersen (1985) propose that EMA and NEM label different sulphydryl 
groups of ANT. The single NEM-alkylated residue has been identified as Cys56 by 
chemical and enzymatic cleavage techniques (Boulay and Vignais, 1984), but the 
functional role, if any, of the other three sulphydryl groups (Cys129, Cys159, Cys256) 
is unknown.
1.2.9 ANT and PTP: prominent members of a family of structurally related 
mitochondrial exchange systems
As previously discussed, the primary structures of the mitochondrial adenine 
nucleotide and phosphate carriers have been elucidated from various sources (see 
Section 1.2.7). In addition to this, the amino acid sequence of a third solute carrier 
involved in energy transfer has been elucidated: the uncoupling protein (UCP) of 
brown fat mitochondria (Aquila et al., 1985). UCP has a function which is somewhat 
contrary to that of the other two carriers (ANT and PTP), as it dissipates oxidative 
energy into heat It functions as an H+ carrier and short-circuits the proton motive force 
generated by electron transport, thus bypassing ATP generation (For review, see 
Nicholls and Locke, 1984). Like ANT, UCP has an adenine nucleotide-binding site, 
but whereas ADP and ATP activate transport by ANT, they inhibit proton translocation 
by UCP. The uncoupling protein is a highly specialised carrier found only in brown 
adipose tissue, which is potentially present in all mammalian organisms (Locke et al., 
1982).
Analysis of the sequences of these three mitochondrial carriers has led to the 
belief that they form a structurally related protein family with a common evolutionary 
origin (Aquila et al., 1987). The elucidation of primary structures has also highlighted 
various similarities and differences between the carriers:-
1) they all contain 300-350 amino acids, with subunit Mr values 30-35,000, although it 
is possible that they exist functionally as homodimers, as previously described for ANT 
(see Section 1.2.8);
2) although all three carriers are nuclear-encoded and synthesised on cytoplasmic
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ribosomes (Hackenberg et al., 1978), there appear to be differences with respect to 
their modes of insertion into the inner mitochondrial membrane. cDNA sequencing of 
ANT from various sources indicates that the precursor form of this carrier does not 
contain a cleavable presequence (Arends and Sebald, 1984; Adrian et al., 1986), 
supporting the view that the information required to target ANT to the mitochondria is 
contained within its primary structure (see Section 1.1.6.2). This also appears to be the 
case for UCP (Freeman et al., 1983). However, the nucleotide sequences of cDNA 
clones encoding PTP from bovine heart (Runswick et al., 1987) and rat liver (Ferreira
et al., 1989) indicate that this protein is synthesised as a higher-Mr precursor with an
N-terminal signal sequence. More recently, Phelps et al. (1991) have cloned and 
sequenced the gene encoding PTP in S.cerevisiae. In contrast to the mammalian carrier, 
no presequence has been detected. Therefore, although these three carriers form a 
family of mitochondrial exchange systems, they appear to differ in their modes of 
biosynthesis;
3) these proteins are very highly conserved over long evolutionary distances. This is 
particularly true for ANT, which has been sequenced from four sources (bovine, 
N.crassa, S.cerevisiae, Z.mays; see Section 1.2.7). In the case of PTP, 116 amino 
acids are conserved between the yeast and bovine proteins (Phelps et al., 1991).
The most striking feature noted about these three carriers upon analysis of their 
amino acid sequences is the high degree of structural homology which exists between 
them (Runswick et al., 1987; Aquila et al., 1987). They all contain a three-fold repeated 
sequence element 100-125 amino acids in length, with the repeats in each of the three 
proteins related to each other (tripartite structure). This implies that the carriers have 
related three-dimensional structures and mechanisms of action. In order to investigate 
the secondary structure and transmembrane folding of the proteins, the average 
hydrophobicity distribution (Kyte and Doolittle, 1982) of ANT and UCP has been 
analysed (Aquila et al., 1985; Aquila et al., 1987). For ANT, only one transmembrane
a-helix was initially detected, whereas three such domains could be visualised in UCP.
However, both proteins contain about 41% a-helical structure according to circular 
dichroism (CD) measurements (Aquila, unpublished data). Also, the fact that these
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carriers are integral membrane proteins strongly suggests that the number of
transmembrane a-helices must be considerably greater. Subsequently, further analysis 
of sided hydropathy profiles allowed for the prediction of amphipathic helices in all 
three carriers (Aquila et al., 1987). In this manner, the similarity in the hydrophobicity 
distribution of the three carriers became obvious and, in particular, the tripartite 
structure of the proteins could be clearly detected.
Further hydropathy profiles, using the HYDROPLOT computer programme 
(Runswick et al., 1987), confirmed the tripartite structure and indicated that each
repeated sequence element consists of two membrane-spanning amphipathic a-helices 
linked by an extensive hydrophilic domain (see Figure 1.2.4). Some of the putative 
membrane-spanning domains are less hydrophobic than others, containing basic and 
acidic residues which are thought to be involved in pore formation. Alignment of the 
hydropathy plots with the primary structures of the carriers shows that the most highly
conserved residues are located in the proposed a-helical segments (I-VI; see Figure
1.2.4) and also in the regions of the hydrophilic domains (A,B and C) that connect
them to the a-helices. The central parts of domains A-C are poorly conserved, as are 
the N- and C-termini and the regions between the repeats. It is possible that these 
regions contribute to the specificities of the carriers.
Aquila et al. (1987) used their hydropathy profiles to suggest a topographical 
arrangement for UCP in the inner mitochondrial membrane, which they propose as a 
common carrier model for this family of proteins (see Figure 1.2.5). The 
transmembrane components of each repeat are visualised as consisting of two
a-helices,the first being more hydrophobic and exposed to the lipid bilayer, with the 
second being more amphipathic and involved in pore formation. The structure of the 
hydrophilic domains remains unknown, although protease resistance (see Section 
1.2.7) suggests that they may be involved in pore formation rather than being exposed
as shown in Figure 1.2.5. The presence of a transmembrane amphipathic (3-strand in 
these carriers was first suggested by Aquila et al. (1985) from hydrophobicity 
distribution studies on ANT, and subsequently proposed as a common feature. For
Figure 1.2.4: Hydropathy plots of UCP. ANT and PTP (Adapted from Runswick et 
a l, 1987)
A comparison is shown of the hydrophobic profiles of the mitochondrial 
carriers UCP (Uncoupler), ANT (ADP/ATP Translocase) and PTP (Phosphate carrier). 
The calculations were made using HYDROPLOT with a window of 11 amino acids. 
The horizontal bar represents an average hydrophobicity as defined by Kyte and 
Doolittle (1982); A, B and C are hydrophilic domains; and I-VI represent putative
membrane-spanning a-helices.
Hy
dr
op
ath
y 
In
de
x 
Hy
dr
op
ath
y 
In
de
x 
Hy
dr
op
ath
y 
In
de
x
Figure 1.2.4: Hydropathy plots of UCP, ANT and PTP
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Figure 1.2.5: Proposed arrangement of PTP in the inner membrane, as representation
for the family of mitochondrial carriers. The six membrane-spanning a-helices are 
shown as boxes and are labelled A-F starting from the N-terminus. A possible
transmembrane p-strand (dashed line) is shown between helices A and B. The 
intervening hydrophilic segments are indicated by hatched boxes as their structure is 
unclear.
(Adapted from Aquila et al., 1987)
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UCP, there is evidence that theC-terminus is situated on the cytosolic surface (Aquila, 
unpublished data) which agrees with an uneven number of membrane-spanning 
domains with the N-terminal on the matrix side. More recently, Ferreira et al. (1991) 
have used anti-peptide directed antibodies, raised against the C-terminal of rat liver 
PTP, to show that this part of the carrier is exposed on the cytosolic surface of the 
membrane. This offers further support to the concept of a 7th transmembrane domain.
However, the presence of P-strands is a rare phenomenon within transmembrane 
proteins and this aspect of the common carrier model requires further research.
Bogner et al. (1986) used the lysine reagent pyridoxal 5-phosphate to elucidate 
the transmembrane arrangement of ANT, by assessing which lysines were accessible 
and which were inaccessible in the presence or absence of CAT, ATR or BKA. As well 
as identifying several lysines possibly involved in the translocation pathway (see 
Section 1.2.7), a transmembrane folding model of ANT was presented, which agrees 
with the putative PTP structure described above and proposed as a common carrier 
model.
The elucidation of the primary structures of ANT, PTP and UCP has thus led to 
a greater understanding of the transmembrane arrangement of this family of 
mitochondrial exchange carriers as well as their modes of action at the molecular level. 
Nevertheless, the most striking observation upon comparison of the amino acid 
sequences is the occurrence of three repeats, and the recurrence of the tripartite structure 
in all three proteins. This observation is supported by hydrophobicity data, and 
suggests that each carrier is composed of three structurally similar domains with a 
common evolutionary origin. If the similarity of the repeats is based upon a true 
homology, it can be further speculated that other mitochondrial anion metabolite 
carriers, eg. the Pj/dicarboxylate carrier, are also derived from the same ancestral gene. 
Subsequent research has indeed indicated that further mitochondrial proteins contain the 
tripartite structure: the malate/2-oxoglutarate carrier and a yeast protein implicated in 
mitochondrial RNA splicing (Gargouri, 1988). Following the ancestral gene 
hypothesis, a hierarchical family of metabolite carriers can be derived, to which the 
primary mitochondrial transporters, ANT and PTP, belong. Furthermore, it is likely 
that PTP appeared first, and contained the single gene from which the other carriers
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evolved. This hypothesis stems from the fact that PTP, unlike ANT, UCP and other 
proposed members of the 'tripartite’ transporters family, is known to be present in 
prokaryotes. Further support has been provided by Pratt et al. (1991), who have clearly 
demonstrated that optimal import of rat liver mitochondrial PTP, unlike ANT and UCP, 
is dependent on the presequence absent from the other carriers. This indicates that the 
ancestral gene first appeared in PTP, and that subsequent evolutionary events leading to 
other mitochondrial carriers eliminated the presequence.
1.3 PYRUVATE DEHYDROGENASE COMPLEX
1.3.1 M ultienzvm e com plexes
Enzymes are biological catalysts which normally function sequentially, 
promoting consecutive chemical reactions linked by intermediate products. When a 
number of enzymes are associated to form a defined entity capable of catalysing a series 
of linked biochemical conversions, this is termed a multienzyme complex. Well 
characterised examples include: tryptophan synthase from E. coli (Yanofsky and 
Crawford, 1972); fatty acid synthase from both S.cerevisiae (Lynen, 1972) and 
mammalian sources (Stoops et al., 1978); and the 2-oxo acid dehydrogenase complexes 
present in all organisms studied to date (Reed, 1974; Perham, 1975). A full description 
of several multienzyme complexes can be found in reviews by Reed and Cox (1966) 
and, more recently, by Hardie and Coggins (1985).
Organisation into a multienzyme complex can provide a number of functional 
advantages including enhancement of catalytic or regulatory efficiency and substrate 
channelling (Perham, 1975). As a form of compartmentalisation, intermediates may be 
positioned on or within the complex in such a manner as to exclude competition by 
other biochemical pathways, or prevent decomposition in aqueous solution of unstable 
intermediates. Interaction of the component polypeptides, as in the case of tryptophan 
synthase, may produce aggregates with catalytic properties not present in the separate 
chains. Assembly of interrelated enzymes also makes it physically easier for the product 
of one enzyme to act as the substrate for the next in sequence. This can increase the 
efficiency of the overall process, although the intrinsic catalytic activity of each
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component may not be altered by the association.
The increased efficiency of a complex as compared to that of separate enzymes 
dispersed at random is most apparent when all intermediate products are strongly bound 
to the complex. In such a case, there is an increased probability of the intermediate 
products of one enzyme reacting with the next. Moreover, substrate can be channelled 
through a series of reactions to avoid competition with other enzymes for the 
intermediate products or to reduce sensitivity to inhibitors in the surrounding medium. 
Such a system thus functions as a mechanism for selecting the metabolic fates of the 
substrate.
1.3.2 2-oxo acid dehydrogenase complexes
The 2-oxo acid dehydrogenase multienzyme complexes are associations of three 
enzymatic activities, a substrate-specific dehydrogenase (El), a distinct dihydrolipoyl 
acyltransferase (E2) and dihydrolipoamide dehydrogenase (E3), a flavoprotein which is 
common to all three complexes.
Each complex catalyses a coordinated sequence of steps which can be 
represented by the following overall reaction:-
R-C0-C02H + CoASH + NAD+ — > R-CO-S-CoA + NADH + H+ + C 02 
R=CH3 (pyruvic acid) for pyruvate dehydrogenase complex (PDC), and H 0 2C-(CH2)2 
(2-oxoglutarate) for the 2-oxoglutarate dehydrogenase complex (OGDC). In the case of 
the branched-chain 2-oxo acid dehydrogenase complex (BCOADC), R-C0-C02H 
represents a 2-oxo acid derived from the metabolism of the branched-chain amino
acids, valine, isoleucine and leucine (a-oxoisovaleric, a-oxoisocaproic and
a-oxo-3-methylvaleric acids).
The acyltransferase (E2) constitutes the core of the complexes to which the E l 
and E3 component enzymes are attached by non-covalent bonds. The total number of 
subunits is large and, depending on the type of complex and its source, generally in the 
range 60-100. These complexes may be self-assembling and form ordered, symmetrical 
structures. There are six coenzymes and prosthetic groups involved in the sequence of 
reactions catalysed by the complexes:- Mg2+, thiamine pyrophosphate (TPP), lipoic 
acid, coenzyme A (CoASH), flavin adenine dinucleotide (FAD) and nicotinamide
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adenine dinucleotide (NAD+).
In different organisms the complexes are subject to regulation by ligand binding 
(Reed, 1974), covalent modification (Linn et al., 1969), control of gene expression 
(Langley and Guest, 1978), proteinase action (Linn, 1974), product inhibition (Garland 
and Randle, 1964), hormonal control (Denton and Hughes, 1978; McCormack and 
Denton, 1984; Reed and Yeaman, 1987) and glucose oxidation i.e. in starvation or 
diabetes (Wieland, 1983). The specific reactions catalysed by PDC, the functionally 
analogous OGDC, and BCOADC are shown in Table 1.3.1.
In the eukaryotic cell PDC, OGDC and BCOADC are located in the 
mitochondrial matrix, and all three complexes play important roles in metabolism. PDC 
represents the critical link between glycolysis in the cytoplasm and the citric acid cycle 
in the matrix. In most aerobic organisms, the oxidation of acetyl CoA (via the citric acid 
cycle) is a major source of reducing power in the form of NADH and 
metabolically-utilisable energy in the form of ATP. The provision of acetyl CoA by 
PDC is also essential for the synthesis of fatty acids, leucine and steroid hormones in 
eukaryotes. OGDC is a major constituent of the citric acid cycle, regulating the flux of 
this pathway in its latter stages. This complex catalyses the formation of succinyl CoA, 
an important biosynthetic intermediate of porphyrins, lysine and methionine. BCOADC 
catalyses the committed step in the degradation of branched-chain amino acids. In 
mammals this is nutritionally important in dealing with excess dietary valine, leucine 
and isoleucine (Goldberg and Chang, 1978). These amino acids are ultimately 
converted to acetyl CoA (ketogenic), succinyl CoA (glucogenic) and propionyl CoA 
(glucogenic). BCOADC may also be involved in the catabolism of methionine and 
threonine since 2-oxobutyrate (Pettit etal., 1978) and 4-methylthio-2-oxobutyrate 
(Jones and Yeaman, 1986) can be used as substrates by the complex. A deficiency in 
BCOADC activity in humans causes Maple Syrup Urine disease.
The major contributor to organisation and catalytic efficiency of the respective 
2-oxo acid complexes is their specific E2 components. This enzyme serves three major 
roles :-
1) it forms a central symmetrical core;
2) it is an acyltransferase, catalysing the formation of the acyl CoA product;
3) it provides attachment sites for the lipoic acid prosthetic groups which are required to
Table 1.3.1 Specific reactions catalysed bv 2-oxo acid dehydrogenase 
multienzvme complexes
(Basic substrate R-CO-CO2H)
Complex R Substrate Product
PDC c h 3 pyruvate acetyl CoA
OGDC C 02(CH2)2 2-oxoglutarate succinyl CoA
BCOADC (CH3)2CH2CH2 2-oxoisocaproate isovaleryl CoA
(CH3CH2)CH3CH 2-oxo-3-methylvalerate 2-methyl butyryl CoA
(CH3)2CH 2-oxoisovalerate isobutyryl CoA
c h 3c h 2 2-oxobutyrate propionyl CoA
CH3-S-(CH2)2 4-methylthio 2-oxobutyrate 3-methylthio- 
propionyl CoA
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interact with the different active sites of all the constituent enzymes of the complex.
The 2-oxo acid dehydrogenase complexes have been purified from a variety of 
prokaryotic and eukaryotic sources. PDC has been isolated from E.coli (Reed and 
Mukeijee, 1969; Danson et al., 1978), Pseudomonas aeruginosa (Jeyasselan et al., 
1980), Bacillus stearothermophilus (Henderson and Perham, 1980), Bacillus subtilis 
(Hodgson et al., 1983), S.cerevisiae (Kresze and Ronft, 1981a), bovine kidney 
(Kresze and Steber, 1979; Cate and Roche, 1979), porcine liver (Roche and Cate,
1977) and bovine heart (Stanley and Perham, 1980). OGDC has been purified from 
E.coli (Reed and Mukeijee, 1969), bovine kidney (Reed and Oliver, 1968) and porcine 
heart (Koike and Koike, 1976). BCOADC has been isolated from Pseudomonas putida 
(Sokatch et al., 1981b), bovine liver and heart (Danner et al., 1979; Pettit et al., 1978) 
and Ascaris suum (Sokatch et al., 1981a).
1.3.3 Structure, function and composition of PDC
The PDC-catalysed conversion of pyruvate to acetyl CoA serves both 
bioenergetic and biosynthetic roles. It is an essentially irreversible reaction in vivo, 
occupying a key position in cellular metabolism controlling the supply of acetyl groups 
in mitochondria arising from the oxidation of carbohydrates and amino acids. In many 
tissues including heart muscle, brain and kidney, the acetyl CoA is almost exclusively 
metabolised via the citric acid cycle, whilst in other tissues such as mammary gland, 
liver and adipose tissue, a significant proportion is utilised in the synthesis of fatty 
acids and sterols. In animals, acetyl CoA cannot be employed in gluconeogenesis and 
the action of PDC thus represents a net reduction in carbohydrate reserves. Regulation 
of this step is therefore of critical importance to the general energy balance and fuel 
economy of the cell. PDC activity is controlled by a range of regulatory mechanisms 
which have evolved to ensure appropriate cellular flux of acetyl groups (see Section
1.3.4).
PDCs isolated from bovine kidney and heart have Mr values of approximately 
7.0xl06 and 8.5xl06, respectively (Linn et al., 1972). The Mr values of the various 
polypeptide chains and the proposed stoichiometry of the bovine heart complex are
presented in Table 1.3.2. The E l component consists of non-identical subunits oc, Mr
Table 1.3.2: Subunit composition of bovine heart PDC (Adapted from 
Stepp etal .. 1983)
Enzyme Mr Subunits 
No. Mr
Subunits per molecule of 
complex
Native complex 8.5xl06
El 154,000 4
E la 2 41,000 60
E ip 2 36,000 60
E2 3.1x106 60 52,000 60
E3 110,000 2 55,000 12
Kinase -100,000 1 47,000 1-3
1 45,000 1-3
Phosphatase -150,000 1 97,000 (not tightly associated
1 50,000 with complex)
Protein X 51,000 1 51,000 8 -1 2
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41,000, and P, Mr 36,000, which form 0 ^ 2  tetramers of Mr 154,000. The E2 core 
enzyme consists of 60 identical polypeptide chains of Mr 52,000. E3 has an overall Mr 
of 110,000, comprising two identical 55,000-Mr subunits, each containing a molecule 
of FAD. The exact stoichiometries of PDC kinase and phosphatase are not known. The 
kinase and phosphatase have however been purified to homogeneity, and each of these 
enzymes consists of two subunits with Mr values of 47,000 and 45,000 for the kinase
(designated a  and P, respectively), and 97-110,000 and 50,000 for the phosphatase 
(Pratt et al., 1982; Stepp et al., 1983).
PDC has also been highly purified from baker's yeast (S.cerevisiae), and its 
molecular structure studied in some detail (Kresze and Ronft, 1981a,b). The complex 
was found to be similar in size (Mr ~8-9xl06) and FAD content to those from 
mammalian mitochondria. The Mr values of the constituent polypeptides, as determined
by SDS-PAGE, are: E2, 58,000; E3, 56,000; Elcc, 45,000; E lp , 35,000. Thus, the 
organisation and subunit Mr values are similar to the mammalian complexes.
In mammalian PDC, a distinct polypeptide of unknown function has been 
observed in recent years. Although this component had been noted previously (Stanley 
and Perham, 1980), it was originally considered to be a degradation product of E2 or 
possibly responsible for the PDC-associated kinase activity. However, De Marcucci 
and Lindsay (1985) demonstrated that the 51,000-Mr polypeptide is immunologically 
distinct and named it component X. The presence of this polypeptide appears to be 
unique to eukaryotic PDC, as no similar component has been detected in the analogous 
2-oxo acid complexes, OGDC and BCOADC. However, a similar polypeptide is 
present in yeast PDC (Kresze and Ronft, 1981a), and the gene encoding protein X 
from S.cerevisiae has been cloned and sequenced (Behai et al., 1989). Although the 
relationship between the mammalian and yeast components has not been confirmed 
conclusively, several similarities between the two polypeptides suggest they may be 
functionally equivalent Independent research indicates that both mammalian and yeast 
component X polypeptides are involved in E3 binding in the respective complexes 
(Neagle et al., 1990; Reed and Hackert, 1990).
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1.3.4 Regulation ofPDC
Mammalian PDC is subject to product inhibition by acetyl CoA and NADH, 
with reversal of inhibition occurring in the presence of CoASH and NAD+ respectively 
(Garland and Randle, 1964; Tsai et al., 1973). Mammalian PDC is also regulated by
ATP-dependent phosphorylation (Reed, 1974; Denton et al., 1975) in which the E l a  
subunit is covalently modified by a specific PDC kinase, with concomitant loss of 
overall complex activity. In PDC from pig heart (Sugden et al., 1978) and bovine 
sources (Yeaman et al., 1978) inactivation is correlated with the phosphorylation of a
specific serine residue in the E la  chain. A specific phosphatase, loosely associated 
with the complex, removes the phosphate group and restores activity (Reed, 1974).
The activities of the PDC kinase and phosphatase enzymes are regulated by various 
metabolites (see Figure 1.3.1). The kinase is activated by Mg2+, acetyl CoA and 
NADH, and inhibited by ADP, pyruvate and CoASH. The phosphatase is activated by 
Mg2+ and Ca2+, and inhibited by NADH (Reed et al., 1980). Ca2+ also inhibits kinase 
activity (Denton et al., 1975).
The steady state activity ofPDC is sensitive to the ratios [ADP]/[ATP], 
[AcSCoA]/[CoASH] and [NAD+]/[NADH]. Pyruvate dehydrogenase (El) and its two 
converter enzymes, kinase and phosphatase, comprise a monocyclic interconvertible 
enzyme cascade. However, the mechanism by which acetyl CoA, CoASH, NAD+ and 
NADH modify kinase activity is not fully understood and is the subject of some 
controversy.
During ATP-induced inactivation ofPDC, phosphorylation occurs at three
serine residues on the E la  subunit of the pyruvate dehydrogenase (El) component 
(Yeaman et al., 1978; Sugden et al., 1978). These sites were identified by tryptic 
digestion of [32P]PDC from bovine kidney and heart. A small monophosphorylated 
peptide containing site 1 was isolated, as well as a diphosphorylated tetradecapeptide 
(sites 1 and 2) and a monophosphorylated nonapeptide (site 3). Sites 1 and 2 are 
located in the same region of the peptide chain (see Figure 1.3.2). Phosphorylation at 
site 1 occurs most rapidly, results essentially in total loss of E l enzymatic activity, and 
closely parallels inactivation of the complex (Sugden et al., 1978; Yeaman et al., 1978).
Figure 1.3.1: Regulation of mammalian PDC bv a phosphorvlation/dephosphorvlation
mechanism on the E la  component of the complex
The covalent modification of PDC by kinase and phosphatase, and its regulation 
by various metabolites is represented schematically (Adapted from Reed et al., 1980).
Figure 1.3.1: Regulation of mammalian PDC bv phosphorylation/ 
dephosphorvlation
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Figure 1.3.2: Phosphorylation sites on the E la  subunit of bovine PDC
(Adapted from Yeaman. 1989)
Site 1 Site 2
Tyr-His-Gly-His-Ser(PVMet-Ser-Asp-Pro-Glv-Val-Ser(PVTyr-Arg-Tyr-
Site 3
-Gly-Met-Gly-Thr-Ser(P)-V al-Glu-Arg
CHAPTER 1 (INTRODUCTION) 3 6 
The role of the additional sites of phosphorylation on PDC has still to be established. It 
has been suggested that phosphorylation at sites 2 and 3, in addition to site 1, markedly 
inhibits the rate of reactivation of the complex by PDC phosphatase (Sugden et al.,
1978; Kerbey and Randall, 1979). On this basis, Randle et al. (1981) proposed a 
multi-site phosphorylation mechanism for regulating the conversion of inactive PDC 
into active complex. However, this model has been criticised by Reed et al. (1980) who 
concluded that the presence of phosphate groups on sites 2 and 3 in bovine kidney PDC 
did not significantly affect the rate of reactivation by the phosphatase. Evidence was 
also obtained that the relative rates of dephosphorylation on sites 1,2 and 3 was 
different, in the order site 2, site 3, site 1. In addition to this, phosphorylation at site 2 
was found to function as well as site 1 phosphorylation in inactivating the complex 
while phosphorylation at site 3 did not cause inactivation.
Mammalian BCOADC is also subject to regulation by 
phosphorylation/dephosphorylation (Reed and Yeaman, 1987) but unlike PDC, has
only two serine residues on the E la  subunit which are acted upon by the kinase. In 
common with PDC however, phosphorylation at site 1 in BCOADC is responsible for 
inactivation of the complex, while the role of the additional phosphorylation site has 
still to be firmly established.
Regulation of PDC activity by a phosphorylation/dephosphorylation mechanism
on the a  subunit of the E l component of the complex is a common theme in eukaryotic 
cells (For reviews, see Reed, 1974; Denton et al., 1975; and Wieland, 1983). Activity 
ofPDC from eukaryotic sources including mammalian, avian and plant tissues, and 
Neurospora crassa is regulated by such a phosphorylation/dephosphorylation cycle. A 
possible exception to this is yeast, with all attempts thus far to demonstrate PDC kinase 
activity being unsuccessful (Kresze and Ronft, 1981a). However, Uhlinger et al.
(1986) demonstrated the phosphorylation and inactivation of purified PDC from 
S.cerevisiae by bovine kidney PDC kinase. Conversely, it was found that the inactive 
complex can be dephosphorylated and reactivated with purified PDC phosphatase from 
bovine heart.
1.4 ATMS OF THE THESIS
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1.4.1 Mitochondrial exchange carriers
The proteins chosen for investigation, ANT and PIP , are major exchange 
carriers of the inner mitochondrial membrane. By following on from previous work 
done on these transmembranous proteins, it was intended to achieve the following 
aims:-
1) to develop a procedure for co-purifying ANT and PTP from mammalian sources and 
efficiently separating the proteins into homogeneous populations. It was initially hoped 
to carry this out on a small scale, using rat liver mitochondria, then apply the procedure 
to large-scale preparations of ANT and PTP from bovine heart mitochondria;
2) to design a method for transferring large-scale preparations of the carriers from their 
isolating detergent, Triton X-100, into detergents suitable for physical analysis by 
circular dichroism (CD), and ultimately for obtaining crystals prior to X-ray diffraction 
studies. It was hoped that by binding co-purified ANT and PTP to suitable columns, it 
would be possible to both separate them by differential elution and, in doing so, switch 
detergents;
3) to develop an assay for isolating PTP in its native conformation. Because this protein 
is not an enzyme, no simple assay exists for assessing its activity. Reconstituting PTP 
into artificial liposomes represents a laborious technique for studying the carrier and, in 
this case, particularly unsatisfactory in view of the low affinity of the PTP for its 
substrate, Pj. Isolation of the carrier in the native state is an important prerequisite for 
CD and X-ray crystallographic studies;
4) to develop and optimise an isolation procedure for PTP from baker's yeast
(S.cerevisiae). This organism was chosen primarily because large quantities were made 
available to us (see Section 2.1.4). The highly developed state of classical and 
molecular genetics in yeast was also taken into account. Subsequently, it was hoped to 
apply some of the procedures described above to a yeast PTP purification scheme 
(co-purification of ANT, separation of co-purified ANT and PTP, assay for native PTP 
conformation).
In summary, it was hoped to carry out a series of purification and
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conformational studies on PTP and ANT from both mammalian sources and 
S.cerevisiae, with the ultimate target being to purify PTP of sufficient quality and 
quantity to obtain crystals suitable for X-ray diffraction studies. It was felt that such 
studies would help elucidate the manner by which PTP functions at the molecular level, 
and increase our understanding of this family of related mitochondrial exchange 
carriers.
1.4.2 Pvruvate dehydrogenase complex
As well as studying the primary mitochondrial exchange carriers, it was decided 
to address a specific problem relating to the control ofPDC activity in yeast. A general 
feature of PDCs from eukaryotic sources is their regulation by a phosphorylation /
dephosphorylation mechanism on the E la  subunit of the complex. However, PDC 
kinase activity has never been detected in yeast (see Section 1.3.4). It was hoped to
demonstrate the phosphorylation of yeast PDC E la  in vivo by isolating intact
mitochondria from S.cerevisiae, and incubating the organelles with [y^PJATP. It 
would then be possible to confirm yeast PDC kinase activity by immune precipitation 
and the use of mammalian kinase inhibitors.
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CHAPTER 2: MATERIALS AND METHODS
2.1 MATERIALS
2.1.1 Chemicals and Biochemicals
The following reagents were obtained from Sigma Chemical Co., Poole, 
Dorset, UK: substrates and coenzymes for enzymatic assays, phenylmethylsulphonyl 
fluoride (PMSF), NNN'N'- Tetramethylethylene-diamine (TEMED), 
benzamidine-HCl, Coomassie Brilliant Blue type R250, 3-{N- Morpholino) 
propane-sulphonic acid (MOPS), Leupeptin, Tween 20, carboxyatractyloside (CAT),
cardiolipin (sodium salt), CCCP, oligomycin, n- octyl (3-D-glucopyranoside (n-
octylglucoside) and n- dodecyl (3-D-maltoside (n- laurylmaltoside). Millmaster-Onyx 
Ltd., UK supplied lauryl dimethyl amine oxide (LDAO), while Triton X-100 was 
purchased from Rohme and Haas (UK) Ltd.
Poly (ethylene glycol) 6000 was obtained from Serva, Heidelberg, Germany. 
Iodgen™ was from Pierce Labs., Rockford, Illinois, USA, while DTT was purchased 
from Koch-Light Labs., Colnbrooke, Berks., UK. Sodium salicylate and 
dichloroacetic acid were obtained from Aldrich Chemical Co., Ltd., Gillingham, UK. 
Yeast extract, peptone and agar were purchased from Difco Labs., Detroit, Michigan, 
USA.
All other chemicals used, including reagents for sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE), were Analar grade from BDH 
Chemicals Ltd., Poole, Dorset, UK, or were of the highest grade commercially 
available.
2.1.2 Radiochemicals
[y32pjATP (100-130 Ci/mmol) and Na[125I]I (carrier-free) were supplied by 
Amersham International, Bucks., UK.
2.1.3 Enzvmes and proteins
Bovine serum albumin (BS A) and protein A {Staphylococcus aureus, Cowan I
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strain) were obtained from Sigma Chemical Co., Poole, Dorset, UK. Yeast lytic 
enzyme (Zymolyase-100) was purchased from Seikagaku Kogyo Co., Ltd., Tokyo, 
Japan.
Marker proteins for Mr determinations by SDS-PAGE were obtained from 
Pharmacia Ltd., Milton Keynes, UK.
2.1.4 Biological materials
Bovine hearts were obtained from Paisley Abbatoir, Sandyford Road, Paisley. 
Hearts were removed from the animals within lh  of slaughter, chilled immediately on 
ice and used in the laboratory within 2h of slaughter. New Zealand White Rabbits and 
150-250g rats (Albino Wistar strain, male or female) were provided by the departmental 
animal house.
Baker's yeast (S.cerevisiae) was supplied by DCL Ltd., Menstrie, 
Clackmannanshire, UK. 1kg tablets of freshly-grown yeast were chilled immediately 
on ice, and subsequently stored at either 4°C (for use within 7 days) or -80°C (for 
long-term storage). Specific strains of S.cerevisiae (D273-10B and S288C) were 
cultured and grown routinely in the laboratory under suitable conditions.
2.1.5 Photographic materials
"Lighting Plus" intensifying screens were purchased from Du Pont Cronex, 
Stirling, UK. Plast-X cassettes, for exposure of X-ray films, were obtained from 
Anthony Monk (England) Ltd., Sutton-in-Ashfield, UK.
X-OMAT S and XAR-5 X-ray films , Kodak FX-40 liquid fixer and Kodak 
LX-24 X-ray developer were supplied by Kodak Ltd., Dallimore Road, Manchester, 
UK.
2.1.6 Chromatography materials
Biogel Hydroxylapatite (HIP) was supplied by Bio-Rad Labs., Holywell 
Industrial Estate, Watford, Herts., UK., and Celite (Type 535) by Serva, after 
distribution by Uniscience, Cambridge, UK. Matrex™ Gels (Procion Red A and 
Procion Blue A) were purchased from Amicon Ltd., Upper Mill, Gloucestershire, UK.
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DEAE Affi-Gel Blue was supplied by Bio-Rad Laboratories, Richmond, California, 
while CM Cellulose and DEAE Cellulose were purchased from Whatman Ltd., 
Maidstone, Kent.
Pre-packed columns (MonoQ™, MonoS™ and Superose™12) for FPLC 
(Fast protein liquid chromatography) were obtained from Pharmacia (GB) Ltd., Milton 
Keynes, Bucks., UK, who also supplied Sepharose CL-2B and DEAE Sephacel.
2.1.7 Miscellaneous
Nitrocellulose paper (0.45 jim pore size) was obtained from either Schleicher 
and Schull, Dassel, Germany, or Amersham International, Bucks., UK (Hybond C 
extra). Novacell™ stirred cells were purchased from Filtron Technologies UK Ltd., 
Warwickshire, UK.
Non-immune rabbit and donkey sera were supplied by the Scottish Antibody 
Production Unit (S APU), Lanarkshire, UK. Pansorbin, standardised 10% (w/v) 
formalinised S.aureus cells, was obtained from Calbiochem-Behring Corp., Bishop's 
Stortford, Herts., UK.
2.2 METHODS
2.2.1 Determination of protein concentration
The concentration of protein was routinely determined by the method of Lowry 
et al. (1951), as modified by Markwell et al. (1976). Standard curves were constructed 
using bovine serum albumin (BSA) as the standard, and absorbances were measured at 
660nrm Alternatively, where appropriate, the Biuret method (Gomall et al., 1949) was 
employed. With this method BSA was used as the standard and absorbances were 
measured at 540nm.
When highly accurate protein concentrations were required, the SERC-funded 
amino acid analysing facility at the University of Aberdeen was utilised. Analyses were 
carried out using an Applied Biosystems 420A amino acid analyser with automatic 
hydrolysis and derivatisation.
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2.2.2 Concentration of protein samples
Protein samples were concentrated by sealing in dialysis tubing, followed by 
exposure to excess poly (ethylene glycol) for 30-60min. Alternatively, Filtron 
Novacell™ stirred cells were employed to reduce sample volumes under high pressure 
(55psi).
Frequently, samples for SDS-PAGE were concentrated by the addition of 4 
volumes of acetone, followed by overnight storage at -20°C. The protein precipitates 
were then pelleted by centrifugation at 500-1,000 xg.
2.2.3 N-terminal analysis of proteins
The SERC-funded amino acid sequencing facility at the University of Aberdeen 
was employed to determine the N-terminal sequence of a protein when required. The 
methodology involves an improvement on the degradation technique of Edman et al. 
(1981). Purified protein samples were resolved by SDS-PAGE according to the 
conditions described in Applied Biosystems User Bulletin no.25. The gel was then 
blotted onto Immobilon membrane (Millipore, Harrow, Middlesex) as described by 
Matsudaira (1987). Protein bands were carefully excised with a scalpel and placed in 
the cartridge block of an Applied Biosystems model 470A protein sequencer equipped 
with a 120A on-line PTH analyser, using the standard 03R PTH programme.
2.2.4 Polyacrylamide gel electrophoresis
(a) Preparation of polypeptides prior to resolution bv SDS-PAGE
Protein solutions were mixed with an equal volume of Laemmli sample buffer 
(0.0625M Tris-HCl, pH 6 .8 , 2% [w/v] SDS, 10% [w/v] sucrose and 0.001% [w/v] 
Pyronin Y) containing 5% (v/v) 2-mercaptoethanol or lOmM DTT, and boiled for 5min 
prior to electrophoresis. Protein samples in pellet form were solubilised in an 
appropriate volume of Laemmli sample buffer and boiled as above.
(b) Conditions for resolution of proteins bv SDS-PAGE
Proteins were electrophoresed on SDS-containing polyacrylamide gels using the 
discontinuous Tris-glycine system according to Laemmli (1970). Analytical gels were 
cast using a home-made apparatus in slabs 19.0cm x 14.0cm x 0.15cm, or when 
greater resolution was required, using vertical gel electrophoresis apparatus (Life
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Technologies Inc.) in slabs 16.0cm x 14.0cm x 0.15cm. Resolving gels (pH 8 .8) 
usually contained 10.0% or 12.5% (w/v) acrylamide, while the stacking gel (pH 6 .8) 
was cast using 4.5% (w/v) acrylamide. Polymerisation was catalysed by TEMED and 
initiated by ammonium persulphate.
(c) Staining of gels with Coomassie blue
Gels were stained for protein in 0.1% (v/v) Coomassie Brilliant Blue R250, 
50% (v/v) methanol and 10% (v/v) acetic acid for lh.
(d) Destaining of gels
Unbound stain was removed by washing the gel several times in 20% (v/v) 
methanol, 10% (v/v) acetic acid solution. 
fe) Processing of gels for fluorographv
Gels to be processed for fluorography were previously stained (and destained) 
or directly fixed overnight by immersing in 25% (v/v) propan-2-ol, 10% (v/v) acetic 
acid solution.
Fluorography was performed according to the method of Chamberlain (1979) 
employing sodium salicylate as fluor. Slab gels were dried under vacuum and exposed 
for a suitable period of time to either X-OMAT S or XAR-5 film at -80°C.
(f) Processing of gels for autoradiography
Gels were stained /  destained or fixed as described above. Before drying, gels 
were immersed for 30min in a solution containing 25% (v/v) propan-2-ol, 10% (v/v) 
acetic acid and 0.5% (v/v) glycerol to reduce the risk of cracking during drying. Dried 
gels were exposed to film as described above.
(g) Determination of Mr value bv SDS-PAGE
The Mr values of polypeptides resolved by SDS-PAGE were determined by 
calibrating with a set of standard proteins on 10% or 12.5% (w/v) slab gels. The 
standard proteins (and apparent Mr values) were as follows: phosphorylase b (Mr 
94,000); BSA (Mr 67,000); ovalbumin (Mr 43,000); carbonic anhydrase (Mr 30,000); 
soybean trypsin inhibitor (Mr 20,000), and lysozyme (Mr 14,000).
Relative mobility (Rf) was calculated for each protein as the ratio: distance 
migrated by the protein/distance migrated by the tracking dye. A plot of Rf versus log
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(Mr) of the standards yields a curved line which can be used for calibration.
2.2.5 Radioiodination of proteins
Iodogen™ (1,3,4,6 - tetrachloro-3a,6a-diphenylglycoluril) is a mild solid 
phase reagent that efficiently reacts with aqueous mixtures of I' and tyrosine groups on 
proteins to produce iodinated proteins (Fracker and Speck, 1978). Iodogen™ was 
used to iodinate protein A for immune replica analyses, and also to radiolabel standard 
calibration proteins for determination of Mr values on immunoblots, autoradiographs 
and fluorographs.
Iodogen™ (lmg) was dissolved in 1ml of chloroform. The solvent was then 
removed with a gentle air stream, in the process producing a thin film of Iodogen™ on
the base of the reaction container. Proteins for iodination (lmg of protein A or 600}4g 
of Mr standards) were dissolved in 0.5ml 0.1M Tris-HCl pH 7.2, 0.15M NaCl and 
transferred into the reaction container with the Iodogen™. After the addition of
200-400|iCi [125i]NaI, the reaction mixture was incubated for 15min at room 
temperature with occasional mixing. The reaction was terminated by removing the 
mixture from the container and passing it through a 10ml Sephadex G-25 column 
equilibrated in 0.1M Tris-HCl pH 7.2, 0.15M NaCl. 1ml fractions were collected in 
disposable Eppendorf tubes, with the iodinated protein generally being found between
fractions 4 and 7. This was confirmed by counting 5p.l aliquots in a liquid scintillation 
counter. Peak fractions were pooled and stored at -20°C. Protein A was dispensed in
10-30|il aliquots, each containing 3 x 106cpm, for immunoblotting analyses.
2.2.6 Immunological techniques
(a) Preparation of antisera
Protein purity was assessed initially by Coomassie blue staining of 
polyacrylamide gels. The acetone-precipitated protein pellet was dissolved in 0.9% 
(w/v) NaCl and mixed thoroughly with an equal volume of Freund's complete adjuvant 
prior to injection subcutaneously at various sites in the neck, back and thighs of the
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rabbit. This treatment was repeated at 2-3 week intervals in the presence of Freund's 
incomplete adjuvant. Antiserum was collected by bleeding the rabbit from a marginal 
ear vein, 10-14 days after the 4th injection of antigen. After allowing the blood to clot 
overnight at 4°C, the antiserum was removed with a pasteur pipette, aliquoted (0.5-lml 
fractions) and stored at -20°C. In some instances the antiserum had to be clarified by 
centrifugation at 2500 xg for lOmin to remove contaminating red blood cells. Before 
subsequent bleedings, the rabbit was injected 10-12  days previously with antigen in 
incomplete adjuvant. All injections and bleedings were carried out by Dr. J. G. Lindsay.
(b) Immune blotting (Immune replica analysis, Western blotting)
The immune blotting procedure was employed to permit immunological 
detection of polypeptides after their electrophoretic transfer from polyacrylamide gels to 
nitrocellulose paper (Towbin et al., 1979; Batteiger et al., 1982).
Polypeptides were resolved by SDS-PAGE (see Section 2.2.4) and transferred 
electrophoretically onto nitrocellulose paper at 350ma for 3h or 40ma for 16-20h using 
a Trans-Blot™ cell. The transfer buffer comprised 25mM Tris-HCl pH 8.3, 192mM 
glycine, 0.02% (w/v) SDS, 20% (v/v) methanol and was stored at 4°C before use.
After transfer the nitrocellulose paper was removed and incubated, face up, in blocking 
buffer (20mM Tris-HCl pH 7.2, 0.15M NaCl, 0.5% [v/v] Tween 20) for lh  at room 
temperature or 4°C overnight.
Nitrocellulose paper was then incubated in fresh blocking buffer supplemented 
with antiserum at a dilution of 1/50-1/100, and 5% (v/v) heat-inactivated donkey serum 
for 90min at room temperature. Excess antibody was then removed by washing with 
five changes of blocking buffer over a period of lh, before incubation for 90min at 
room temperature with blocking buffer containing 125I-labelled protein A (approx.
3xl06 cpm per blot). Excess radiolabelled protein was removed by several washes with 
blocking buffer as above. The processed nitrocellulose paper was then allowed to dry at 
room temperature before analysis by autoradiography. On some occasions, immune 
blots were further analysed by scanning densitometry, using an LKB 2202 Ultroscan 
Laser Densitometer.
(c) Immune precipitation of r32P1phosphoproteins from mitochondria
Phosphoproteins were immune precipitated from [y^2P] ATP-labelled
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mitochondria by adapting the method as used by Jones and Yeaman (1986a). The 
labelled mitochondrial pellet was used fresh or frozen instantly on dry ice and stored at 
-80°C prior to use.
The pellet was resuspended in 80jil of ice-cold dilution buffer (20mM NaPP* 
pH 7.0, 0.5% [v/v] Triton X-100, 0.5% [w/v] SDS, 1% [w/v] sodium deoxycholate, 
ImM EDTA, ImM EGTA, 5mM NaF, ImM DTT, 0.5mM PMSF, 0.5mM
benzamidine-HCl, 0.3jiM leupeptin), and the mitochondria lysed by vortex-mixing for 
15s. This mitochondrial solution was then centrifuged at 1,000 xg for 20s (to remove 
oil) and 10,000 xg for 30s (to remove lipid). The inffanatant was extracted and
incubated with 5-50|il of antiserum for lh  at room temperature, then overnight at 4°C.
Pansorbin (lOjil) was added, and the solution incubated for lh  at room temperature 
with occasional end-over-end mixing. Following a 2.5min centrifugation at 10,000 xg, 
the supernatant was discarded and the pellet washed three times in wash buffer (50mM 
Tris-HCl pH 7.5,0.9% [w/v] NaCl, 0.1% [w/v] SDS, 1% [v/v] Triton X-100). The 
pellet was then given a fourth and final wash in detergent-free wash buffer. The 
immune precipitate was dissociated by boiling in Laemmli sample buffer, subjected to 
SDS-PAGE and analysed by autoradiography.
2.2.7 Isolation of mitochondria
(a) Preparation of rat liver mitochondria
Rat liver mitochondria were isolated by differential centrifugation (Chance and 
Hagihara, 1963). Rats (150-250g) were starved overnight and killed by cervical 
dislocation. Livers were removed, chopped finely with scissors and transferred into 
ice-cold isolation medium (0.225M mannitol, 0.075M sucrose, 0.5mM EGTA, 2mM 
MOPS, pH adjusted to 7.4 with NaOH). Chopped livers were homogenised in 
isolation medium, initially with a loose-fitting, then with a tight-fitting Potter-Elvehjem 
homogenizer. Subsequently, mitochondria were isolated by differential centrifugation. 
Nuclei, cell debris and red blood cells were removed by centrifuging at 800 xg for 
7min, prior to spinning for 15min at 6,500 xg to sediment the crude mitochondrial 
fraction. The low-speed spin was then repeated on the resuspended mitochondrial pellet
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to remove subcellular contaminants. Subsequent centrifugation of this supernatant at 
6,500 xg for 15min pelleted the mitochondria.
The final pellets, containing highly purified mitochondria, were used fresh or 
stored at -20°C until required.
(b) Preparation of bovine heart mitochondria
Bovine heart mitochondria were isolated by differential centrifugation as 
described by Smith (1967). The homogenisation step was however, replaced by 
blending the heart tissue at high speed for lmin in a Philip's (UK) Ltd. blender. 
Approx. 1.5-1.8g of mitochondrial protein was obtained from 300g of tissue. 
Mitochondrial pellets were used fresh or stored at -20°C until required.
(c) Preparation of veast mitochondria
Yeast mitochondria were isolated by adapting the method as described by 
Rickwood et al. (1988). Yeast cells were harvested by centrifuging at 1,000 xg for 
lOmin at 4°C, washed once in cold distilled water, and resuspended in 2 vol 0.1M 
Tris-SC>4 pH 9.3, lOmM DTT. After a 30min incubation at 30°C, the suspension was 
re-centrifuged and the pelleted cells washed once in 1.2M sorbitol, 20mM KPj pH 7.4. 
The cells were then resuspended to 0.15g wet weight/ml in the sorbitol/KPj buffer, and 
the cell walls digested by the action of yeast lytic enzyme (0.25mg Zymolyase-100/g 
wet cell weight). After a lh  incubation at 30°C, spheroplasts were pelleted by 
centrifugation at 1,000 xg for lOmin, and washed twice in the sorbitol/KPj buffer. All 
subsequent steps were carried out at 4°C. The spheroplast pellet was suspended in 2 
vol breaking buffer (0.6M mannitol, 20mM HEPES-KOH pH 7.4, ImM PMSF) and 
homogenised at maximum speed using a Dounce homogenizer (pestle B, 10 strokes). 1 
vol breaking buffer was added to the homogenate, and nuclear and cellular 
contaminants were removed by centrifugation at 1,000 xg for lOmin. Mitochondria 
were pelleted by high speed centrifugation of the supernatant (6,500 xg for 15min), and 
washed once in 0.6M mannitol, 20mM HEPES-KOH pH 7.4 to remove PMSF. 
Mitochondrial pellets were used fresh or stored at -20°C until required.
2.2.8 Preparation of PTP from bovine heart and rat liver mitochondria
The phosphate transport protein was purified from bovine heart and rat liver
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mitochondria as described by Gibb et al. (1986), a modification of the method of Kolbe 
etal. (1981). This modification involved the pre-extraction of mitochondria with a low 
Triton X-100 buffer (20mM LiCl, O.lmM EDTA, 0.5mM DTT, 20mM H3PO4 , 0.5% 
[w/v] Triton X-100, adjusted to pH 7.0 with LiOH). After centrifugation for lh  at
105,000 xg, the resulting pellet was solubilised by incubation for 15min at 4°C in the 
above buffer supplemented with 8 % (w/v) Triton X-100 to extract the PTP. 1 vol 
ice-cold distilled water was added, residual insoluble material was removed by 
centrifugation at 105,000 xg for lh, and the supernatant fraction was subjected to 
adsorption chromatography on hydroxylapatite. A batch procedure was adopted for this 
step (0.5g HTP/ml solubilised membrane). In some cases, a further adsorption 
chromatography step was undertaken on the HTP-adsorbed supernatant, using Celite 
(type 535). A similar batch procedure was adopted for this step.
For some experiments, PTP was purified in the presence of cardiolipin which 
was added to the extraction buffer to a final concentration of lmg/ml.
2.2.9 Chromatographic techniques
Adsorption chromatography was carried out on HTP and Celite as described 
above (Section 2.2.8). Manual chromatography was also carried out using the 
Matrex™ gels Procion Red A and Procion Blue A. 2.0-5.0cm x 1.0cm columns were 
poured and equilibrated in 20mM Tris-HCl pH 7.0-9.0. The exact size of the columns, 
pH of the buffer, and the inclusion of various detergents in the buffer were determined 
by the nature of the experiment and are described in the appropriate figure legends.
Column chromatography was also undertaken using the Pharmacia FPLC 
system. The following columns were used: Superose™12 and Sepharose CL-2B 
(poured manually), gel filtration columns; MonoQ™, an anion exchanger; MonoS™, 
a cation exchanger.
2.2.10 Circular dichroism
Circular dichroism (CD) spectra were recorded at 20°C in a Jasco J-600 
spectropolarimeter at Stirling University by Miss Sharon Kelly. Spectra in the far UV 
(250-205nm) and the near UV (320-260nm) were recorded in cells of path lengths
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1mm and 10mm respectively. Data was collected and analysed on data processors
attached to the spectropolarimeter. The spectra were plotted as [ct]^ against wavelength
(nm).
Samples of protein in the presence and absence of guanidine-HCl (GdnHCl) 
were prepared and the spectra were recorded 15min after addition of this reagent. 
Measurements were corrected by the inclusion of appropriate blanks.
2.2.11 Purification of PDC
(a) Purification of bovine heart PDC
PDC was purified from bovine heart essentially as described by Stanley and 
Perham (1980), with the modifications outlined below.
All operations were carried out at 4°C, starting with 250g of cubed bovine 
heart. Cubes of tissue were blended and extracted in 50mM MOPS, 2.7mM EDTA, 3% 
(w/v) Triton X-100, O.lmM DTT, adjusted to pH 7.0 with NaOH. Residual material 
was discarded. The extracts contained assayable amounts of OGDC activity; however, 
the presence of lactate dehydrogenase interfered with the estimation of PDC activity at 
the early stages of purification.
PDC was precipitated by the addition of 0.12 vol of a 35% (w/v) poly (ethylene 
glycol) solution at pH 6.45. Pellets were resuspended in 50mM MOPS, 1% (w/v)
Triton X-100, 2.7mM EDTA, O.lmM DTT, 1.5pM leupeptin, adjusted to pH 6 .8  with 
NaOH, by homogenisation with a loose-fitting teflon-glass homogenizer. This extract 
was adjusted to 13mM MgCl2 and 50mM NaPj before the addition of 0.12 vol poly 
(ethylene glycol) for a second precipitation.
The 2-oxo acid dehydrogenase complexes were separated by differential 
precipitation with poly (ethylene glycol). 0.04-0.06 vol 35% (w/v) poly (ethylene 
glycol) was required to precipitate 90% of OGDC activity. OGDC was pelleted at
18,000 xg for lOmin, and the resulting supernatant fraction was found to contain 
90-95% of the PDC activity. PDC was concentrated by centrifugation at 170,000 xg for 
2.5h, or by the addition of 0.15 vol 35% poly (ethylene glycol) followed by 
centrifugation at 30,000 xg for lOmin.
The PDC pellet was purified further by solubilising in column buffer (50mM
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NaPj, pH 7.0,1% [w/v] Triton X-100,2.7mM EDTA, 0.2mM TPP, ImM MgC^) 
and separating residual OGDC by gel filtration chromatography on a Sepharose CL-2B 
column (106cm x 3.5cm) equilibrated in column buffer, at a flow rate of 24ml/h. 
Approx 60 x 12ml fractions were collected and assayed for PDC and OGDC activities. 
Fractions with maximal PDC activity were pooled and concentrated by centrifugation at
170,000 xg for 2.5h.
The yellow PDC pellets were resuspended by standing overnight in a small
volume of column buffer supplemented with 0.01% NaN3,0.15|iM  leupeptin. The 
complex was stored until required at 4°C at a final concentration of 20-30mg/ml.
(b) Purification of veast PDC
PDC was prepared from baker's yeast (S.cerevisiae) essentially as described 
by Kresze and Ronft (1981a). On some occasions the modifications introduced by 
Uhlinger et al. (1986) were also adopted for further purification of the complex.
Yeast PDC utilised in this study was prepared by Drs. J.McKee and S.West in 
our laboratory, and stored at 4°C until required.
2.2.12 Enzymatic assays
(a) PDC activity
Overall PDC activity was determined spectrophotometrically by measuring 
NADH formation at 340nm at 30°C (Brown and Perham, 1976). Assays were 
performed in a final volume 0.67ml of 50mM KPj pH 7.4, 2mM TPP, ImM MgCl2, 
2.5mM NAD+, 0.13mM CoASH, 2.6mM cysteine-HCl, 2mM sodium pyruvate. A 
unit of activity (Kat) was defined as the amount of enzyme which produced lmol 
NADH/sec at 30°C under the assay conditions.
(b) PDC kinase activity
The activity of bovine heart PDC kinase (EC 2.7.1.99) was assayed by 
measuring the rate of inactivation of the complex in the presence of 0.2mM ATP at 
30°C (Hucho et al., 1972), or by estimation of the rate of incorporation of 32P-labelled
phosphoryl groups from ['y32P]ATP into serine residues on the E la  subunit of PDC 
(Stepp et al., 1983).
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2.2.13 Separation ofPDC components
PDC was separated into its individual components by FPLC, a modification of 
the method of Kresze and Ronft (1981b). The complex was first separated into E1/E3 
and the E2/X core assembly using a Superose™ 12 column of 100ml bed volume. The 
column was equilibrated with 2 vol running buffer (50mM Tris-HCl pH 9 .0 ,1M NaCl, 
ImM DTT, 0.01% [w/v] Triton X-100), and then preinjected with 4ml of running 
buffer containing 4M NaCl, in order to create a high molarity band onto which the 
dissociated complex was loaded. PDC (maximum lOOmg) was loaded after a 1:1 
dilution and incubation with 4M NaCl running buffer (to dissociate E1/E3 from E2/X), 
and 2ml fractions were collected.
A MonoQ™ column was used to separate E3, E l and the associated kinase. 
The column was equilibrated with running buffer (50mM imidazole pH 7.2, ImM 
DTT, 0.01% Triton X-100), against which the E1/E3 fraction was also dialysed prior 
to loading. E l, E3 and kinase were differentially eluted with a salt gradient (0-1.0M 
NaCl). 1ml fractions were collected and analysed by SDS-PAGE and PDC kinase 
activity assays (see Section 2.2.12b).
2.2.14 Growth of cultured veast cells
Cultured yeast cells 0S.cerevisiae, strains D273-10B and S288C) were grown 
aerobically in the following media, all containing 1% (w/v) yeast extract and 2 % (w/v) 
peptone, and buffered with 0.1M KPj pH 6.0: YPD, 2% (w/v) glucose; YPG, 2%
(w/v) galactose; YPEG, 2% (v/v) glycerol, 3% (v/v) ethanol; YPDG, 0.1% (w/v) 
glucose, 3% (v/v) glycerol; YPS, 2% (w/v) sodium succinate pH 6.0; YPL, 2% (w/v) 
sodium lactate pH 6.0.
Yeast stocks were stored at 4°C on 10ml solid slopes of YPG supplemented 
with 2% (w/v) agar. These slopes were replaced at three-monthly intervals to maintain 
viable colonies of the microorganisms.
2.2.15 Preparation of extracts from veast cells grown in the presence of CCCP 
The yeast cytoplasmic petite (rho") mutant S.cerevisiae D273-10B-1 was
grown at 23°C in YPG to early exponential phase. The culture was then divided into
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six aliquots and CCCP was added to five of them at final concentrations of 1,2, 5,10
and 20 pM. Growth was then continued at 23°C for 8h. Cell extracts were 
subsequently prepared as described by Reid and Schatz (1982). Cell suspensions were 
mixed with 0 .2  vol of 100% (w/v) trichloroacetic acid, the denatured cells were broken 
by agitation with glass beads, and proteins were extracted with SDS buffer (2% [w/v] 
SDS, 2mM EDTA, 50mM Tris-HCl, 10% [v/v] glycerol). After neutralisation with 1M 
Tris base, the samples were boiled for 3 min and centrifuged for 10 min at 1000 xg. 
The supernatants were subjected to SDS-PAGE prior to immune replica analysis.
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CHAPTER 3: PROTEIN-CHEMICAL STUDIES ON THE
MAMMALIAN PHOSPHATE AND ADENINE NUCLEOTIDE 
MITOCHONDRIAL CARRIERS
3.1 INTRODUCTION
The inner membrane phosphate transport protein (PTP) represents a major 
protein component of the mitochondrion. The intimate involvement of this carrier in 
oxidative phosphorylation (see Section 1.2.3), the primary function of mitochondria, 
demonstrates the biological importance of PTP. In view of this, much research has 
been carried out in our laboratory, specifically aimed at the isolation and 
characterisation of mammalian PTP (Gibb, 1985; Gibb et a/., 1986; Phelps, 1987).
The aim of this part of the project was to follow on from the above research, 
extending our understanding of the structural and physical properties of PTP. The 
closely related adenine nucleotide translocase (ANT) was also included in the study 
since these two proteins (PTP and ANT), designated as the primary exchange carriers 
of the inner mitochondrial membrane, appear to be members of a structurally related 
family of mitochondrial exchange systems with a common evolutionary origin (see 
Section 1.2.9).
In view of the close similarities in the isolation procedures for PTP and ANT 
(see Sections 1.2.4 and 1.2.5), it was hoped to develop a method for co-purifying the 
two carriers and efficiently separating them in order to obtain maximum yields of both 
from a single mitochondrial preparation. Isolation of the carriers in their native 
conformations, an important pre-requisite for physical analyses and X-ray 
crystallography, was also studied.
The long-term aim of this project is to obtain crystals of PTP (and/or ANT) of 
sufficient quality for X-ray diffraction studies, thus greatly increasing our 
understanding of a family of important mitochondrial exchange carriers. Accordingly, 
many of the experiments in this study, although initially carried out on rat liver 
mitochondria, were subsequently applied to bovine heart mitochondria in order to 
significantly increase yields.
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3.2 PURIFICATION OF MAMMALIAN PTP AND ANT
3.2.1 Purification of mammalian PTP
The phosphate carrier was isolated from rat liver and bovine heart mitochondria 
basically as described by Gibb et al. (1986; see Section 2.2.8). Pre-extraction with a 
0.5% (w/v) Triton X-100 buffer was followed by extraction with 8% (w/v) Triton 
X-100 and batch chromatography with firstly hydroxylapatite (HTP), then Celite. The 
Coomassie blue-stained profile of the various stages of rat liver PTP purification is 
illustrated in Figure 3.2.1. Analysis by SDS-PAGE reveals an apparently 
homogeneous 34,000-Mr single polypeptide after Celite fractionation. Similarly, 
SDS-PAGE analysis of the various stages of bovine heart PTP isolation also reveals a 
single 34,000-Mr polypeptide band after the ultimate purification step. These 
observations contrast with the findings of Kolbe et al. (1984), who detected two 
protein bands at the final stage of bovine heart PTP purification. Historically, the 
isolation of this carrier has been hampered by the apparent heterogeneity of 
preparations. It should be noted that on a few occasions a single contaminating band of 
very similar Mr value (32-33,000) to PTP was also detected in the above preparations 
(this can be observed in various figures in this chapter). This phenomenon was ignored 
for subsequent experiments, as it can be explained by the formation of transient 
disulphide bonds during electrophoresis (see Section 1.2.5). However, it is also 
possible that the extra band represents minor contamination by the mitochondrial outer 
membrane protein, porin (T. Lever, personal communication) or proteolytically 
degraded PTP.
Figure 3.2.1 also demonstrates that the crucial step in mammalian PTP isolation 
is adsorption chromatography on HTP. Virtually all proteins present in the 8% (w/v) 
Triton X-100 extract remain bound to the column matrix, while only PTP and a few 
other proteins of similar Mr values are present in the eluate. Contaminating bands in this 
supernatant are then adsorbed out by Celite. However it is possible, with careful 
preparation, to obtain a homogeneous isolate of PTP following HTP extraction.
The lack of homogeneous preparations has presented obvious difficulties when 
raising antibodies to PTP, since any contaminating bands may be more immunogenic
Figure 3.2.1: Purification of PTP from rat liver mitochondria
Mitochondria were prepared as described in Section 2.2.7(a), and PTP was 
purified as outlined in Section 2.2.8. Samples were acetone-precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was Coomassie 
blue-stained. Lanes: 1, rat liver mitochondria; 2,0.5% (w/v) Triton X-100 
pre-extracted pellet; 3, 8% (w/v) Triton X-100 extract; 4, HTP-adsorbed extract; 5, 
Celite-adsorbed extract; S, Mr standards.
Figure 3.2.1: Purification of PTP from rat liver mitochondria
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than the chosen antigen. Antibodies represent a powerful biochemical tool and although 
their use is limited in this project, it was decided to raise antiserum against the rat liver 
phosphate carrier in view of the apparent homogeneity of the isolate. Anti-rat liver FTP 
serum was prepared by immunising a New Zealand White rabbit as described in 
Section 2.2.6(a). The antiserum was characterised by employing it for immune replica 
analysis of the various steps in the isolation of rat liver PIP, as illustrated in Figure 
3.2.2. The monospecificity of the anti-PTP serum is clearly demonstrated, as no 
cross-reactivity with any other mitochondrial proteins is apparent
3.2.2 Co-purification of mammalian PTP and ANT
The purification schemes for PTP and its closely related companion protein 
ANT contain many similarities, with the critical stage in both involving adsorption 
chromatography on HTP (see Sections 1.2.4 and 1.2.5). However, ANT will denature 
upon extraction and be adsorbed out by HTP unless it has been stabilised by one of its 
inhibitors, especially carboxyatractyloside (CAT; Klingenberg et al., 1974). 
Accordingly, it was decided to attempt to co-purify mammalian PTP and ANT in the 
HTP-adsorbed extract by carrying out a standard PTP preparation on rat liver
mitochondria which were pre-incubated (when fresh) with 50-100|jM CAT for 30min 
at 4°C. Analysis by SDS-PAGE (Figure 3.2.3) reveals the presence of both PTP and a
30.000-Mr CAT-stabilised polypeptide following chromatography on HTP. The
30.000-Mr protein, assumed to be ANT, is adsorbed out by Celite, which agrees with 
previous observations by Wohlrab (1980) and Wohlrab and Flowers (1982) who 
detected contaminating ANT in their PTP isolates. Figure 3.2.4 illustrates the effect of 
CAT on the isolation of PTP from rat liver mitochondria. In this experiment, a single 
batch of fresh mitochondria was used, with half being pre-incubated with CAT
(IOOjiM) as described above, and half being treated as normal.
ANT will also co-purify with PTP when the above procedure is carried out on 
bovine heart mitochondria pre-loaded with CAT. It is thus possible to co-purify the two 
carriers on a relatively large scale (l-3mg of each).
Comparison of the above procedure for co-purifying PTP and ANT from
Figure 3.2.2: Western blot analysis of PTP purification from rat liver mitochondria 
Mitochondria were prepared as described in Section 2.2.7(a), and PTP was 
purified as outlined in Section 2.2.8. Samples were acetone-precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was transferred to 
nitrocellulose paper and subjected to immune replica analysis with anti-rat liver PTP 
serum. Lanes: 1, rat liver mitochondria; 2,0.5% (w/v) Triton X-100 pre-extracted 
pellet; 3, 8% (w/v) Triton X-100 extract; 4, HTP-adsorbed extract; 5, Celite-adsorbed 
extract; S, Mr standards (l25I-radiolabelled).
Figure 3.2.2: Western blot analysis of PTP purification from rat liver
mitochondria
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Figure 3.2.3: Purification of PTP (+ANT) from rat liver mitochondria pre-incubated
with CAT
Mitochondria were prepared as described in Section 2.2.7(a), and the proteins 
were purified as outlined in Section 3.2.2. Samples were acetone-precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was Coomassie 
blue-stained. Lanes: 1, rat liver mitochondria; 2,0.5% (w/v) Triton X-100 
pre-extracted pellet; 3, 8 % (w/v) Triton X-100 extract; 4, HTP-adsorbed extract; 5, 
Celite-adsorbed extract; S, Mr standards.
Figure 3.2.3: Purification of PTP (and ANT) from rat liver mitochondria
nre-incuhated with CAT
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Figure 3.2.4: Effect of CAT on the -purification of PTP from rat liver mitochondria 
PTP was purified from rat liver mitochondria pre-incubated with the ANT 
inhibitor carboxyatractyloside (CAT; see Section 3.2.2), and also from mitochondria 
not subjected to CAT-pretreatment. In each case the HTP and Celite-adsorbed extracts 
were acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: 1 and 2, HTP and Celite extracts 
respectively; 3 and 4, HTP and Celite extracts (mitochondria pre-incubated with CAT); 
S, Mr standards.
Figure 3.2.4: Effect of CAT on the purification of PTP from rat liver
mitochondria
(Mr x 1 0 " 3 )
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mammalian mitochondria with the established method for the isolation of the ADP/ATP 
carrier (Riccio et al., 1975a,b) reveals that the two methods are essentially identical. 
The only differences that exist are in the type of buffer used (20mM MOPS, pH 7.2 for 
ANT; 20mM H2PO4", pH 7.0 for PTP/ANT), and the inclusion of salt (0.4-0.5M 
NaCl or KC1) in the Triton X-100 solutions when isolating ANT. Accordingly, it was 
decided to assess the effect of investigating these factors in relation to the PTP/ANT 
co-purification procedure described above.
Changing from a phosphate to a MOPS buffer system had absolutely no effect 
on the co-purification of PTP and ANT in the HTP-adsorbed extract from rat liver or 
bovine heart mitochondria. The effect of KC1 on the purification of rat liver PTP and 
ANT was analysed by SDS-PAGE and is illustrated in Figure 3.2.5. The inclusion of 
0.5M KC1 in the 0.5% (w/v) Triton X-100 pre-extraction buffer clearly did not 
influence the final protein content of the subsequent HTP-adsorbed extracts. However, 
the inclusion of 0.5M KC1 in the 8% (w/v) Triton X-100 extraction buffer markedly 
increased the relative content of ANT in the subsequent co-isolate. Nevertheless, it was 
not possible to purify a homogeneous preparation of ANT without significant PTP 
contamination.
3-3 ANALYSIS OF MAMMALIAN PTP AND ANT BY 
COLUMN CHROMATOGRAPHY
3.3.1 Introduction
The above section (3.2.2) describes the methodology for the co-isolation of 
PTP and the closely related ADP/ATP carrier. In order to obtain optimal yields of both 
carriers from a single mitochondrial preparation, it would be necessary to develop a 
procedure for efficiently separating them. Such a procedure would require to identify 
differences between two proteins with a high degree of structural and functional 
homology. In order to achieve this, various types of column chromatography were 
employed. The identification of a column to which only one of the carriers could bind 
and subsequently be eluted from under defined conditions would be sufficient to 
separate PTP and ANT. However, it was hoped to bind both proteins to a suitable
Figure 3.2.5: Effect of KC1 on the purification of ANT and PTP
Rat liver mitochondria pre-incubated with CAT were pie-extracted in the 0.5% 
(w/v) Triton X-100 buffer in the presence and absence of 0.5M KC1. Subsequently, 
extraction of ANT and PTP was carried out with the 8% (w/v) Triton X-100 buffer, 
also in the presence and absence of 0.5M KC1. The extracts were subjected to 
adsorption chromatography on HTP and acetone-precipitated prior to resolution on a 
12.5% (w/v) SDS-polyacrylamide gel which was Coomassie blue-stained. Lanes: 1, 
8% (w/v) Triton X-100 extract + 0.5M KC1; 2, 8% (w/v) Triton X-100 extract 
(Extracts 1 and 2 prepared from mitochondria pre-extracted with 0.5% [w/v] Triton 
X-100); 3 and 4, identical to extracts 1 and 2, except prepared from mitochondria 
pre-extracted with 0.5% (w/v) Triton X-100 + 0.5M KC1; S, Mr standards.
Figure 3.2.5: Effect of KC1 on the purification of ANT and PTP
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column and obtain separation by differential elution. In this manner, it should be 
possible to replace the solubilising detergent Triton X-100 with detergents more 
suitable for physical analyses of the proteins and crystallisation trials.
Co-isolated mammalian PTP and ANT was analysed by various 
chromatographic techniques including FPLC (Fast protein liquid chromatography).
Two pre-packed FPLC columns were used: the MonoQ anion exchanger, and the cation 
exchange MonoS column. In addition to this, the HTP-adsorbed extracts of mammalian 
CAT-loaded mitochondria were analysed using DEAE Affi-gel Blue, DEAE Sephacel, 
CM Cellulose and DEAE Cellulose as well as the Matrex gels, Procion Red A and 
Procion Blue A. Binding experiments were carried out in 20mM Tris HC1 buffer pH
7.0-8.0, 0.5% (w/v) Triton X-100 and the columns (2.0 x 1.0cm in each case) were 
eluted with salt (0-1.0M NaCl). Following analysis of the unbound and NaCl-eluted 
fractions from each column by SDS-PAGE, it was found that, under the above 
conditions, optimal binding of both carriers was achieved using the Matrex gels. 
Although PTP appeared to bind more tightly to Procion Red A, it was readily eluted 
from both columns with NaCl (0.1M for Procion Blue A; 0.25M for Procion Red A). 
However, the binding of ANT to both these gels was observed to be considerably 
stronger, particularly in the case of Procion Blue A, where significant amounts of ANT 
remained bound to the column even after elution with 1% (w/v) SDS. Since it was 
ultimately hoped to obtain homogeneous ANT in its native state, all subsequent 
experiments were carried out using Procion Red A.
3.3.2 Analysis of mammalian PTP and ANT bv FPLC
The HTP-adsorbed extract isolated from rat liver mitochondria pre-incubated 
with CAT was initially analysed by FPLC using the MonoQ anion exchange column. 
The PTP/ANT co-isolate was dialysed into 20mM Tris-HCl pH 8.0 or pH 7.0, 0.5% 
(w/v) Triton X-100, and loaded onto the column which was equilibrated in the same 
buffer. Elution was carried out using a salt gradient (0-1.0M NaCl). Under both 
conditions (pH 8.0 and pH 7.0), a large unbound peak was detected by the trace (see 
Figure 3.3.1), but no peaks were detected during elution with the salt gradient. The 
high levels of Triton X-100 present in the preparation are partly responsible for the 
absorbance of the unbound fraction. Analysis of the unbound fractions and the pooled
Figure 3.3.1: FPLC trace of MonoQ analysis of rat liver mitochondrial f+CAT) HTP 
extract
The HTP-adsorbed fraction containing PTP and ANT was dialysed into 20mM 
Tris-HCl pH 7.0, 0.5% (w/v) Triton X-100, loaded onto a MonoQ column equilibrated 
in the same buffer, and eluted with 0-1.0M NaCl.
Figure 3.3.1: FPLC trace of MonoQ analysis of rat liver
mitochondrial (+CAT) HTP extract
SAMPLE : RAT LIVER PTP/ANT 
CO LUM N: MONOQ 
BUFFER : 20  mM TR IS-H C 1, pH 8.0 
GRADIENT: 0.0 - 1.0M N a C l
LOAD UNBOUND N a C l GRADIENT
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NaCl-eluates by SDS-PAGE, as illustrated in Figure 3.3.2, revealed a more interesting 
result. At the higher pH, ANT binds so tightly to the column that an increase in the 
ionic strength as described above does not lead to its elution. However, a reduction in 
pH of only one unit results in the ADP/ATP carrier co-eluting with PTP in the unbound 
fraction. PTP does not bind to the column under these experimental conditions. The 
above experiment was then repeated at pH values of 7.2 and 7.5 in an attempt to 
identify conditions at which ANT would bind to the column and be eluted by increasing 
ionic strength, thus separating the carriers with PTP in the unbound fraction. However, 
at both pH values, the FPLC trace obtained was as illustrated in Figure 3.3.1. 
SDS-PAGE analysis of the fractions confirmed the absence of any protein in the salt 
eluates. In both cases, PTP and ANT were detected in the unbound fraction, as 
illustrated in Figure 3.3.2 (lanes 4-6).
Since the MonoQ is an anion exchange column, the above results suggest that 
PTP has a net positive charge over the pH range 7.0-8.0, while ANT is also positively 
charged at pH 7.0-7.5. However at pH 8.0, the increase in the negative charge on the 
ADP/ATP carrier appears to be such that it binds very tightly to the column. In view of 
this, it was decided to carry out further FPLC analysis of the rat liver PTP and ANT 
co-isolate using the MonoS cation exchange column. Under suitable conditions, such a 
column should bind only to PTP, leaving ANT in the unbound fraction. Assuming PTP 
could be eluted, separation of the carriers could thus be achieved. Co-purified rat liver 
PTP and ANT was loaded onto the MonoS column as described above for the MonoQ. 
Elution was carried out using a 0-1.0M KH2PO4 gradient. Analysis was carried out 
initially at pH 7.0, then at pH 8.0 and pH 6.0. However in all three cases, the trace 
obtained was identical to that illustrated in Figure 3.3.1, with a large unbound peak but 
no KH2P0 4 ~eluted peaks. SDS-PAGE analysis of the unbound fraction and pooled 
salt-eluates at pH 7.0 is illustrated in Figure 3.3.3, with an identical pattern being 
observed for the corresponding fractions at pH 8.0 and pH 6.0. Thus, over the pH 
range 6.0-8.0, neither PTP nor ANT were found to bind to the MonoS column.
Figure 3.3.2: Analysis of rat liver mitochondrial (+CAT) HTP extract bv FPLC
(MonoQ column)
The HTP-adsorbed extract containing ANT and PTP was dialysed into 20mM 
Tris-HCl pH 8.0 or pH 7.0, 0.5% (w/v) Triton X-100, loaded onto a MonoQ column 
equilibrated in the same buffer, and eluted with a 0-1.0M NaCl gradient. At each pH a 
large unbound fraction was detected and collected, and in each case no peaks were 
detected after elution with the salt gradient. The NaCl-eluates were pooled, concentrated 
by exposure to poly (ethylene glycol) and, like the unbound fractions, 
acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: 1 and 4, rat liver HTP extract; 2 and 3, 
unbound fraction and NaCl-eluate respectively at pH 8.0; 5 and 6 , unbound fraction 
and NaCl-eluate respectively at pH 7.0; S, Mr standards.
Figure 3.3.2: Analysis of rat liver mitochondrial (+CAT) HTP extract bv
FPLC (MonoQ column)
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Figure 3-3.3: Analysis of rat liver mitochondrial (+CAT) HTP extract bv FPLC
(MonoS columnV
The HTP-adsorbed extract was dialysed into 20mM Tris-HCl pH 7.0,0.5% 
(w/v) Triton X-100, loaded onto a MonoS column equilibrated in the same buffer, and 
eluted with a 0-1.0M KH2PO4 gradient. A large unbound fraction was detected and 
collected and, although no peaks were detected during salt-elution, the KH2PO4 eluates 
were collected and pooled. The fractions were concentrated by exposure to poly 
(ethylene glycol) and acetone-precipitated prior to resolution on a 12.5% (w/v)
SDS-polyacrylamide gel which was Coomassie blue-stained. Lanes: 1, rat liver HTP 
extract; 2, unbound fraction; 3, pooled KH2PO4 eluates; S, Mr standards.
Figure 3.3.3: Analysis of rat liver mitochondrial (+CAT) HTP extract bv 
FPLC (MonoS column)
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3.3.3 Analysis of mammalian PTP and ANT bv Procion Red A column
chromatography
The HTP-adsorbed extract isolated from rat liver mitochondria pre-loaded with 
CAT was analysed using 2.0 x 1.0cm columns of the Matrex gel Procion Red A. The 
PTP/ANT co-isolate was dialysed into 20mM Tris-HCl pH 7.0,0.5% (w/v) Triton 
X-100, and loaded onto the column which was equilibrated in the same buffer. Elution 
was carried out using increasing concentrations of NaCl (0.1-1.0M) and finally with 
1% (w/v) SDS. Unbound and eluted fractions were concentrated by exposure to poly 
(ethylene glycol) as described in Section 2.2.2, and prepared for analysis by 
SDS-PAGE (see Figure 3.3.4). As Figure 3.3.4 illustrates, both carriers readily bind to 
the Procion Red A column at pH 7.0. However, whereas PTP is eluted at 0.1-0.5M 
NaCl (optimally at 0.25M), ANT remains bound to the column during treatment with 
salt and is dislodged only upon elution with SDS, which will also result in denaturation 
of the carrier. A further observation was that a significant proportion of the loaded 
PTP behaves in a similar manner to ANT, remaining bound to the column until 
treatment with SDS. This will be discussed in a subsequent section (3.3.4). The 
apparent existence of PTP as a heterodimer in Figure 3.3.4 (Lane 7) is discussed in 
Section 3.2.1. The elution profiles of bovine heart PTP and ANT were found to be 
identical to those observed for the rat liver carriers, under the conditions described 
above (except using a 5.0 x 1.0cm column for the bovine heart co-isolate).
The above results indicate that the binding of PTP to Procion Red A is 
electrostatic, since an increase in ionic strength leads to elution of the carrier. However, 
the mode of binding of ANT to the column is unclear. Matrex gels consist of a highly 
complex molecular structure and, as a result, binding of proteins may involve 
electrostatic interactions, hydrophobic interactions and/or affinity binding.
Consequently, it was decided to repeat the above experiment and attempt to dislodge 
ANT from the column by eluting with an increased concentration of NaCl (3.0M) as 
well as a collection of substrates and substrate analogues (ADP, ATP and NADP; all at 
ImM). SDS-PAGE analysis of the unbound and eluted fractions is illustrated in Figure 
3.3.5. Once again, ANT was observed to elute only upon treatment of the column with 
1% (w/v) SDS. The absence of PTP in the SDS-eluate is discussed in Section 3.3.4.
The possibility that the ADP/ATP carrier binds electrostatically to Procion Red
Figure 3.3.4: Analysis of rat liver mitochondrial f+CAT) HTP extract bv Procion Red
A column chromatography
The HTP-adsorbed fraction containing ANT and PTP was dialysed into 20mM 
Tris-HCl pH 7.0, 0.5% (w/v) Triton X-100, loaded onto a 2.0 x 1.0cm Procion Red A 
column equilibrated in the same buffer, and eluted with 0.1-1.0M NaCl and 1% (w/v) 
SDS. Fractions were collected and acetone-precipitated prior to resolution on a 12.5% 
(w/v) SDS-polyacrylamide gel which was Coomassie blue-stained. Lanes: 1, rat liver 
HTP extract; 2, unbound fraction; 3-6, salt-eluates (0.1, 0.25,0.5 and 1.0M NaCl); 7, 
1% (w/v) SDS eluate; S, Mr standards.
Figure 3.3.4: Analysis of rat liver mitochondrial (+CAT) HTP extract by
Procion Red A column chromatography (1)
(Mr x 10 3 )
-----94
— -----67
----- 43
mm mm •ggf
----- 30
----- 20
1 2 3 4 5 6 7 S
Figure 3.3.5: Analysis of rat liver mitochondrial (+CAT) HTP extract bv Procion Red
A column chromatography
The HTP-adsorbed fraction containing ANT and PTP was dialysed into 20mM 
Tris-HCl pH 7.0,0.5% (w/v) Triton X-100, loaded onto a 2.0 x 1.0cm Procion Red A 
column equilibrated in the same buffer, a n d  eluted with 0.1-3.0M NaCl, ImM ADP, 
ImM ATP, ImM NADP and 1% (w/v) SDS. Fractions were collected and 
acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: 1, rat liver HTP extract; 2, unbound 
fraction; 3-7, salt-eluates (0.1,0.25, 0.5,1.0 and 3.0M NaCl); 8 , ADP-eluate; 9, 
ATP-eluate; 10, NADP-eluate; 11, SDS-eluate; S, Mr standards.
(The co-isolate used in this experiment was extracted in the presence of lmg/ml 
cardiolipin [see Section 3.3.4])
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A was further investigated by determining the pH-dependence of the binding and 
elution profiles of the carriers with respect to the column. Accordingly, the analysis of 
the rat liver PTP and ANT co-isolate by Procion Red A column chromatography (as 
described above) was repeated at pH 6.0 (using KPj as the buffer) and pH 8.0 
(Tris-HCl). When the unbound and eluted fractions were analysed by SDS-PAGE the 
results obtained were identical to those illustrated in Figure 3.3.4 at both pH values. 
However, when the experiments were repeated with the HTP-adsorbed extract isolated 
from CAT-loaded bovine heart mitochondria, a small amount of ANT was detected in 
the 1.0M NaCl-eluate at pH 8.0 (see Figure 3.3.6). The elution profile of PTP was not 
affected, with optimal dislodgement of the carrier occuring at 0.25M NaCl, as 
illustrated in Figure 3.3.6. The data thus suggested that, by increasing the pH from 7.0 
to 8.0, the net negative charge on bovine heart ANT is increased sufficiently (or the net 
positive charge is sufficiently decreased) for a proportion of the bound carrier to elute 
upon increasing ionic strength. The failure of rat liver ANT to elute under the same 
conditions could be explained by a slightly different net charge on the protein.
In an attempt to increase the yield of NaCl-eluted ANT and separate the carriers 
more effectively, the analysis of the bovine heart PTP and ANT co-isolate by Procion 
Red A column chromatography was repeated at pH 8 .8 . SDS-PAGE analysis of the 
fractions is illustrated in Figure 3.3.7, and clearly demonstrates the efficient separation 
of homogeneous populations of PTP (optimally eluted at 0.25M NaCl) and ANT 
(eluted at 1.0M NaCl). At pH 8 .8 , all bound ANT was salt-eluted, with none of the 
carrier being detected in the SDS-eluate (see Figure 3.3.7). When this experiment was 
repeated with rat liver PTP and ANT, and the fractions analysed by SDS-PAGE, the 
pattern observed was identical to that illustrated in Figure 3.3.7. Therefore, although 
ANTs from bovine heart and rat liver sources have slightly different elution profiles at 
pH 8.0, this discrepancy is corrected by a further increase in pH. This indicates that the 
varying elution profiles of the two mammalian ANTs at pH 8.0 is due to a slight 
difference in their overall charges, as previously suspected.
Following chromatographic separation, the identities of the bovine heart PTP 
and ANT were confirmed by N-terminal analysis, as described in Section 2.2.3. The 
primary sequences were compared to those previously described by Aquila et al.
Figure 3.3.6: Preliminary separation of bovine heart mitochondrial ANT and PTP bv 
Procion Red A column chromatography
The HTP-adsorbed fraction (from mitochondria pre-incubated with CAT) 
containing ANT and PTP was dialysed into 20mM Tris-HCl pH 8.0, 0.5% (w/v) 
Triton X-100, loaded onto a 5.0 x 1.0cm Procion Red A column equilibrated in the 
same buffer, and eluted with 0.1-3.0M NaCl. Fractions were collected and 
acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: S, Mr standards; 1, unbound fraction; 2-6, 
salt-eluates (0.1, 0.25, 0.5,1.0 and 3.0M NaCl).
Figure 3.3.6: Preliminary separation of bovine heart mitochondrial PTP 
and ANT bv Procion Red A column chromatographv
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Figure 3.3.7: Separation of bovine heart mitochondrial ANT and PTP bv Procion Red 
A column chromatography
The HTP-adsorbed extract (from mitochondria pre-incubated with CAT) 
containing ANT and PTP was dialysed into 20mM Tris-HCl pH 8 .8 ,0.5% (w/v) 
Triton X-100, loaded onto a 5.0 x 1.0cm Procion Red A column equilibrated in the 
same buffer, and eluted with 0.1-1.0M NaCl and 1% (w/v) SDS. Fractions were 
collected and acetone-precipitated prior to resolution on a 12.5% (w/v)
SDS-polyacrylamide gel which was Coomassie blue-stained. Lanes: S, Mr standards; 
1, unbound fraction; 2-5, salt-eluates (0.1,0.25, 0.5 and 1.0M NaCl); 6 , 1% (w/v) 
SDS eluate.
(The co-isolate used in this experiment was extracted in the presence of lmg/ml 
cardiolipin [see Section 3.3.4])
Figure 3.3.7: Separation of bovine heart mitochondrial PTP and ANT bv 
Procion Red A column chromatography
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(1982b) for ANT and Runswick et al. (1987) for PTP.
3.3.4 Procion Red A column chromatography represents an assay for native PTP 
conformation
During analysis of the HTP-adsorbed extracts from mammalian mitochondria 
pre-loaded with CAT by Procion Red A column chromatography, a discrepancy was 
noted in the elution profile of PTP. While some of the carrier was eluted with NaCl 
(optimally at 0.25M), a significant proportion remained bound to the column until 
treatment with SDS (see Figure 3.3.4). However, when cardiolipin (lmg/ml) was 
included in the extraction of the co-isolate (see Section 2.2.8), as in Figures 3.3.5 and 
3.3.7, no PTP was detected in the SDS-eluate. This was re-examined by repeating the 
experiment illustrated in Figure 3.3.4, using rat liver mitochondria from the same 
preparation, but including cardiolipin (lmg/ml) in the extraction buffer. Analysis of the 
column fractions by SDS-PAGE clearly demonstrates the lack of significant quantities 
of PTP in the SDS-eluate (see Figure 3.3.8), with almost all the bound carrier being 
NaCl-eluted. The inclusion of cardiolipin had no observed effect on the subsequent 
elution profile of ANT at pH 7.0.
The above observations indicate that two distinct populations of PTP exist in the 
mammalian co-isolates, and both are capable of binding to Procion Red A. However, 
only one population can be eluted with NaCl, and the inclusion of cardiolipin in the 
purification procedure appears to greatly increase the proportion of the carrier in this 
conformation. As discussed previously (see Section 1.2.6), cardiolipin is thought to 
maintain PTP in its native conformation in reconstitution studies (Kadenbach et al., 
1982; Mende et al., 1982; Cheneval et al., 1983). It can thus be postulated that the 
fraction of PTP which is NaCl-eluted from the Procion Red A column exists in a native 
conformation, an important pre-requisite for physical analyses and crystallisation trials 
prior to X-ray diffraction studies.
This hypothesis was further tested by analysing denatured mammalian 
mitochondrial co-purified PTP and ANT by Procion Red A column chromatography. 
The HTP-adsorbed fraction from CAT-loaded rat liver mitochondria was 
heat-denatured at 80°C for lOmin prior to loading onto a 2.0 x 1.0cm Procion Red A 
column. Analysis of the column fractions by SDS-PAGE is illustrated in Figure 3.3.9,
Figure 3.3.8: Analysis of rat liver mitochondrial (+CAT) HTP extract f+cardiolipin) bv
Procion Red A column chromatography
The HTP-adsorbed fraction containing ANT and PTP was prepared in the 
presence of lmg/ml cardiolipin (see Section 2.2.8), dialysed into 20mM Tris-HCl pH 
7.0, 0.5% (w/v) Triton X-100, loaded onto a 2.0 x 1.0cm Procion Red A column 
equilibrated in the same buffer, and eluted with 0.1-3.0M NaCl and 1% (w/v) SDS. 
Fractions were collected and acetone-precipitated prior to resolution on a 12.5% (w/v) 
SDS-polyacrylamide gel which was Coomassie blue-stained. Lanes: 1, rat liver HTP 
extract; 2, unbound fraction; 3-8, salt-eluates (0.1, 0.25, 0.5,1.0,2.0 and 3.0M 
NaCl); 9,1%  (w/v) SDS eluate; S, Mr standards.
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Figure 3.3.9: Analysis of denatured rat liver mitochondrial (+CAT) HTP extract bv
Procion Red A column chromatography
The HTP-adsorbed fraction containing ANT and PTP was dialysed into 20mM 
Tris-HCl pH 8 .8 , 0.5% (w/v) Triton X-100, heat-denatured at 80°C for lOmin, loaded 
onto a 2.0 x 1.0cm Procion Red A column equilibrated in the same buffer, and eluted 
with 0.1-1.0M NaCl and 1% (w/v) SDS. Fractions were collected and 
acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: 1, rat liver HTP extract; 2, unbound 
fraction; 3-6, salt-eluates (0.1,0.25,0.5 and 1.0M NaCl); 7,1%  (w/v) SDS eluate; S, 
Mr standards.'
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and clearly demonstrates that denatured PTP binds to the Matrex gel but is eluted only 
upon treatment with SDS. This lends further support to the proposal that the Procion 
Red A column represents an assay for native PTP conformation. As this experiment 
was performed at pH 8 .8 , it was also possible to determine the effect of 
heat-denaturation on the elution profile of ANT. Figure 3.3.9 illustrates that ANT also 
remains bound to the column until treatment with SDS, indicating that the Matrex gel 
may represent an assay for both these carriers in their native states.
3.3.5 Preparation of PTP for analysis bv Circular Dichroism
The preceding Sections (3.3.3 and 3.3.4) outline the methodology for the 
elution of a homogeneous population of native mammalian PTP from a Procion Red A 
column. Thus, important criteria for further analysis of the carrier have been satisified. 
However, the detergent used in the preparation of PTP, Triton X-100, is unsuitable for 
both circular dichroism (CD) studies and X-ray crystallography. The non-ionic 
detergents most commonly used for physical analysis and crystallographic studies on 
membrane proteins are lauryl dimethyl amine oxide (LDAO), n- octylglucoside and n- 
laurylmaltoside. However, with the exception of LDAO, the cost of these detergents 
limits their use in the large-scale preparation of a membrane carrier such as PTP. It was 
thus decided to employ the Procion Red A Matrex gel in an attempt to obtain purified 
native PTP solubilised in each of the above detergents in place of Triton X-100.
The concentrations of LDAO, n- octylglucoside and n- laurylmaltoside to be 
used for solubilising PTP were chosen after reference to the critical micelle 
concentration (CMC) values of the detergents. Although data were unavailable for 
LDAO, a concentration of 1% (w/v) was used on the basis of previous studies in our 
laboratory. For n- laurylmaltoside, a concentration of 0.5% (w/v) was chosen, easily 
fulfilling the criteria that a detergent should be used above its CMC value (Womack et 
al., 1983) and at a detergent/protein weight ratio of at least 10 (Matson and Goheen, 
1986). In contrast, n- octylglucoside has an extremely high CMC value (0.73% [w/v]), 
~50-100x greater than those of n- laurylmaltoside (0.006% [w/v]) and Triton X-100 
(0.015% [w/v]). A concentration of 1% (w/v) was chosen for this detergent. Although 
this exceeds the CMC value, potential solubility problems were envisaged since the 
detergent/protein weight ratio may, on-some occa sions, be less than 10. The cost of
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this detergent limited its use at higher concentrations.
Initial attempts to switch PTP from solution in Triton X-100 to detergents 
suitable for analysis by CD were carried out using the rat liver carrier. Ultimately 
though, bovine heart PTP would be used to maximise protein yield. The HTP-adsorbed 
fraction (extracted in the presence of lmg/ml cardiolipin) from CAT-loaded rat liver 
mitochondria was dialysed into 20mM Tris-HCl pH 7.0, 0.5% (w/v) Triton X-100, 
and loaded onto a 2.0 x 1.0cm Procion Red A column equilibrated in the same buffer. 
Subsequently, the column was washed firstly with 5 vol 20mM Tris-HCl pH 7.0 (to 
wash out the Triton X-100), then with 5 vol of the same buffer supplemented with 1% 
(w/v) LDAO. 5 vol 20mM Tris-HCl pH 7.0,1% (w/v) LDAO, 0.25M NaCl was then 
applied to the column to elute the PTP. This experiment was also carried out using 
0.5% (w/v) n- laurylmaltoside and 1% (w/v) n- octylglucoside in place of LDAO. 
Eluates were concentrated in Novacell stirred cells (see Section 2.2.2) and analysed by 
SDS-PAGE. In all three cases, no PTP was detected in the NaCl-eluted fractions. 
However, when the columns were washed with 1% (w/v) SDS, the carrier was eluted 
in each case.
It was presumed that, in the above experiments, precipitation of PTP had 
occurred in the absence of detergent when the columns were washed with 20mM 
Tris-HCl pH 7.0. It was thus decided to repeat the chromatographic analyses, omitting 
the detergent-free wash in each case. SDS-PAGE analysis of the fractions demonstrated 
quantitative recovery of PTP in the 0.25M NaCl-eluates using all three detergents. The 
transfer of PTP from solution in Triton X-100 to n- octylglucoside is illustrated in 
Figure 3.3.10.
Subsequently, it was shown that bovine heart PTP can be transferred from 
solution in Triton X-100 to the other non-ionic detergents by application of the above 
methodology, except using a 5.0 x 1.0cm Procion Red A column. Bovine heart PTP 
was prepared in 0.5% (w/v) n- laurylmaltoside and 1% (w/v) n- octylglucoside for 
analysis by CD at the SERC-funded facility at Stirling University (see Section 2.2.10). 
Small samples of these preparations were also reserved for determination of protein 
concentration by amino acid analysis (see Section 2.2.1). It was thus possible to 
confirm the identity of the purified carrier as PTP from its amino acid content and 
subunit molecular weight. However, the protein concentrations obtained were
Figure 3.3.10: Transfer of rat liver mitochondrial PTP from solution in Triton X-100 to
n- octylglucoside
The rat liver HTP extract containing PTP and ANT was dialysed into 20mM 
Tris-HCl pH 7.0, 0.5% (w/v) Triton X-100 (buffer A) and loaded onto a 2.0 x 1.0cm 
Procion Red A column equilibrated in the same buffer. The column was then 
re-equilibrated in 20mM Tris-HCl pH 7.0,1.0% n- octylglucoside (buffer B) and the 
PTP eluted with 0.25M NaCl in buffer B. Fractions were collected and 
acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: 1, HTP extract; 2, unbound fraction; 3, 
0.25M NaCl eluate; 4 ,1.0M NaCl eluate; S, Mr standards.
(The co-isolate used in this experiment was extracted in the presence of lmg/ml 
cardiolipin)
Figure 3.3.10: Transfer of rat liver PTP from solution in Triton X-100 
to n- octylglucoside
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considerably lower than expected (0.02-0.05mg/ml). This may be due to some 
denaturadon of the Procion Red A-bound carrier during the detergent switch and/or the 
adhesion of mixed PTP-detergent micelles to the filter during protein concentration in 
Novacell stirred cells. In the case of n- octylglucoside, the detergent/protein weight 
ratio may be low enough to inhibit solubilisation of the PTP.
The CD spectra of bovine heart PTP in n- octylglucoside and n- laurylmaltoside 
are illustrated in Figure 3.3.11. The spectra show that there is very good correlation 
between the secondary structures of the carrier in both detergents. Computer analysis of 
the data in conjunction with the calculated protein levels revealed the values for the 
nature of the secondary structure in each case (see Figure 3.3.11). The extremely high
a-helical contents (85-95%) are at least double the 41 % value reported by Aquila 
(unpublished data) for ANT and UCP, and may be partly the result of discrepancies 
caused by the spectra being so noisy over the range 190-200nm. However, bovine 
heart PTP has at least 6 transmembrane domains and is also extremely resistant to 
proteolysis (Phelps, 1987), indicating that such high values may not be unreasonable. 
Considerable doubt must also be placed on Aquila's data which was both unpublished 
and reported when the technology associated with spectropolarimeters was severely 
restricted. In addition, limited data bases were available for the calculation of secondary 
structures.
In n- octylglucoside, PTP was calculated to contain a small (5%) (3-sheet 
structure, which may correspond to the putative 7th transmembrane domain (Aquila et 
al., 1985) proposed for PTP, ANT and other related carriers (see Section 1.2.9).
However, in n- laurylmaltoside, no evidence was obtained for the presence of (3-pleated 
sheet structures.
The preparation of bovine heart PTP in 1% (w/v) n- octylglucoside was also 
employed to analyse the denaturation spectra of the purified carrier in this detergent. 
PTP was denatured by incubation with increasing concentrations (2.0-6.0M) of 
guanidine-HCl (GdnHCl), as described in Section 2.2.10, prior to secondary structure 
analysis by CD. The resulting spectra (see Figure 3.3.12) are illustrated over the 
wavelength range 210-260nm in order to concentrate on the main changes in secondary
Figure 3.3.11: CD spectra for bovine heart PTP
Bovine heart PTP was prepared in 1% (w/v) n- octylglucoside and 0.5% (w/v) 
n- laurylmaltoside, and CD-analysed using a spectropolarimeter linked to data 
processors.
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Figure 3.3.12: CD spectra for bovine heart PTP in the presence of GdnHCl
Bovine heart PTP was prepared in 1% (w/v) n- octylglucoside for analysis by 
CD. Samples of the purified protein were prepared in the presence and absence of 
varying concentrations of guanidine-HCl (GdnHCl), with the spectra being recorded 
15min after the addition of this reagent.
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structure, which occur at 210-230nm. Figure 3.3.12 demonstrates that the largest such
change at [^225 occurs between 2.0 and 2.5M GdnHCl, corresponding to the
denaturation of secondary structure. Based upon this data, bovine heart PTP remains 
essentially in its native conformation at GdnHCl concentrations of up to approximately 
2.0M. However, at concentrations above this level the carrier is rapidly denatured. This 
experiment was not repeated in an alternative detergent to determine the effect of this on 
the stability of PTP. In addition to this, no equivalent data were available for 
structurally related proteins for comparison with that obtained for PTP.
3.4 DISCUSSION
A variety of studies were carried out on the inner membrane carriers, PTP and 
ANT, from both rat liver and bovine heart mitochondria. PTP was purified to 
homogeneity from both mammalian sources, and monospecific high titre antiserum was 
raised against the rat liver carrier. In addition, it was found that, by pre-incubating 
freshly-prepared mitochondria with CAT, it was possible to stabilise the ADP/ATP 
carrier, thus facilitating the co-purification of the two inner membrane proteins (PTP 
and ANT) following adsorption chromatography on HTP. Further fractionation with 
Celite adsorbed out ANT.
The co-isolation procedure for PTP and ANT is almost identical to the reported 
methodology for purifying the ADP/ATP carrier to apparent homogeneity (Riccio et al., 
1975a,b), except that salt (0.5M NaCl or KC1) is included in the extraction buffer of the 
latter procedure. However, although the inclusion of 0.5M KC1 in the extraction buffer 
of the co-isolate increased the proportion of ANT present, it was not possible to purify 
the translocase in this manner without significant PTP contamination. This result places 
an element of doubt on the observations of Riccio et al. (1975a,b), and subsequent 
reports on the purification and characterisation of ANT (Kramer et al., 1977; Kramer 
and Klingenberg, 1977a,b; Kramer and Klingenberg, 1979). Significantly, none of the 
above reports includes an illustration of the analysis of ANT isolation by SDS-PAGE.
It therefore seems likely that the results presented in these reports may have been 
influenced by the presence of contaminating PTP in the ANT preparations.
Various types of column were employed in an attempt to chromatographically
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separate co-purified PTP and ANT. Initially, the co-isolate was applied to the FPLC 
columns, MonoQ (an anion exchanger) and MonoS (a cation exchanger). However, 
neither of these was found to be suitable for separation of the carriers. PTP did not bind 
to either column under the conditions tested, while ANT was found to bind only to the 
MonoQ column at pH 8.0. Although ANT remained in the unbound fraction over the 
pH range 7.0-7.5, it was not possibleto identifythe conditions at which the bound carrier 
could be eluted from the column by increasing the ionic strength (0-1.0M NaCl 
gradient). Such a binding pattern indicates that the adsorption of ANT to the MonoQ 
column is not solely electrostatic. No conditions were identified at which either carrier 
bound to the MonoS column.
In contrast to the FPLC columns, both PTP and ANT were observed to bind to 
the Matrex gel, Procion Red A, at pH 7.0. Although PTP was eluted with NaCl 
(optimally at 0.25M), elution of ANT resulted only after washing the column with 
SDS. However, when the pH was raised to 8 .8 , co-purified PTP and ANT were 
separated into homogeneous populations by differential elution from the Procion Red A 
column. PTP was eluted with 0.25M NaCl, ANT with 1.0M NaCl. Since this 
separation procedure works for both rat liver and bovine heart co-isolates, it is possible 
to purify large (l-3mg) quantities of both carriers from a single mitochondrial 
preparation. Following separation, the identities of the bovine heart carriers were 
confirmed by N-terminal protein sequence analysis.
The Procion Red A column was also found to represent an assay for native PTP 
conformation, an important pre-requisite for physical studies of the carrier and 
crystallisation trials. Heat-denatured PTP binds to Procion Red A, but can only be 
eluted with SDS. The inclusion of cardiolipin in the extraction process resulted in a 
greater proportion of the carrier being detected in the 0.25M NaCl-eluate. This was 
presumed to be due to the reported enhancement of PTP activity by this lipid (see 
Section 1.2.6). The use of this Matrex gel as an assay for native PTP conformation is 
particularly beneficial in view of the difficulty in reconstituting active PTP into artificial 
liposomes, and the low affinity of the carrier for its substrate, Pj. However, in future it 
will be necessary to assess the potential of Procion Red A as an assay for the native 
carrier by comparing the Pj-exchange activities of reconstituted PTP populations with
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their elution profiles from the Matrex gel.
The conformations of the two PTP populations described above were not 
investigated. It is possible that PTP binds electrostatically to Procion Red A, but is 
eluted by increased ionic strength (0.25M NaCl) only if the carrier is in a homodimeric 
state, the proposed native conformation of Kramer and Klingenberg (1979) for ANT 
and related carriers. The complex molecular structure of Matrex gels would permit such 
a phenomenon. It would thus be reasonable to assume that Procion Red A also 
represents an assay for native ANT activity. Chromatographic analysis of the denatured 
PTP/ANT co-isolate at pH 8.8 indicated that this is the case. The conformation of 
purified ANT can be further checked by application to an HTP column, which would 
adsorb out any denatured carrier (Klingenberg et al., 1974; Schleyer and Neupert, 
1984).
Procion Red A column chromatography was also employed as a technique for 
transferring PTP from solution in Triton X-100 to non-ionic detergents suitable for 
physical analyses and crystallography trials. Although PTP was successfully 
transferred into LDAO, n- laurylmaltoside and n- octylglucoside, significant reductions 
in protein yields (~70-80%) were frequently observed during this process. This was 
thought to be due to some denaturation of the bound carrier during the detergent switch 
and/or attachment of mixed PTP-detergent micelles to the filter during protein 
concentration in Novacell stirred cells. Further research is required to minimise this 
protein loss, particularly in view of the relatively high protein concentrations required 
for crystallisation trials. Although the formation of crystals suitable for X-ray 
diffraction studies from membrane proteins is a difficult process, the techniques have 
been employed previously in our laboratory to analyse the B800-850 light harvesting 
complex from Rps. acidophila (strain 10050), and determine its oligomeric state (Papiz 
et al., 1989). Ultimately, it is hoped that, by obtaining crystals of PTP suitable for 
X-ray diffraction studies, it will be possible to elucidate the high resolution 
three-dimensional structure of the protein. This in turn should lead to a greater 
understanding of the molecular mechanisms underlying the membrane insertion, 
intramembrane organisation and catalytic mechanisms of a family of related 
mitochondrial carriers (PTP, ANT, UCP, etc. ; see Section 1.2.9). In addition, the 
highly refined X-ray structure of PTP should reveal the protein's substrate-binding site,
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inviting comparison with the recently reported ligand-binding site of a bacterial 
phosphate transport protein (Luecke and Quiocho, 1990). Originally crystallised four 
years earlier (Kubena et al., 1986), this phosphate-binding protein (PBP) is not, like 
the mammalian PTP, a transmembrane carrier, but instead is a periplasmic protein 
which acts as an initial high-affinity receptor for an osmotic active transport system for 
phosphate. This bacterial transport system involves the co-operation of a variety of 
proteins. It is likely that PBP and PTP possess structurally different substrate-binding 
sites since the bacterial protein, unlike the mammalian carrier, contains a very tight 
phosphate-binding site, which can also bind to and facilitate the transport of arsenate 
(Kubena et al., 1986; Luecke and Quiocho, 1990).
Although the transfer of ANT from solution in Triton X-100 to alternative 
non-ionic detergents was not investigated, it is likely that the Procion Red A column 
could be employed for this carrier also. Figure 3.4.1 outlines a proposed scheme for 
the preparation of mammalian PTP and ANT for physical analyses and X-ray 
crystallography.
Bovine heart PTP was prepared in 0.5% (w/v) n- laurylmaltoside and 1.0% 
(w/v) n- octylglucoside for analysis by CD. The secondary structure of the carrier was
extremely similar in each case, with a-helical content in the range 85-95%, suggesting 
that PTP was in a native conformation in both detergents. Although possibly rather
high, such a value for a  structure is not unrealistic in view of the 6-7  transmembrane 
domains possessed by PTP, and the protease-resistance of the carrier in the membrane 
(Phelps, 1987). CD analysis also indicated a slight structural difference in each
detergent: the 5% p-sheet structure present in n- octylglucoside, which may correspond 
to the putative 7th transmembrane domain, was not detected in n- laurylmaltoside. The 
low level of this secondary structure observed in the former detergent may be below the 
level of significance.
Another possible reason for the apparently high a-helical content of PTP is the 
procedure adopted to deduce the secondary structure of CD-analysed proteins. This 
CONTIN procedure (Provencher and Glockner, 1981) is based on reference CD 
spectra derived ffom 16 actual globular proteins of known secondary structure (from
Figure 3.4.1: Preparation of mammalian PTP and ANT for nhvsieal 
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X-ray diffraction studies). When used to analyse the CD spectra of other globular 
proteins, the reference values in the CONTIN data are appropriate. However, this may 
not be the case for non-globular and membrane-spanning proteins. Chen et al. (1974) 
report that the mean residue weight CD signal due to a helix is actually a function of the 
helix length, increasing to a limit as the helix lengthens. Thus, for proteins with very 
high helical content or long stretches of helix, the CONTIN reference values may not be 
appropriate and may overestimate the % helical content This may be the case for a 
membrane-spanning protein such as PTP.
By incubating bovine heart PTP in n- octylglucoside with increasing 
concentrations of GdnHCl (2.0-6.0M), it was also possible to obtain the denaturation 
spectra for the carrier in this detergent. CD analyses indicated that the largest change in 
the spectrum occurred between 2.0 and 2.5M GdnHCl, corresponding to the rapid loss 
of secondary structure. However, no comparison with structurally related proteins was 
possible as no such data have been reported in the literature. In future, it is hoped to 
repeat the CD analyses of native and denatured PTP in different detergents, and 
compare the data with that obtained previously, and also with equivalent analyses of the 
bovine heart ADP/ATP carrier, prepared as described in Section 3.3.3. In this manner, 
it will be possible to assess the stability of ANT and PTP in a variety of detergents and 
determine which is the most suitable for crystallisation trials on the carriers.
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CHAPTER 4: ISOLATION AND CHARACTERISATION OF
THE YEAST MITOCHONDRIAL PHOSPHATE AND 
ADENINE NUCLEOTIDE CARRIERS 
4.1 INTRODUCTION
In recent years, much biochemical and genetic research has been carried out 
using yeast, in particular strains of the baker's yeast S.cerevisiae. As a result, classical 
genetics have become highly developed in this organism, making it a suitable model for 
both advanced molecular genetic analyses and further biochemical research. In our 
laboratory, the use of S.cerevisiae as a biochemical model has been facilitated by the 
availability of large quantities of baker's yeast (see Section 2.1.4).
Recent work in our laboratory has identified a 30,000-Mr polypeptide in 
S.cerevisiae whole cell and mitochondrial extracts which cross-reacts strongly with 
antibodies raised against rat liver PTP (Gibb, 1985). It has been further demonstrated 
that the cytosolic precursor of this putative yeast PTP lacks a cleavable presequence 
(Hodgson et al., 1988; see Section 4.2). Since Wohlrab's group were attempting to 
clone and sequence the gene encoding yeast PTP at this stage (Phelps et al., 1991), it 
was decided to develop and optimise a procedure for purifying this carrier from yeast 
mitochondria. This was carried out by taking advantage of the aforementioned 
cross-reactivity of anti-rat liver PTP serum with the equivalent yeast carrier, and by 
utilising the established procedure for the preparation of mammalian PTP (Gibb et al., 
1986). Further protein-chemical analyses were performed to establish a method for 
co-purifying PTP and the closely associated ANT from yeast mitochondria, and to 
carry out preliminary characterisation of the carriers.
4.2 BIOSYNTHESIS OF YEAST PTP
The biosynthesis of the 30,000-Mr putative yeast PTP identified by Gibb 
(1985) was investigated by immune replica analysis of CCCP-inhibited yeast cells. In 
this study, cell extracts containing accumulated cytosolic precursors were prepared 
following growth of the yeast petite (rho") mutant S.cerevisiae D273-10B-1 in the 
presence of the respiratory uncoupler CCCP, as described in Section 2.2.15 (Reid and
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Schatz, 1982). Cell extracts were subjected to analysis by SDS-PAGE followed by 
Western blotting with antiserum raised against bovine heart pyruvate dehydrogenase 
multienzyme complex (PDC; see Figure 4.2.1), and anti-rat liver PTP serum (see 
Figure 4.2.2). Figure 4.2.1 clearly demonstrates the presence of higher-Mr precursors
of subunits of yeast PDC (El(3 and E2; no cross-reaction of yeast E la , E3 or X with 
bovine anti-PDC serum was observed). Accumulation of pre-E2, with an Mr value 
3-4,000 greater than its mature counterpart, is particularly apparent. In contrast, the 
presence of a higher-Mr precursor to the putative yeast PTP is not detected (see Figure 
4.2.2) suggesting that pre-PTP exhibits a similar mobility to the mature carrier.
These results are bome out by densitometric scanning of the immune blots 
illustrated in Figures 4.2.1 and 4.2.2, with the data being presented graphically (see
Figure 4.2.3). In the presence of l-5|iM  CCCP, an increase in the levels of pre-PDC 
E2 per cell is observed, corresponding to decreasing levels of its mature equivalent.
The apparent reduction in precursor accumulation at CCCP concentrations >5|iM 
reflects significant inhibition of growth of S.cerevisiae D273-10B-1 at these levels of 
the uncoupler. In the case of PTP, constant levels of the 30,000-Mr polypeptide per cell 
irrespective of CCCP concentration indicates the absence of a higher-Mr cytosolic 
precursor of this protein. A decline in the levels of the 30,000-Mr putative yeast PTP 
per cell upon increasing CCCP concentrations (as observed for PDC E2) would have 
indicated the presence of an undetectable higher-Mr pre-PTP.
The results in this section indicate that yeast PTP, unlike its mammalian 
counterparts (Runswick et al., 1987; Ferreira et al., 1989), is not initially synthesised 
with a proteolytically-cleavable N-terminal extension. In common with ANT from 
various sources, this protein may contain an internal sequence responsible for 
mitochondrial targeting (see Section 1.1.6.2).
Figure 4.2.1: Accumulation of PDC subunit precursors in veast cells inhibited bv
CCCP
As described in Section 2.2.15, cell extracts were prepared from S.cerevisiae 
D-273-10B-1 grown on YPG in the presence of increasing concentrations of CCCP (0,
1, 2, 5,10 and 20 jiM as illustrated). Extracts w ere subjected to SDS-PAGE prior to 
im m une replica analysis w ith anti-bovine heart PDC serum. Lanes: S, Mr standards 
(125i_radiolabelled).
Figure 4t2,l: Accumulation of PDC subunit precursors in veast cells
inhibited with CCCP
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Figure 4.2.2: Accumulation of PTP precursors in veast cells inhibited bv CCCP
As described in Section 2.2.15, cell extracts were prepared from S.cerevisiae 
D273-10B-1 grown in the presence of increasing concentrations of CCCP (0,1, 2, 5,
10 and 20 pM in lanes 1, 2, 3, 4, 5, and 6  respectively). Extracts were subjected to 
SDS-PAGE prior to immune replica analysis with anti-rat liver PTP serum. Lanes: 7, 
purified rat liver PTP; 8 , Mr standards (125I-radiolabelled).
The apparent low Mr value bands in lanes 2 and 3 represent contaminating
1 I
l25I-radiolabelled protein A and not immunogenic polypeptides.
Figure 4.2.2: Accumulation of PTP precursors in veast cells inhibited
with CCCP
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Figure 4.2.3: Densitometric scan of precursor accumulation in CCCP-inhibited veast
cells
The Western blots illustrated in Figures 4.2.1 and 4.2.2 were further analysed 
by scanning densitometry, as described in Section 2.2.6(b). The data are illustrated
graphically as percent mature antigen versus CCCP concentration (fiM).
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Figure 4.2.3: Densitometric scan of precursor accumulation in
CCCP-inhihited veast cells
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4.3 PURIFICATION OF YEAST PTP AND ANT
4.3.1 Purification of veast PTP
The phosphate carrier was isolated from yeast (S. cerevisiae) mitochondria 
basically by employing the purification scheme previously described for the equivalent 
mammalian protein (see Section 2.2.8). Mitochondria were prepared from yeast tablets 
supplied by DCL Ltd. (see Section 2.1.4), as described in Section 2.2.7(c). The 
organelles were pre-extracted with a 0.5% (w/v) Triton X-100 buffer, and the resultant 
pellet extracted with 8% (w/v) Triton X-100 prior to fractionation with hydroxylapatite 
(HTP) and Celite. Fractions from the various purification steps were analysed by 
SDS-PAGE (see Figure 4.3.1), revealing an apparently homogeneous 30,000-Mr 
polypeptide following adsorption chromatography on Celite. As with the corresponding 
mammalian preparation, the critical step in the isolation of the putative yeast PTP is 
HTP fractionation (see Figure 4.3.1). Virtually all proteins present in the 8 % (w/v) 
Triton X-100 extract are adsorbed out by the column matrix, with only PTP and, on 
occasions, a few other proteins of similar Mr values remaining in the unbound fraction. 
Further treatment with Celite adsorbs out these contaminating proteins. However, as 
Figure 4.3.1 illustrates, it is possible, with careful preparation, to obtain a 
homogeneous preparation of the 30,000-Mr yeast protein following HTP extraction.
Preliminary characterisation of the putative yeast PTP was carried out 
immunologically in order to ensure that it corresponds to the 30,000-Mr protein 
identified by Gibb (1985), which cross-reacts strongly with anti-rat liver PTP serum.
In addition to this, antiserum was raised against the purified yeast protein by 
immunising a New Zealand White rabbit as described in Section 2.2.6(a). This 
antiserum was also characterised by employing it for immune replica analysis of the 
various steps in purification of the putative yeast PTP. Immunological characterisation 
of the yeast protein and its antiserum is illustrated in Figure 4.3.2. Fractions from the 
yeast PTP purification scheme were subjected to SDS-PAGE prior to Western blot 
analysis using antisera raised against both the rat liver and yeast carriers. The 
monospecificity of the anti-yeast PTP serum is clearly demonstrated by Figure 
4.3.2(A), as no cross-reactivity with any other mitochondrial proteins is apparent.
Figure 4.3.1: Purification of PTP from veast (S.cerevisiae) mitochondria
Mitochondria were prepared as described in Section 2.2.7(c), and PTP was 
purified as outlined in Section 4.3.1. Samples were acetone-precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was Coomassie 
blue-stained. Lanes: 1, yeast mitochondria; 2,0.5% (w/v) Triton X-100 pre-extracted 
pellet; 3, 8% (w/v) Triton X-100 extract; 4, HTP-adsorbed extract; 5, Celite-adsorbed 
extract; S, Mr standards.
Figure 4.3.1: Purification of PTP from veast mitochondria
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Figure 4.3.2: Western blot analysis of PTP purification from veast (S.cerevisiae)
mitochondria
Mitochondria were prepared as described in Section 2.2.7(c), and PTP was 
purified as outlined in Section 4.3.1. Samples were acetone-precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was transferred to 
nitrocellulose paper and subjected to immune replica analysis with anti-yeast PTP 
serum (A) and anti-rat liver PTP serum (B). Lanes: 1, yeast mitochondria; 2, 0.5% 
(w/v) Triton X-100 pre-extracted pellet; 3, 8% (w/v) Triton X-100 extract; 4, 
HTP-adsorbed extract; 5, Celite-adsorbed extract; S, Mr standards (125I-radiolabelled).
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Figure 4.3.2(B) illustrates the strong and unique cross-reactivity of the yeast
mitochondrial 30,000-Mr protein with monospecific, high titre anti-rat liver PTP serum, 
indicating that it corresponds to the immunogenic polypeptide identified by Gibb 
(1985). Further Western blot analysis of the anti-yeast PTP semm was carried out by
assessing its cross-reactivity with equivalent amounts (0.1, 0.2 and 0.5}ig) of the rat 
liver and yeast carriers. As Figure 4.3.3 illustrates, the antiserum shows significant 
cross-reactivity with rat liver PTP, though less strongly than with the corresponding 
yeast protein.
The purification scheme for the putative yeast PTP and the immunological 
characteristics of this protein strongly resemble those of the equivalent mammalian 
carrier. This suggests that the isolated protein corresponds to the yeast mitochondrial 
phosphate carrier.
4.3.2 Co-purification of veast PTP and ANT
The purification schemes for the mammalian primary mitochondrial exchange 
carriers, PTP and the closely related ADP/ATP translocase, contain many similarities, 
with HTP fractionation representing the critical step in both (see Sections 1.2.4 and 
1.2.5). However, unless ANT is first stabilised by one of its specific inhibitors (ATR, 
CAT or BKA), the carrier is denatured upon extraction and is adsorbed out by HTP 
(Klingenberg e ta l., 1974). The previous chapter (Section 3.2.2) describes the 
co-purification of PTP and ANT from rat liver and bovine heart mitochondria in the 
HTP-adsorbed extract, following the inclusion of CAT in the preparations.
A similar procedure was adopted in order to obtain a yeast PTP/ANT co-isolate.
Freshly-prepared yeast mitochondria were pre-incubated with 50-100|iM CAT for 
30min at 4°C prior to being subjected to a standard PTP preparation, as described in the 
preceding Section (4.3.1). Analysis by SDS-PAGE (Figure 4.3.4) reveals the presence 
of both PTP (Mr 30,000) and a 34,000-Mr CAT-stabilised polypeptide following 
chromatography on HTP. The 34,000-Mr protein, assumed to be yeast ANT, is 
adsorbed out by Celite. This agrees with the behaviour of the co-isolated mammalian 
ADP/ATP carrier (see Section 3.2.2), and with previous observations by Wohlrab
Figure 4.3.3: Western blot analysis of purified PTP from rat liver and veast
(S.cerevisiae) mitochondria
Varying amounts of rat liver and yeast PTP were acetone precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was transferred to 
nitrocellulose paper and subjected to immune replica analysis with anti-yeast PTP
serum. Lanes: 1-3,0.1,0.2 and 0.5|ig rat liver PTP respectively; 4-6, 0.1, 0.2 and 
0.5jig yeast PTP respectively; S, Mr standards (125I-radiolabelled).
Figure 4.3.3: Western blot analysis of purified PTP from rat liver and
veast mitochondria
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Figure 4.3.4: Purification of PTP (and ANT) from veast (S.cerevisiae) mitochondria
pre-incubated with CAT
Mitochondria were prepared as described in Section 2.2.7(c), and the proteins 
were purified as outlined in Section 4.3.2. Samples were acetone-precipitated prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was Coomassie 
blue-stained. Lanes: 1, yeast mitochondria; 2, 0.5% (w/v) Triton X-100 pre-extracted 
pellet; 3, 8% (w/v) Triton X-100 extract; 4, HTP-adsorbed extract; 5, Celite-adsorbed 
extract; S, Mr standards.
Figure 4.3.4: Purification of PTP (and ANT) from veast mitochondria
pre-incubated with CAT
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(1980) and Wohlrab and Flowers (1982) who detected contaminating ANT in their PTP 
preparations. Figure 4.3.5 illustrates the effect of CAT on the isolation of PTP from 
yeast mitochondria. In this experiment, a single batch of fresh mitochondria was used,
with half being pre-incubated with CAT (lOOpM) as described above, and half being 
treated as normal.
4.4 ANALYSIS OF YEAST PTP AND ANT BY COLUMN 
CHROMATOGRAPHY
4.4.1 Introduction
The above section (4.3.2) outlines the methology for the co-purification of PTP 
and the closely related ADP/ATP carrier from yeast (S.cerevisiae) mitochondria. In the 
previous chapter (Section 3.3), the analysis of a similarly prepared mammalian 
co-isolate by various chromatographic techniques is described. Accordingly, it was 
decided to carry out similar analyses of the HTP-adsorbed extracts from CAT-loaded 
yeast mitochondria in order to obtain preliminary characterisation of the co-purified 
proteins. It was also hoped to develop a chromatographic procedure for efficiently 
separating the carriers, as the basis for obtaining optimal yields of both from a single 
mitochondrial preparation.
Unfortunately, insufficient time was available to repeat the full range of 
chromatographic analyses of the mammalian PTP/ANT co-isolate outlined in Chapter 3. 
In view of the encouraging results obtained when rat liver PTP/ANT was subjected to 
chromatography using the Matrex gel, Procion Red A (see Section 3.3.3), it was 
decided to concentrate on this technique for the analysis of the yeast mitochondrial 
PTP/ANT co-isolate.
4.4.2 Analysis of veast PTP and ANT bv Procion Red A column chromatography
The HTP-adsorbed extract isolated from yeast mitochondria pre-loaded with 
CAT was analysed using columns poured with the Matrex gel, Procion Red A. 
Co-purified PTP and ANT was dialysed into 20mM NaCl pH 7.0,0.5% (w/v) Triton 
X-100, and loaded onto a 2.0 x 1.0cm column which was equilibrated in the same
Figure 4.3.5: Effect of CAT on the purification of PTP from veast mitochondria
PTP was purified from yeast (S.cerevisiae) mitochondria pre-incubated with 
the ANT inhibitor carboxyatractyloside (CAT; see Section 4.3.2), and also from 
mitochondria not subjected to CAT-pretreatment. The HTP and Celite-adsorbed extracts 
were acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyaciylamide gel 
which was Coomassie blue-stained. Lanes: 1 and 2, HTP and Celite extracts 
respectively; 3 and 4, HTP and Celite extracts (mitochondria pre-incubated with CAT); 
S, Mr standards.
Figure 4.3.5: Effect of CAT on the purification of PTP from veast
mitochondria
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buffer. Elution was carried out using a salt gradient (0.1-1.0M NaCl) and 1% (w/v) 
SDS. Unbound and eluted fractions were concentrated by exposure to poly (ethylene 
glycol) as described in Section 2.2.2, and prepared for analysis by SDS-PAGE (see 
Figure 4.4.1).
The binding and elution profiles of the yeast carriers at pH 7.0 are very similar 
to those of their mammalian counterparts (see Figure 3.3.4). As Figure 4.4.1 
illustrates, PTP is eluted at 0.1-1.0M NaCl (0.1-0.5M for mammalian PTP), with 
optimal release at 0.5M NaCl (0.25M NaCl for mammalian PTP). In common with the 
equivalent mammalian carrier, a significant proportion of the loaded PTP remains 
bound to the column until treatment with SDS and may represent denatured protein. 
Yeast ANT, like its mammalian equivalent, readily binds to Procion Red A at pH 7.0, 
remains bound during treatment with salt, and is dislodged only upon elution with 
SDS, resulting in denaturation of the carrier.
Whereas mammalian PTP readily binds to Procion Red A, Figure 4.4.1 clearly 
demonstrates the existence of a third population of the 30,000-Mr polypeptide 
preparation (in addition to the NaCl- and SDS-eluted fractions) which elutes with the 
unbound fraction. It is possible that this is due to saturation of the protein-binding sites 
on the Procion Red A column. However, this is unlikely in view of the reported 
binding capacity of Matrex gels (l-3mg protein/ml) and the amount of protein used in
this experiment (200|ig). It thus appears that purified yeast PTP may exist in three 
distinct conformations. Alternatively, it is possible that the unbound fraction represents 
a distinct mitochondrial protein with an apparent Mr value virtually identical to that of 
the putative phosphate transporter (-30,000). If this is the case, the most likely 
candidate for the contaminant is the outer membrane pore-forming protein, porin (Mr
29,000). This protein has been previously purified from yeast (Mihara et al., 1982) and 
subsequently characterised (Gasser and Schatz, 1983). Its mode of synthesis and 
membrane insertion has also been investigated in vitro (Mihara et al., 1982; Gasser and 
Schatz, 1983). Interestingly, porin is also a common contaminant in mammalian PTP 
preparations (T. Lever, personal communication) and has been implicated as the 
mitochondrial DCCD-reactive protein, previously thought to be PTP (see Section
Figure 4.4.1: Analysis of veast mitochondrial (+CAT) HTP extract bv Procion Red A
column chromatography
The HTP-adsorbed fraction containing ANT and PTP was dialysed into 20mM 
Tris-HCl pH 7.0, 0.5% (w/v) Triton X-100, loaded onto a 2.0 x 1.0cm Procion Red A 
column equilibrated in the same buffer, and eluted with 0.1-1.0M NaCl and 1% (w/v) 
SDS. Fractions were collected and acetone-precipitated prior to resolution on a 12.5% 
(w/v) SDS-polyacrylamide gel which was Coomassie blue-stained. Lanes: 1, yeast 
HTP extract; 2, unbound fraction; 3-6, salt-eluates (0.1,0.25,0.5 and 1.0M NaCl); 7, 
1% (w/v) SDS eluate; S, Mr standards.
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The above results indicate that the binding to Procion Red A of the NaCl-eluted
fraction of the 30,000-Mr polypeptide preparation, possibly representative of yeast 
PTP, is electrostatic, since an increase in ionic strength leads to elution of the carrier. 
However, the mode of binding of yeast ANT to the column is unclear, and may involve 
electrostatic interactions, hydrophobic interactions and/or affinity binding. Previous 
results indicating that mammalian ANT binds electrostatically to Procion Red A led to 
the separation of the mammalian carriers (see Section 3.3.3). Consequently, it was 
decided to repeat the above chromatographic analysis of yeast mitochondrial co-purified 
PTP and ANT at pH 6.0 (using KPj as the buffer) and 8.0 (Tris-HCl). However, when 
the unbound and salt-eluted fractions were analysed by SDS-PAGE, the results 
obtained were identical to those illustrated in Figure 4.4.1 at both pH values. Thus, 
under the conditions tested, it was not possible to separate co-isolated yeast PTP and 
ANT; nor was the mode of binding of ANT to the column established. Further Procion 
Red A analysis is required to clarify these points: elution with higher NaCl 
concentrations, substrates/substrate analogues; further investigation of the 
pH-dependence of binding (mammalian ANT elutes with 1.0M NaCl at pH 8.8  [see 
Section 3.3.3]).
In the previous chapter it is postulated that Procion Red A column 
chromatography represents an assay for native mammalian PTP conformation (see 
Section 3.3.4). In order to ascertain if this also applies to the equivalent yeast carrier, 
chromatographic analysis was carried out on the denatured yeast co-isolate. The 
HTP-adsorbed fraction from CAT-loaded yeast mitochondria was heat-denatured at 
80°C for lOmin prior to loading onto a 2.0 x 1.0cm Procion Red A column. Elution 
was carried out with a salt gradient (0.1-1.0M NaCl) and 1% (w/v) SDS as before. 
Analysis of the column fractions by SDS-PAGE is illustrated in Figure 4.4.2, and 
demonstrates that, upon denaturation, the 30,000-Mr polypeptide population which is 
normally NaCl-eluted appears to bind to the Matrex gel as before, but is dislodged only 
upon treatment with SDS. This lends credence to the proposal that only native PTP can 
be NaCl-eluted from the Procion Red A column. Unfortunately, insufficient time was 
available to further investigate this possibility by chromatographically analysing the 
yeast PTP/ANT co-isolate prepared in the presence of cardiolipin. Figure 4.4.2 also
Figure 4.4.2: Analysis of denatured veast mitochondrial (+CAT) HTP extract bv
Procion Red A column chromatography
The HTP-adsorbed fraction containing ANT and PTP was dialysed into 20mM 
Tris-HCl pH 7.0, 0.5% (w/v) Triton X-100, heat-denatured at 80°C for lOmin, loaded 
onto a 2.0 x 1.0cm Procion Red A column equilibrated in the same buffer, and eluted 
with 0.1-1.0M NaCl and 1% (w/v) SDS. Fractions were collected and 
acetone-precipitated prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: 1, yeast HTP extract; 2, unbound fraction; 
3-6, salt-eluates (0.1,0.25, 0.5 and 1.0M NaCl); 7,1% (w/v) SDS eluate; S, Mr 
standards.
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demonstrates the continued presence of an unbound 30,000-Mr polypeptide population, 
possibly representing contaminating porin.
4.5 N-TERMINAL AMINO ACID ANALYSTS OF PTJTATTVE 
YEAST PTP
The 30,000-Mr putative phosphate carrier was purified to homogeneity from 
yeast mitochondria as outlined in Section 4.3.1. The absence of contaminating 
polypeptides in the preparation was confirmed by SDS-PAGE analysis, although the 
presence of another protein with a near-identical Mr value, probably porin, could not be 
ruled out (see Section 4.4.2). The purified protein was subjected to N-terminal analysis 
at the SERC-funded amino acid sequencing facility at the University of Aberdeen (see 
Section 2.2.3). Eighteen of the first 20 residues at the N-terminus were resolved, with 
sixteen of these being confirmed by a second analysis (see Figure 4.5.1).
The primary structure of the putative yeast PTP was compared with those of the 
equivalent bovine heart and rat liver carriers (Runswick et al., 1987; Ferreira et al., 
1989; see Figure 4.5.1). Although there is no apparent homology between the yeast 
carrier and its mammalian counterparts at the N-terminal region, this is perhaps not 
surprising since the most highly conserved domains among the tripartite family of
mitochondrial carriers are the proposed a-helical segments and the regions of the 
hydrophilic domains that connect them to the helices (Runswick et al., 1987). The N- 
and C-termini are among the most poorly conserved domains.
Figure 4.5.1 also illustrates that the 30,000-Mr yeast mitochondrial protein does 
not correspond to the ADP/ATP carrier, as its N-terminus is clearly different from that 
of yeast ANT (Adrian et a l, 1986). The amino acid sequence also differs from those 
proteins encoded by the two further ANT genes identified in yeast (AAC2 and AAC3 ; 
Lawson and Douglas, 1988). As Section 4.3.2 outlines, the 34,000-Mr CAT-stabilised 
protein co-isolated with PTP from yeast mitochondria is proposed to represent ANT. 
Accordingly, it had been hoped to confirm its identity by N-terminal analysis. 
However, this was not possible as separation of the co-purified carriers was not 
achieved under the conditions tested (see Section 4.4.2). The co-isolate was prepared
Figure 4.5.1: N-terminal amino acid sequences of mitochondrial inner
membrane proteins
Putative veast PTP (as outlined in Section 4.5)
1 20
SPPVYSDI(S)(R)NINDLLN-F
0 , unconfirmed residue; undetected residue
Bovine heart PTP (Runswick et al.. 1987) 
1 20
AVEEQYSCDYGSGRFFILCG
Rat liver PTP (Ferreira et a l. 1989)
1 20
A VEG YSCEFGSMKY Y ALC GF
Yeast ANT (Adrian et al.. 1986)
1 20 
MSHTETQTQQSHFGVDFLMG
Yeast import receptor (Murakami et al.. 1990) 
1 20
M Y V S A AP AIPQY S VSD YMKF
Yeast PTP (Phelps e ta l.  1991)
1 20
MS V S A AP AIPQ Y S VSD YMKF
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for amino acid analysis in an attempt to elucidate the N-terminii of both carriers. 
However, when the sample was subjected to the continuous SDS-PAGE system 
employed prior to Edman degradation, no resolution of the two carriers was observed 
and only the 30,000-Mr polypeptide was ultimately sequenced. This contrasts with the 
behaviour of the co-purified carriers on the discontinuous SDS-PAGE system 
employed in our laboratory, which results in clear resolution of the proteins (see 
Figures 4.3.4 and 4.3.5).
Figure 4.5.1 also illustrates the N-terminal amino acid sequences of a putative 
yeast import receptor (Murakami et al., 1990) and phosphate carrier (Phelps et al., 
1991). These proteins differ in the N-terminal regions by one residue only (residue 2: 
tyrosine in the import receptor, serine in PTP), and further analysis of their primary 
structures reveals that there are only seven further residue discrepancies. Clearly, both 
these groups have cloned and sequenced the same gene. However, there is controversy 
over whether it encodes a phosphate carrier, as suggested by Wohlrab's group (Phelps 
et al., 1991), or a receptor for protein import into yeast mitochondria, as proposed by 
Blobel's group (Pain et al., 1990; Murakami et al., 1990). Both groups agree that the 
encoded protein has an Mr value of 32,800 and shows approximately 40% homology 
with the primary structures of rat liver and bovine heart PTP (Runswick et al., 1987; 
Ferreira et al., 1989). There is also general agreement that the protein contains the 
tripartite structure common to PTP, ANT, UCP and other members of this family of 
structurally related mitochondrial membrane proteins which are thought to evolve from 
a single gene (see Section 1.2.9). The observed homology with mammalian PTPs is the 
basis for the identification of this protein as the equivalent yeast carrier by Wohlrab's 
group. Phelps et al. (1991) also claim that the protein is identical to a reconstitutively 
active PTP which has been reported as isolated from yeast mitochondria by Guerin et 
al. (1991, in press). In contrast, Blobel's group have used anti-idiotype antibodies to 
characterise the 32,800-Mr integral membrane protein as an import receptor (Pain et 
a l, 1990). These antibodies were prepared using a chemically synthesised signal 
peptide of a mitochondrial precursor protein, subsequently demonstrated to be the 
32,800-Mr protein. It is claimed, from immunoelectron microscopy and 
subfractionation of the organelles, that this protein is located in contact sites between
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the inner and outer mitochondrial membranes. The role of these sites in protein import 
has been discussed previously (see Section 1.1.6.4).
The N-terminal data illustrated in Figure 4.5.1 suggests that the protein 
discussed above, which may represent yeast PTP, is not identical to the putative 
phosphate carrier isolated in this study. However, it may not be possible to carry out 
Edman degradation of yeast PTP as a result of the N-terminus being masked (A.
Phelps, personal communication). If this is the case, it is still possible that the two 
proteins are identical and that the sequence obtained (Figure 4.5.1) may represent the 
N-terminal of a contaminant in the yeast PTP preparation, probably porin (see Section 
4.4.2). N-terminal analysis of the Procion Red A unbound and NaCl-eluted 30,000-Mr 
polypeptide fractions was subsequently carried out to investigate this possibility. As 
illustrated in Figure 4.5.2, it was not possible to obtain any sequence data for the 
salt-eluted protein, while the N-terminal amino acid sequence obtained previously 
(Figure 4.5.1) was shown to be that of the unbound polypeptide fraction. Figure 4.5.2 
also illustrates the N-terminal protein sequence of S.cerevisiae porin from the 
corresponding cDNA clone (Kleene et al., 1987). With the exception of the terminal 
methionine residue, which is missing from the sequence of the Procion Red A unbound 
polypeptide , it is apparent that
these two proteins (porin and the unbound 30,000-Mr protein fraction) are identical.
The above data indicate that the protein present in the Procion Red A 
NaCl-eluate has a masked N-terminus and may thus represent yeast PTP (A. Phelps, 
personal communication), while the unbound fraction has been positively identified as 
corresponding to contaminating porin in the PTP preparation as previously suspected 
(see Section 4.4.2).
4.6 DISCUSSION
The biosynthesis of the putative yeast mitochondrial phosphate carrier was 
investigated by accumulating cytosolic precursors in yeast cells (S.cerevisiae 
D-273-10B-1) grown in the presence of CCCP. Analysis of the cell extracts by 
SDS-PAGE and immune blotting indicated that yeast PTP, in contrast to the equivalent 
bovine heart and rat liver carriers (Runswick et al., 1987; Ferreira et al., 1989), is not
Figure 4.5.2: N-terminal amino acid sequences of veast mitochondrial
30,000-Mr proteins
Procion Red A NaCl-eluate: N-terminal blocked
Procion Red A unbound fraction 
1 20
SPP V Y SDI(S) (R)NINDLLN - -F
0 , unconfirmed residue; undetected residue
S.cerevisiae porin (TCleene et al.. 1987)
1 20
MSPPVYSDISRNINDLLNKD
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initially synthesised as a higher-Mr precursor. However, these results agree with the 
observations of Phelps et al. (1991), who have cloned and sequenced the gene 
encoding yeast PTP and noted the absence of an N-terminal-extended signal sequence.
A variety of protein-chemical studies were subsequently carried out on the 
isolation and preliminary characterisation of the inner membrane carriers, PTP and 
ANT, from yeast {S.cerevisiae) mitochondria. By employing the purification scheme 
for the equivalent carrier from mammalian mitochondria, yeast PTP was purified to 
apparent homogeneity. The putative yeast carrier has an apparent Mr value of -30,000 
from SDS-PAGE. Antiserum was raised against the purified
yeast protein and was shown to cross-react strongly with rat liver PTP. In addition, 
anti-rat liver PTP serum was employed to demonstrate that the 30,000-Mr polypeptide 
is identical to the putative yeast phosphate carrier identified immunologically by Gibb 
(1985). The PTP isolated in this study is thus characterised on the bases of its 
purification procedure and imunological properties in relation to the corresponding rat 
liver carrier.
The procedure previously utilised to co-purify PTP and the closely related 
ADP/ATP carrier from mammalian mitochondria was repeated to obtain a co-isolate of 
the equivalent yeast carriers. It was found that, by pre-incubating freshly-prepared 
yeast mitochondria with CAT, it was possible to stabilise a 34,000-Mr protein which 
subsequently co-purified with PTP following adsorption chromatography on HTP. 
Further fractionation with Celite adsorbed out this additional protein. On the basis of its 
stabilisation by CAT, the 34,000-Mr protein is presumed to represent yeast ANT. This 
proposal is further supported by its purification characteristics, which are identical to 
those of the mammalian ADP/ATP carrier.
In the previous chapter (Sections 3.3.3-3.3.5), Procion Red A columns were 
used to separate co-purified mammalian PTP and ANT, assay for native PTP 
conformation, and prepare native PTP in detergents other than Triton X-100 for 
analysis by CD. Accordingly, this Matrex gel was employed for chromatographic 
analysis and further characterisation of the yeast mitochondrial co-isolate. At pH 7.0, 
the binding and elution characteristics of the yeast PTP/ANT co-isolate were broadly 
similar to those of the equivalent mammalian proteins. Both carriers were observed to
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bind to the Procion Red A column, with PTP eluting optimally at 0.5M NaCl. Elution 
of ANT resulted only after washing of the column with SDS. A significant proportion 
of the loaded PTP behaves in a similar manner to ANT, remaining bound to the column 
until treatment with SDS. This observation was also noted for mammalian PTP, and 
was explained by the presence of denatured carrier which electrostatically binds to 
Procion Red A, but cannot be dislodged by increased ionic strength due to its 
conformation. This may also be the case for the equivalent yeast carrier.
In contrast to the mammalian analyses, a proportion of the putative yeast PTP 
was also observed in the unbound fraction from the Procion Red A column. In view of 
the relatively high binding capacity (l-3mg/ml) of Matrex gels, this is unlikely to be due 
to saturation of the Procion Red A column. It thus appeared possible that a third PTP 
population, with a distinct conformation, was present in the yeast mitochondrial 
co-isolate. It is also feasible that the 30,000-Mr yeast mitochondrial isolate represents 
two subunits of a multimeric phosphate transport system, as exists in bacteria. 
However, it is more likely that the unbound fraction represents a distinct polypeptide 
with the same apparent Mr value as yeast PTP, the most likely candidate being porin 
(see Section 4.4.2). In order to investigate this possibility, the sequence obtained for 
the unbound Procion Red A polypeptide fraction (see Section 4.5) was compared to the 
published primary structure of yeast porin (Kleene et al., 1987). The two proteins were 
shown to be identical.
In future, it may be beneficial to attempt chromatographic separation of the two 
~30,000-Mr yeast mitochondrial polypeptides by application to mersalyl-ultrogel, 
which can be used to remove contaminating porin from mammalian PTP preparations 
(T. Lever, personal communication). All fractions prepared would subsequently be 
subjected to N-terminal amino acid analysis. The efficient separation of PTP and porin 
by one or both of the above chromatographic techniques (mersalyl-ultrogel, Procion 
Red A) may also be the basis for establishing which of these carriers is the 
mitochondrial DCCD-reactive protein (see Section 1.2.7). Mersalyl-ultrogel 
chromatography of the yeast 30,000-Mr fraction holds added interest since Phelps et al. 
(1991) have reported that yeast PTP lacks the NEM-reactive Cys42 presumed to be 
responsible for binding to the chromatography matrix.
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Chromatographic analysis of the yeast mitochondrial co-isolate was repeated in 
order to assess the pH-dependence of the carriers' binding and elution profiles with 
respect to Procion Red A. In this manner, it was hoped to separate the two proteins into 
homogeneous populations. However, varying the the pH over the range 6.0-8.0 had no 
effect on the binding or elution properties of either PTP or ANT. This had also been the 
case for the corresponding rat liver carriers, although a small fraction of bound bovine 
heart ANT was eluted with 1.0M NaCl at pH 8.0. Therefore, although it was not 
possible to chromatographically separate the co-purified carriers under the conditions 
tested, the binding and elution properties of the isolated proteins with Procion Red A 
over the pH range 6.0-8.0 further support the proposal that they represent the yeast 
mitochondrial phosphate and adenine nucleotide carriers. Unfortunately, insufficient 
time was available to repeat the Procion Red A analysis of the yeast PTP/ANT 
co-isolate at pH 8 .8 , the level at which separation of the equivalent mammalian carriers 
was achieved.
The Procion Red A column was previously demonstrated to represent a 
potential assay for the native conformation of mammalian PTP, and possibly for the 
ADP/ATP carrier also (see Sections 3.3.4 and 3.4). The possibility that this also 
applies to yeast PTP was investigated by chromatographically analysing heat-denatured 
yeast PTP/ANT. Under these conditions, the yeast PTP fraction which, when native, 
elutes optimally with 0.5M NaCl, was observed to remain bound to the column until 
treatment with SDS. As this was also the case for mammalian PTP, evidence is thus 
provided that Procion Red A column chromatography may also represent an assay for 
native yeast PTP conformation. However, it will be necessary to assess the effect of the 
inclusion of cardiolipin in the extraction process of the yeast co-isolate. If this results in 
a greater proportion of PTP being detected in the 0.5M NaCl-eluate following Procion 
Red A column chromatography, it would strongly support the suggestion that the 
Matrex gel is assaying for native carrier. Further to this, it will be necessary to compare 
the Pj-exchange activities of reconstituted yeast PTP populations with their Procion Red 
A elution profiles. The presence of an unbound 30,000-Mr polypeptide fraction 
following chromatography was unaffected by heat-denaturation.
The SERC-funded amino acid sequencing facility at the University of Aberdeen
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was employed to determine the N-terminal sequence of the putative yeast PTP. No 
homology was observed with the N-terminii of the equivalent mammalian phosphate 
carriers. This was as expected, since the N- and C-terminii represent poorly-conserved 
domains within the family of mitochondrial inner membrane carriers with related 
tripartite structures (Runswick et al., 1987). Primary structure analysis also 
demonstrated that the purified 30,000-Mr yeast mitochondrial protein does not 
correspond to the ADP/ATP carrier. It had been hoped to confirm the identity of ANT 
by determining the N-terminal sequence of the CAT-inhibited 34,000-Mr protein 
co-purified from yeast mitochondria with PTP. However, chromatographic separation 
of the co-isolate was not achieved under the conditions tested, and it was not possible 
to resolve the carriers using the continuous SDS-PAGE system employed prior to 
Edman degradation. Separation of the carriers, and subsequent N-terminal analysis of 
the CAT-stabilised protein thus represents the major step for characterising yeast ANT.
Determination of the N-terminal sequence of yeast PTP initially indicated that 
the protein was distinct from that encoded by the gene cloned and sequenced by 
Murakami et al. (1990) and Phelps et al. (1991). This transmembrane inner 
mitochondrial membrane protein is claimed to represent either a phosphate carrier 
(Phelps et al., 1991) or a protein import receptor (Murakami et al., 1991). However, if 
the N-terminal of yeast PTP is masked (A. Phelps, personal communication), it is 
possible that the proteins are identical and that the sequence obtained represents the 
N-terminus of contaminating porin. N-terminal protein sequence analysis of the 
Procion Red A unbound and salt-eluted polypeptide fractions indicated that this is the 
case (see Section 4.5).
The evidence presented by each of the above groups in relation to the yeast PTP 
and/or import receptor gene is summarised in Section 4.5. Wohlrab's group have 
demonstrated that the 32,800-Mr protein lacks the NEM-sensitive Cys42 present in 
mammalian PTP's; this being replaced by a Thr residue. The reconstitutively active 
yeast PTP purified by Guerin et a/. (1991, in press) is also insensitive to NEM, lending 
some support to Wohlrab's group's claim that they have isolated the gene encoding this 
carrier (Phelps et al., 1991). The NEM-sensitivity of the putative PTP isolated in this 
study was not investigated, and this clearly represents an important area of future
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research. Phelps et al. (1991) have also established that the precursor to the 32,800-Mr 
protein lacks the N-terminal presequence present in the bovine heart and rat liver PTP's 
(Runswick et al., 1987; Ferreira et al., 1989). This also appears to be the case for the 
putative PTP isolated in this study (Hodgson et al., 1988; see Section 4.2).
The 40% identity of the yeast 32,800-Mr protein with rat liver and bovine heart 
PTPs is strong evidence that it represents the equivalent yeast carrier. Alternatively, this 
homology may simply represent the conservation of amino acids intimately involved in 
the formation of the tripartite structure possessed by this family of mitochondrial 
proteins. It is quite feasible that an import receptor could be a member of this family. A 
yeast RNA-splicing protein has also been reported to possess the tripartite structure 
common to PTP, ANT, UCP and the malate/2-oxoglutarate carrier (Gargouri, 1988).
The evidence presented by Blobel's group that the 32,800-Mr protein represents 
an import receptor is based on a relatively new technique with a simple yet elegant 
principle. Initially, a first antibody is raised that recognises a ligand in a fashion that 
mimics recognition by the physiological receptor. The combining site of this 
receptor-mimicing antibody thus has structural features similar to those of the receptor's 
own ligand-binding site. Subsequently, a second set of antibodies is raised against the 
combining site of the first antibodies, and are similar in structure to the regions of the 
ligand which bind to the physiological receptor. These anti-idiotype antibodies mimic 
the original ligand in binding to its receptor, with the obvious advantage that affinities 
should be high enough to isolate that receptor. This technique has been successfully 
employed to identify the cell-surface receptors for hormones, neurotransmitters, 
neuropeptides and growth factors (Kohler et al., 1989).
By first producing an antiserum against a synthetic version of the signal 
sequence of cytochrome oxidase subunit IV, and then raising anti-idiotype antibodies to 
the original antiserum, Pain et al. (1990) identified the 32,800-Mr integral membrane 
protein as a strong candidate for a yeast mitochondrial import receptor. The gene 
encoding this protein was subsequently cloned, characterised and sequenced 
(Murakami et al., 1990). However, there are considerable doubts over the reliability of 
receptor anti-idiotypes, particularly in relation to alleged import receptors (Meyer,
1990, "Mimics-or gimmicks"). The use of anti-idiotype antibodies or synthetic signal
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sequences to isolate | import receptors has consistently resulted in the identification of 
previously characterised transport proteins (Meyer, 1990; Schnell et al., 1991). These 
findings have created the notion of bifunctional translocators within the membranes of 
intracellular organelles. It would thus appear reasonable to suggest that the 32,800-Mr 
mitochondrial protein characterised by Blobel’s and Wohlrab’s groups, possibly 
identical to that purified in this study, can transport both phosphate and protein 
precursors. Further support for this concept comes from recent evidence that a single 
mitochondrial protein can have two distinct functions: the Neurospora enhancing 
protein of the matrix-processing peptidase complex is also a component of the 
cytochrome reductase complex in the inner membrane (Schulte et al., 1989).
In summary, further characterisation studies, in particular reconstitution 
experiments, are required to establish if the 32,800-Mr yeast mitochondrial inner 
membrane protein represents a phosphate transporter, an import receptor, or both. The 
same applies to the 30,000-Mr putative yeast PTP isolated in this study. If these 
proteins are different, it is possible that they represent individual subunits of a complex 
multimeric yeast phosphate transport system as exists in bacteria. The more likely 
scenario that the two proteins are identical also requires further investigation. It would 
be beneficial to proteolytically digest the putative yeast PTP isolated in this study and 
obtain some internal sequence for comparison with the primary structure of the protein 
encoded by the gene cloned by Murakami et al. (1990) and Phelps et al. (1991).
CHAPTER 5 (YEAST PDC) 86
CHAPTER 5: REGULATION OF THE YEAST PYRUVATE 
DEHYDROGENASE COMPLEX
5.1 INTRODUCTION
The mitochondrial pyruvate dehydrogenase multienzyme complex (PDC) 
occupies a key position in the metabolism of the eukaryotic cell, catalysing the 
essentially irreversible conversion of pyruvate to acetyl CoA. Activity of PDC from 
eukaryotic sources, including mammalian, avian, and plant tissues, and Neurospora 
crassa is regulated by a phosphorylation-dephosphorylation cycle (see Reed, 1974, 
Denton et al., 1975 and Wieland, 1983 for reviews). Phosphorylation by PDC kinase 
inactivates the complex, while dephosphorylation by PDC phosphatase results in its 
reactivation. The phosphorylation sites in mammalian PDC are located on three serine
residues in the a  subunit of the pyruvate dehydrogenase (El) component of the 
complex (Yeaman eta l., 1978; Sugden e ta l., 1979; Mullinax eta l., 1985).
Attempts thus far to demonstrate PDC kinase activity in yeast have been 
unsuccessful (Kresze and Ronft, 1981a). However, the first indirect evidence that yeast 
PDC may be controlled in vivo by a phosphorylation-dephosphorylation mechanism 
was presented by Uhlinger et al. (1986). In this paper, highly purified PDC from 
S.cerevisiae was phosphorylated and inactivated with a purified heterologous (bovine
kidney) PDC kinase, in the presence of [y 2^P] ATP. The protein-bound radioactivity
was localised in the E la  subunit of the complex. Furthermore, dephosphorylation and 
reactivation of the phosphorylated, inactive complex was demonstrated in the presence 
PDC phosphatase from bovine heart. Tryptic digestion of the 32P-labelled complex 
yielded a single phosphopeptide, which was purified to homogeneity and subjected to 
amino acid sequencing. The resulting sequence was found to be very similar to that of a
tryptic phosphopeptide derived from the E la  subunit of bovine kidney and heart PDC.
It was decided to determine the presence or absence of PDC kinase activity in 
yeast by in situ studies. Freshly prepared, intact yeast mitochondria were incubated
with [y^2P] ATP, and analysed by SDS-PAGE and autoradiography. Prior to this, 
inactivation and radiolabelling studies were carried out on purified yeast PDC in the
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presence and absence of a heterologous kinase.
5.2 INACTIVATION AND RADIOLABELLING STUDIES
ON PURIFIED PDC
Prior to employing in situ studies on yeast mitochondria, a series of 
experiments were carried out on purified PDC from bovine heart and yeast sources.
The complex was purified from bovine heart as outlined in Section 2.2.11(a), while 
yeast PDC was prepared from S.cerevisiae supplied by DCL Ltd. (see Section 2.1.4) 
as described in Section 2.2.11(b). In both cases, PDC activity was checked at each 
purification stage as outlined in Section 2.2.12(a). Following preparation, the 
mitochondrial complexes were analysed by SDS-PAGE to determine the degree of 
purity. As Figure 5.2.1 clearly illustrates, both the bovine heart and yeast PDCs were 
purified to near homogeneity. Very few contaminants are apparent in both preparations 
upon Coomassie blue-staining, although an 80,000-Mr polypeptide of unknown origin 
is clearly visualised in the yeast PDC isolate. This contaminant may represent the E l 
subunit of OGDC. Furthermore, the E2 (subunit Mr value 58,000) and E3 (56,000) 
subunits of the yeast complex are poorly resolved on this gel.
For the purposes of subsequent inactivation and radiolabelling studies on the 
yeast complex, a purified heterologous PDC kinase was required. Bovine heart PDC 
was thus separated into its individual components by FPLC, employing the Superose 
and MonoQ columns as described in Section 2.2.13. SDS-PAGE analysis of the 
resulting column fractions is illustrated in Figure 5.2.2. The dissociation of the whole 
complex into E2/X and E1/E3 fractions is clearly demonstrated (Lanes 2 and 3), as is 
the separation of the E1/E3 fraction into individual components (Lanes 4 and 5). This 
technique also serves as a purification scheme for PDC kinase, which is differentially 
eluted from the MonoQ column upon application of a salt (NaCl) gradient. Although 
kinase activity was checked at all stages of purification as outlined in Section 2.2.12(b), 
purified PDC kinase was not detected by Coomassie blue-staining of the 
SDS-polyacrylamide gel (see Figure 5.2.2). In contrast, a small amount of residual E3 
in the preparation is detectable in this manner.
A variety of studies were carried out using the purified preparations of bovine
Figure 5.2.1: Purification of PDC from bovine heart and veast sources
PDC was prepared from bovine heart as described in Section 2.2.11(a), and 
from yeast {S.cerevisiae) as described in Section 2.2.11(b). Samples were mixed with 
Laemmli sample buffer prior to resolution on a 10% (w/v) SDS-polyacrylamide gel 
which was Coomassie blue-stained. Lanes: S, Mr standards; 1, bovine heart PDC
(subunit Mr values: E 2 ,72,000; E3, 55,000; X, 51,000; Eloc, 41,000; El(3, 36,000);
2, yeast PDC (subunit Mr values: E2, 58,000; E3, 56,000; E la , 45,000; E ip,
35,000).
Figure 5.2.1: Purification of PDC from bovine heart and veast sources
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Figure 5.2.2: Separation of PDC components bv FPLC
PDC was separated into its individual components by FPLC, as described in 
Section 2.2.13. The complex was first dissociated into E1/E3 and the E2/X core 
assembly using a Superose 12 column. A MonoQ column was then used to separate 
E3, E l and the associated kinase. All fractions were mixed with Laemmli sample buffer 
prior to resolution on a 10% (w/v) SDS-polyacrylamide gel which was Coomassie 
blue-stained. Lanes: 1, intact bovine PDC; 2 and 3, Superose 12 fractions (E2/X and 
E1/E3 respectively); 4-6, NaCl-eluates from MonoQ column (4, E3; 5, E l; 6 , kinase 
and residual E3); S, Mr standards.
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heart PDC, yeast PDC and bovine kinase. The purified complexes were assayed for 
PDC kinase activity as outlined in Section 2.2.12(b). In addition to this, the effect of a 
heterologous (bovine heart) kinase on the activity of yeast PDC was assessed. Kinase 
activity was assayed in each case by measuring the rate of inactivation of the complex in 
the presence of 0.2mM ATP at 30°C (Hucho et al., 1972), and also by estimation of
the rate of incorporation of 32P-phosphoryl groups from [y^PJATP into the E la  
subunit of PDC (Stepp et al., 1983). In the case of bovine heart PDC, both rapid 
inactivation of the complex and incorporation of 32P-phosphoryl groups were 
observed, presumably due to intrinsic kinase activity. The phosphorylation and 
inactivation of the yeast complex in the presence of a heterologous kinase were also 
demonstrated, confirming the results of Uhlinger et al. (1986), as discussed in Section 
5.1. However, in the absence of the bovine heart kinase, no reduction in yeast PDC 
activity was observed; nor was there any indication of 32P-phosphoryl incorporation
into the yeast PDC E la  subunit. These results agree with previous observations by 
Kresze and Ronft (1981a) and Uhlinger et al. (1986), who detected no intrinsic kinase 
activity at any stage during purification of yeast PDC.
There exist a variety of possible reasons for the inability to detect PDC kinase 
activity in yeast:-
1) yeast is unique among eukaryotic organisms, in that PDC is not regulated by a
phosphorylation-dephosphorylation mechanism on the E la  subunit;
2) the kinase is labile;
3) the kinase is loosely bound to the complex and dissociates during purification;
4) the level of control exhibited by the yeast kinase is not as critical as for mammalian 
PDC. If this is so, the kinase may be present at virtually undetectable levels;
5) regulation of yeast PDC is dependent on growth conditions. If this is the case, the 
kinase may be inducible.
CHAPTER 5 (YEAST PDC) 89
5.3 RADIOLABELLING STUDIES ON INTACT 
MITOCHONDRIA
5.3.1 r^PlATP-labellin^ of rat liver mitochondria
Prior to the application of radiolabelling experiments on yeast mitochondria, 
similar in situ studies were initially carried out on the equivalent organelles from a 
mammalian source. In addition to serving as a control for the subsequent
[y32p]ATP-labelling of yeast mitochondria, these experiments would facilitate the 
optimisation of conditions for the radiolabelling of mitochondrial proteins. Two 
reversibly phosphorylated proteins are known to exist in mammalian mitochondria: the
E la  subunits of the multienzyme complexes PDC and BCOADC (Reed, 1974; Denton 
et al., 1975; Reed and Yeaman, 1987). Both complexes contain an intrinsic kinase
which phosphorylates the corresponding E la  subunit and inactivates the complex.
Radiolabelling experiments were carried out on freshly prepared, intact rat liver 
mitochondria suspended in isolation buffer (see Section 2.2.7[a]) to a final assay
volume of 250|il. Mitochondria (500|ig protein/assay) were labelled in the presence of
10|iCi [y32p] ATP/assay. The following reagents were also included in the assay
samples to the denoted final concentrations: ATP (2pM); 25mM NaF (to inhibit 
phosphatase activity); protease inhibitors (0.5mM PMSF, 0.5mM benzamidine-HCl,
0.3|iM leupeptin). The samples were incubated at 37°C for 15min, following which the 
mitochondria were pelleted (10,000 xg for 5min) and solubilised in Laemmli sample 
buffer prior to analysis by SDS-PAGE and autoradiography. Figure 5.3.1 illustrates 
the ATP-dependent 32P-phosphorylation of rat liver mitochondrial proteins. In this 
experiment, increasing amounts of the mammalian kinase inhibitor dichloroacetate were 
also included. The two heavily labelled polypeptides in Lanes 1 and 2 are presumed to
represent the E la  subunits of PDC and BCOADC (Mr values 41,000 and 46,000 
respectively). This is confirmed by dichloroacetate inhibition of the kinase activities: as
Figure 5.3.1: PDC kinase and BCOADC kinase activities in rat liver mitochondria
Rat liver mitochondria (500{ig/assay) were incubated with [y^PJATP
(lOjiiCi/assay) as described in Section 5.3.1. The mammalian kinase inhibitor
dichloroacetate was included to inhibit radiolabelling of the PDC and BCOADC E la  
subunits. Mitochondria were pelleted and solubilised in Laemmli sample buffer prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was processed for
autoradiography. Lanes: 1 and 2, [t^^P] ATP-labelled rat liver mitochondria; 3-6, in the 
presence of dichloroacetate (1 ,2 ,5  and lOmM respectively).
Figure 5.3.1: PDC kinase and BCOADC kinase activities in rat liver
mitochondria
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the concentration of this reagent increases from l-10mM (Lanes 3-6), there is a
significant reduction in the level of phosphorylation of the 41,000- and 46,000-Mr
polypeptides.
Of additional interest in this autoradiograph is the presence of two
phosphoproteins of unknown origin with Mr values lower than the E la  subunits. The 
radiolabelling of these polypeptides is also inhibited by dichloroacetate and they may
represent degradation products of the PDC and/or BCOADC E la  subunits. However, 
although preliminary experiments indicated that at least one of these phosphopeptides 
may be immunologically distinct from both PDC and BCOADC, this line of research 
was not pursued further.
5.3.2 T^PlATP-labelling of veast mitochondria
S.cerevisiae D273-10B were grown aerobically in yeast growth media 
supplemented with various carbon sources (as outlined in Section 2.2.14) to an 
absorbance at 600nm of 1.0-2.0, representing the late logarithmic phase. Yeast 
mitochondria were subsequently prepared as outlined in Section 2.2.7(c). 
Radiolabelling experiments were carried out on freshly prepared, intact mitochondria in
isolation buffer (see Section 2.2.7[c]) to a final assay volume of 250ptl. Yeast
mitochondria (500|ig protein/assay) were incubated at 37°C for 15min in the presence
of [t32?] ATP (10]iCi/assay) prior to being pelleted (10,000 xg for 5min), solubilised 
in Laemmli sample buffer and analysed by SDS-PAGE and autoradiography. Also 
included in the assay samples was 25mM NaF to inhibit phosphatase activity. 
Furthermore, the following variations in growth and assay conditions were included in 
order to optimise the phosphorylation of yeast mitochondrial proteins:-
1) the concentration of unlabelled ATP was varied (2 and 20jjM  final);
2) protease inhibitors (0.5mM PMSF, 0.5mM benzamidine-HCl, 0.3|iM leupeptin) 
were included in some assay samples;
3) some assay samples were supplemented with oligomycin (0.1 mg/ml) and CCCP
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(10mM). It was hoped that by uncoupling the mitochondria with CCCP and inhibiting 
ATPase activity with oligomycin, it would be possible to facilitate the entry of 
exogenous ATP and prevent its subsequent breakdown;
4) prior to mitochondrial preparation, yeast were grown in media supplemented with a 
variety of carbon sources, both fermentable and non-fermentable: YPG (galactose),
YPD (glucose), YPEG (ethanol/glycerol), YPDG (glycerol/glucose), YPS (succinate), 
YPL (lactate). This was to investigate the possibility that the kinase is inducible under 
certain growth conditions;
5) in order to further investigate the possible inducibility of yeast PDC kinase, yeast 
were grown aerobically in YPG, followed by lh  of anoxic growth prior to 
mitochondrial preparation.
6 ) mitochondria isolated from yeast supplied by DCL Ltd. were also assayed for kinase 
activity;
Figure 5.3.2 illustrates the [y^2P] ATP-radiolabelling of yeast mitochondria 
under the conditions described above, with the additional inclusion of rat liver 
mitochondria as a control. The presence of a 45,000-Mr phosphoprotein is apparent, 
notably in Lanes 37-40 (yeast grown aerobically in YPG; mitochondria assayed in the
absence of oligomycin and CCCP). This polypeptide may correspond to the E la  
subunit of yeast PDC. Phosphorylation of this polypeptide is greater in the presence of
2|iM, rather than 20|iM ATP. There are no apparent beneficial effects of the protease 
inhibitors, although they were included in future experiments as a precaution.
Optimisation of yeast mitochondrial protein phosphorylation was thus observed 
following growth in medium supplemented with galactose, a fermentable substrate. 
Additional experiments confirmed that sugar substrates were generally superior to 
non-fermentable carbon sources for the subsequent radiolabelling of mitochondria, with 
the apparent exception of glucose-supplemented growth medium. However, in some 
experiments, the 45,000-Mr phosphoprotein also labelled well following growth in 
lactate-supplemented medium (YPL).
A series of radiolabelling experiments were carried out on freshly isolated,
Figure 5.3.2: hffiPl ATP-labelling of rat liver and veast mitochondria
Mitochondria (500|ig/assay) were prepared from rat liver (lanes 1-4) and yeast 
(S.cerevisiae D273 10B) grown in YPG (lanes 5-8 and 37-40), YPD
(lanes 9-12), YPEG (lanes 13-16), YPDG (lanes 17-20), YPS (lanes 21-24), YPL 
(lanes 25-28), YPG (with lh  anoxic growth prior to harvesting; lanes 29-32), and also
from yeast supplied by DCL (lanes 33-36). [y32P]ATP (lOpCi/assay) was included, as 
was unlabelled ATP to a final concentration of 20|iM (lanes 1,2, 5, 6 ,9 ,10 ,13 ,14 ,
17.18, 21,22, 25, 26, 29, 30, 33, 34, 37, 38) or 2pM (lanes 3 ,4 ,7 , 8 ,11, 12,15,
16.19, 20, 23, 24, 27,28, 31, 32, 35, 36, 39,40). Other variables were included:
protease inhibitors (0.5mM PMSF, 0.5mM benzamidine-HCl, 0.3|iM leupeptin; lanes 
2, 4, 6 , 8 , 10 ,12,14,16,18,20, 22, 24, 26,28, 30, 32, 34, 36, 38, 40); O.lmg/ml 
oligomycin and lOmM CCCP (lanes 1-36). Mitochondria were pelleted and solubilised 
in Laemmli sample buffer prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel 
which was processed for autoradiography. S, Mr standards (125I-radiolabelled).
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intact yeast mitochondria (500|ig/assay) following aerobic growth of S.cerevisiae in 
YPG to the late logarithmic phase. On the basis of the results described above and
illustrated in Figure 5.3.2, prepared samples of 250pl mitochondrial suspension/assay
were incubated in the presence of lOpCi [y^P] ATP/assay under the following
conditions: ATP (2jiM final concentration); NaF (25mM); protease inhibitors (0.5mM
PMSF, 0.5mM benzamidine-HCl, 0.3jiM leupeptin). In addition to this, the 
mammalian PDC kinase inhibitor dichloroacetate (1,2,5, lOmM final concentrations) 
was included in some of the assay samples, and mitochondria isolated from a further 
strain of yeast (S.cerevisiae S288C) were assayed for kinase activity in an identical 
manner to S.cerevisiae D273-10B mitochondria. As before, the radiolabelled 
mitochondria were pelleted (10,000 xg for 5min), solubilised in Laemmli sample buffer 
and analysed by SDS-PAGE and autoradiography. Figure 5.3.3 illustrates the
[y32P] ATP-radiolabelling of yeast mitochondria under the conditions described above.
The presence of a 45,000-Mr phosphoprotein, which may correspond to PDC E la ,  is 
apparent in the samples originating from both strains of yeast. However, in each case, a
reduction in ^2P-phosphorylation of the putative PDC E la  in the presence of increasing 
concentrations of dichloroacetate, which would correspond to the inhibition of kinase 
activity, is not observed.
In order to positively identify the 45,000-Mr yeast mitochondrial
phosphoprotein as the E la  component of PDC, immune precipitation studies were
carried out on the radiolabelled organelles. Yeast mitochondria (100 and 500jig/assay) 
were prepared from both strains of S.cerevisiae (D273-10B and S288C) grown to late
logarithmic phase in YPG, and incubated in the presence of 10}iCi [y^PJATP/assay. 
Assay conditions were as described above. Samples were subsequently subjected, to 
analysis by immune precipitation as outlined in Section 2.2.6(c) using anti-yeast PDC
El serum (10 and 50p.l/assay), and non-immune rabbit serum (NRS; 50p.l/assay) as a
Figure 5.3.3: Incubation of veast mitochondria with fy^PlATP
Yeast (iS.cerevisiae D273-10B and S288C) mitochondria (500|ig/assay) were
incubated with [y32P]ATP (lOjiCi/assay) as described in Section 5.3.2. The 
mammalian kinase inhibitor dichloroacetate was included to ascertain its effect on the
putative radiolabelling of yeast PDC E la . Mitochondria were pelleted and solubilised 
in Laemmli sample buffer prior to resolution on a 12.5% (w/v) SDS-polyacrylamide gel
which was processed for autoradiography. Lanes: 1, [y^PjATP-labelled D273-10B 
mitochondria; 2-5, in the presence of dichloroacetate (1 ,2 ,5  and lOmM respectively); 
6-10, identical to lanes 1-5 except using S288C mitochondria; S, Mr standards 
(125I-radiolabelled).
Figure 5.3.3: Incubation of veast mitochondria with ly^PIATP
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negative control. A sample of S.cerevisiae D273-10B mitochondria (500}ig/assay)
incubated with lOfiCi [y^PJATP but not subjected to immune precipitation served as a 
positive control. Following dissociation, the immune precipitates were analysed by 
SDS-PAGE and fluorography. Figure 5.3.4 illustrates the immune precipitation of
phosphoproteins from [y^PJATP-labelled yeast mitochondria under the conditions 
described above. It is apparent that, in mitochondria from both strains of S.cerevisiae,
the 45,000-Mr 32P-phosphoprotein is immune precipitated with either 10 or 50j l i 1 yeast
PDC E l antiserum. This applies to both the 100 and 500)0.1 assay samples of yeast 
mitochondrial protein. These results strongly suggest that the 45,000-Mr polypeptide 
which is phosphorylated under the conditions adopted in these experiments
corresponds to the E la  subunit of yeast PDC, thus indicating the presence of PDC 
kinase activity in yeast mitochondria.
5.4 DISCUSSION
A series of experiments' was carried out to investigate an apparent anomaly in 
the regulation of the yeast PDC multienzyme complex. Whereas PDC activity in all 
other eukaryotic organisms investigated thus far is controlled by a
phosphorylation-dephosphorylation cycle on the a  subunit of the pyruvate 
dehydrogenase (El) component of the complex, no such mechanism had yet been 
detected in yeast.
Initially, inactivation and radiolabelling studies were carried out on highly 
purified yeast PDC prepared from S.cerevisiae supplied by DCL Ltd. The complex 
was subjected to PDC kinase activity assays in the presence and absence of a 
heterologous kinase dissociated from bovine heart PDC during separation of the 
complex by FPLC. Highly purified bovine heart PDC was treated in an identical 
manner as a control. Although inactivation and phosphorylation of the mammalian 
complex was demonstrated under the assay conditions, no intrinsic kinase activity was 
detected in Yeast PDC, agreeing with the previous observations of Kresze and Ronft
Figure 5.3.4: Immune precipitation of phosphoproteins from fT^PlATP-labelled veast 
mitochondria
Yeast (S.cerevisiae D273-10B and S288C) mitochondria were incubated with
[y32p]ATP (10|iCi/assay) and subjected to immune precipitation with yeast PDC E l 
antiserum and non-immune rabbit serum (NRS), as described in Section 2.2.6(c). 
Immune precipitates were dissociated by boiling in Laemmli sample buffer prior to 
resolution on a 12.5% (w/v) SDS-polyacrylamide gel which was processed for
fluorography. Lanes: 1, [y^P]ATP-labelled D273-10B mitochondria (500|ig); 2-4,
[y32p]ATP-labelled D273-10B mitochondria (500|ig) immune precipitated with yeast
PDC E l antiserum (10 and 50pl) and NRS (50|il) respectively; 5-7, identical to lanes
2-4, except using lOOjig D273-10B mitochondria; 8-13, identical to lanes 2-7, except 
using S288C mitochondria; S, Mr standards (125I-radiolabelled).
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(1981a) and Uhlinger et al. (1986). However, the yeast complex was 
32P-phosphorylated and inactivated in the presence of mammalian kinase, a 
phenomenon previously detected by Uhlinger et al. (1986).
Initially, in situ radiolabelling studies were carried out on freshly prepared,
intact rat liver mitochondria in the presence of [y^PJATP. Phosphorylation of the PDC
and BCOADC E la  subunits was demonstrated under these conditions. The presence of 
PDC and BCOADC kinase activities was confirmed by the reduction of radiolabelling 
observed in the presence of the mammalian kinase inhibitor dichloroacetate. Two
additional phosphoproteins, with lower Mr values than the E la  subunits of the
complexes, were detected during the [y^PJATP radiolabelling of rat liver 
mitochondria. The origin of these polypeptides is unknown, although at least one 
appears to be immunologically distinct from PDC and BCOADC. Further research is 
clearly required to identify and characterise these phosphoproteins.
Similar in situ [y^P] ATP-radiolabelling studies were subsequently carried out 
on intact yeast mitochondria, freshly prepared from S.cerevisiae D273-10B subjected 
to a variety of growth conditions. The assay contents were also manipulated in several 
ways in order to establish the optimal conditions for phosphorylation of yeast 
mitochondrial proteins. Following aerobic growth in galactose-supplemented growth 
medium (YPG), a 45,000-Mr phosphoprotein was observed in yeast mitochondria,
possibly corresponding to the E la  subunit of PDC. This polypeptide was also detected 
in mitochondria prepared from a further strain of yeast, S.cerevisiae S288C. However, 
in mitochondria from both yeast strains, no significant reduction in the radiolabelling of 
this 32P-phosphoprotein was observed in the presence of the mammalian PDC kinase 
inhibitor dichloroacetate. This suggests that the yeast mitochondrial kinase which 
phosphorylates the 45,000-Mr polypeptide is resistant, or possibly less susceptible, to 
dichloroacetate inhibition.
The strongest evidence thus far for the presence of PDC kinase activity in yeast
was obtained from immune precipitation experiments on [y32?] ATP-radiolabelled yeast
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mitochondria. In mitochondria prepared from both strains of yeast, the 45,000-Mr
phosphoprotein was immmunologically identified as the E la  component of yeast PDC. 
It therefore seems likely that PDC activity in yeast, in common with all other eukaryotic 
organisms thus investigated, is regulated by a phosphorylation-dephosphorylation
mechanism on the E la  subunit of the complex. However, as indicated in this and 
previous studies (Kresze and Ronft, 1981a; Uhlinger et al., 1986), PDC kinase is not 
co-purified with the complex. In contrast, the mammalian kinase is tightly bound to 
PDC, is co-purified with the complex, and can be dissociated by FPLC (see Section 
2.2.13). The results obtained in this study thus indicate that yeast PDC kinase may be 
loosely bound to the complex and is dissociated during PDC purification. However, 
preliminary experiments have failed to detect PDC kinase activity in crude yeast 
mitochondrial extracts, suggesting that this regulatory enzyme may be labile. 
Alternatively, this may be due to the presence of a kinase- (or phosphatase-) regulating 
protein factor in yeast mitochondria.
As discussed above, optimal radiolabelling of the yeast PDC E la  occurred 
following aerobic growth in medium supplemented with galactose, a fermentable 
carbon source. In general, growth on fermentable carbon sources resulted in better
phosphorylation of the E la  component than growth on non-fermentable carbon 
sources, suggesting that the kinase is inducible. However, this observation may also be
due to different phosphorylation states of the E la  subunit prior to assaying for kinase 
activity, following growth in each type of substrate. In a fermentable carbon source,
PDC is likely to be very active with the E la  subunit in an non-phosphorylated state. 
Therefore, considerable scope exists for phosphorylation under the assay conditions. In 
contrast, PDC is likely to be inactive during growth on a non-fermentable carbon
source. Thus, the E la  subunit is already heavily phosphorylated prior to application of
the mitochondrial kinase assay. The poor radiolabelling of the E la  subunit following 
growth in glucose-supplemented medium is probably due to catabolite repression. If 
this is the case, growth on this substrate would result in depressed levels of all
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mitochondrial enzymes including PDC (Dawes and Lindsay, personal communication).
Phosphorylated E la  was also observed following growth in YPL. This may be due to 
the conversion of lactate to pyruvate (by lactate dehydrogenase) prior to entry into the 
citric acid cycle. PDC would thus require to be active during growth on this substrate.
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CHAPTER 6: GENERAL DISCUSSION & FUTURE
DIRECTION 
6.1 PTP AND ANT
A series of protein-chemical studies was carried out on the mitochondrial 
phosphate and adenine nucleotide transport proteins (PTP and ANT) from both 
mammalian and yeast sources. PTP was purified to apparent homogeneity from rat 
liver, bovine heart and yeast mitochondria, with the inclusion of carboxyatractyloside 
(CAT) resulting in the co-isolation of ANT in each case.
The mammalian PTP/ANT co-isolate was subjected to rigorous 
chromatographic analysis in order to separate the carriers into homogeneous 
populations. It was ultimately observed that following application of the co-purified 
proteins to the Matrex gel Procion Red A, the carriers were differentially eluted by a salt 
gradient (0-1.OM NaCl) at pH 8 .8 . At this stage, the identities of bovine heart PTP and 
ANT were confirmed by N-terminal protein sequence analysis.
Considerable evidence was also presented that Procion Red A column 
chromatography represents an assay for native mammalian PTP conformation, an 
important pre-requisite for further analysis of the carrier. However, as indicated in 
Section 3.4, it will be necessary to confirm this observation by conducting 
reconstitution experiments and comparing the phosphate flux of different PTP 
populations with their Procion Red A elution profiles.
It was further proposed in Section 3.4 that Procion Red A also represents an 
assay for native mammalian ANT conformation, on the basis that the Matrex gel is 
selectively eluting carriers in the homodimeric state. This hypothesis also requires 
further research in the form of reconstitution experiments (as described above), and 
comparison of the elution profiles of ANT populations from hydroxylapatite (HTP) and 
Procion Red A columns. As outlined previously (Section 3.4), HTP adsorbs out 
denatured ANT (Klingenberg et al., 1974; Schleyer and Neupert, 1984).
The Matrex gel Procion Red A was further employed as a technique for 
transferring mammalian PTP from solution in Triton X-100 to alternative non-ionic 
detergents more suitable for physical analyses of the carrier and crystallography trials.
It is proposed that this methodology would function equally well for ANT; however, it
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will be necessary to confirm this experimentally. Further work will also be required to 
identify and rectify the significant reductions in protein yield observed during the 
detergent replacement process. This is particularly important in view of the protein 
levels required for crystallisation trials. The conditions for the detergent switch may 
have to be altered if it results in denaturation of the bound carrier; e.g. an increase in 
the wash volumes may be required before and/or after the switch. Alternatively, if 
mixed PTP-detergent micelles are attaching to the filter during protein concentration in 
the Novacell stirred cells, it may be necessary to employ an alternative protein 
concentration technique.
In future, it is hoped to carry out further CD analyses of mammalian PTP in 
alternative detergents, both in the native state and following exposure to the denaturing 
agent GdnHCl. The spectra and predicted secondary structures will be compared to 
those obtained previously (see Section 3.3.5). The CD spectra for mammalian native 
and denatured ANT will also be obtained in a range of detergents. In this way, it will be 
possible to assess the relative stability of each of the carriers in various detergents and 
determine which are the most suitable for crystallisation trials. Similarly, the effects of 
freezing, exposure to heat, and time since purification on the stability of PTP and ANT 
in each detergent will be assessed by CD analysis.
In addition to the above, further physical analysis of the proteins will be carried 
out by differential scanning microcalorimetry (DSC). An added advantage of this 
technique is that it can be applied to samples prepared in Triton X-100. DSC analysis 
permits measurement of the thermal transitions occurring in aqueous solution during the 
unfolding of individual domains of proteins. As with CD, the stability of PTP and ANT 
in various detergents will be determined.
Ultimately it is hoped to obtain crystals of bovine heart PTP and/or ANT 
suitable for X-ray diffraction studies and determine the high resolution 
three-dimensional structure of at least one of the carriers. It may then be possible to 
elucidate the molecular mechanisms underlying the membrane insertion, intramembrane 
organisation, and catalytic mechanisms of the 'tripartite' family of mitochondrial 
carriers.
Furthermore, it is hoped to carry out the physical analyses and X-ray 
crystallography studies described above on PTP and ANT isolated from yeast
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mitochondria. However, several criteria require to be fulfilled and various problems 
solved before equivalent studies can be undertaken with the yeast carriers. There may 
be problems with crystallography studies on yeast PTP and ANT since the levels of 
mitochondria and subsequently purified protein obtained from yeast are significantly 
lower than from bovine heart. No such restrictions are envisaged prior to the physical 
analyses.
As outlined in Chapter 4, the 30,000-Mr protein isolated from yeast 
mitochondria using the mammalian PTP purification scheme was identified tentatively 
as yeast PTP on the basis of its immunological characteristics. Similarly, the 
co-purified CAT-stabilised 34,000-Mr polypeptide was identified as yeast ANT on the 
basis of its complexing with the specific inhibitor. However, although the identity of 
the ADP/ATP carrier can be confidently assumed on this basis, further characterisation 
studies are required to positively identify the putative yeast PTP isolated in this study. 
These studies are necessitated by the results obtained from the chromatographic 
analysis of the yeast mitochondrial co-isolate, and recently published literature (Pain et 
al., 1990; Murakami et al., 1990; Phelps etal., 1991).
In contrast to mammalian PTP and ANT, application of the yeast mitochondrial 
co-isolate to the Matrex gel Procion Red A did not result in the separation of the carriers 
into homogeneous populations under the conditions tested. However, it is hoped that 
this will be achieved by repeating the chromatographic analysis at a higher pH. As 
stated above, the mammalian carriers were differentially eluted by a salt gradient 
(0-1.0M NaCl) at pH 8 .8 . Separation of the yeast carriers would facilitate positive 
identification of ANT by N-terminal amino acid analysis.
The potential of Procion Red A analysis as an assay for native yeast PTP and 
ANT is suggested. However, as is the case for the mammalian carriers, this hypothesis 
requires further research in the form of reconstitution studies (for PTP and ANT) and 
comparison of elution profiles from Procion Red A and HTP (for ANT). An interesting 
observation during chromatographic analyses of the yeast co-isolate was the presence 
of an unbound protein population following application to Procion Red A. This 
indicates that the 30,000-Mr polypeptide isolate represents two proteins with 
near-identical Mr values. As outlined in Sections 4.4-4.6, the most likely explanation is
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that the NaCl-eluate corresponds to yeast PTP while the unbound fraction represents 
contamination by the outer membrane protein porin.
Recently, Wohlrab's group have cloned and sequenced the gene encoding yeast 
PTP (Phelps et al., 1991). However, Blobel's group have isolated the same gene and 
determined that it encodes a mitochondrial protein import receptor (Pain et al., 1990; 
Murakami et al., 1990). The in vivo role of the protein encoded by this gene is clearly 
a matter of considerable debate although, as discussed in Section 4.6, it may function 
as a transporter for both proteins and phosphate. Whatever its function, the protein was 
initially thought to be distinct from that isolated in this study, as indicated by comparing 
the N-terminal amino acid sequences of both. However, since the N-terminal of yeast 
PTP is masked (A. Phelps, personal communication), the protein sequence obtained in 
this study may be that of the contaminant porin. Subsequent N-terminal amino acid 
analyses of the unbound and NaCl-eluted Procion Red A 30,000-Mr fractions strongly 
suggested that this is the case. Whereas the N-terminal of the salt-eluted polypeptide 
was found to be blocked, the contaminating unbound protein was positively identified 
as porin.
It thus appears likely that the putative yeast PTP isolated in this study is 
identical to that encoded by the gene cloned by Murakami et al. (1990) and Phelps et al. 
(1991). This postulation is based upon chromatographic analysis of the proposed 
PTP/ANT/porin yeast mitochondrial isolate as well as the putative yeast PTP's 
purification properties and immunological characteristics in relation to the equivalent 
mammalian carrier. Furthermore, the N-terminal of both putative yeast PTPs is 
blocked. The absence of an N-terminal-extended signal sequence in both proteins lends 
further support to the above proposal. Guerin et al. (1991, in press) have also isolated a 
reconstitutively active yeast mitochondrial PTP. Wohlrab's group claim that this 
represents the protein encoded by the gene they have cloned (Phelps et a l, 1991) on the 
basis that both lack the NEM-reactive Cys42 present in mammalian PTPs.
There is clearly a requirement to elucidate the functional role of the various 
proteins implicated in phosphate transport in yeast mitochondria: the protein encoded by 
the gene cloned by Blobel's and Wohlrab's groups (Murakami et al., 1990; Phelps et 
al., 1991); Guerin's reconstitutively active PTP (1991, in press); the 30,000-Mr protein 
isolated in this study. This research will involve detailed structural and functional 
studies, and reconstitution experiments on each of the proteins involved. It will also be
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necessary to obtain internal amino acid sequences from the putative yeast PTPs isolated
by Guerin et al. (1991, in press) and in this study to determine if they are identical to
the protein encoded by the PTP and/or import receptor gene previously cloned.
6^ 2 YEAST PDC
A series of experiments were carried out to investigate an apparent anomaly
related to the control of PDC activity in yeast. Whereas activity of this multienzyme
complex in all other eukaryotic systems studied thus far is regulated by a
phosphorylation-dephosphorylation mechanism on the E la  subunit, no PDC kinase 
activity has ever been detected in yeast cells.
Initially, the absence of intrinsic kinase activity in purified yeast PDC was 
confirmed by inactivation and radiolabelling studies, supporting previous observations 
by Kresze and Ronft (1981a) and Uhlinger et al. (1986). A novel in situ approach was 
thus adopted to determine the presence or absence of PDC kinase in yeast cells. Freshly 
prepared, intact mitochondria from two strains of S.cerevisiae were subjected to
radiolabelling studies with [y^PjATP. As outlined in Chapter 5, a 45,000-Mr
phosphoprotein was identified which may correspond to the E la  subunit of PDC, 
indicating the presence of kinase activity in yeast mitochondria. Immune precipitation 
studies with anti-yeast PDC E l serum strongly supported this conclusion. The strong 
labelling of this phosphoprotein observed following growth in galactose-supplemented 
medium could be caused by the PDC being in an active, non-phosphorylated state prior 
to assaying. Alternatively, the kinase may be inducible. Radiolabelling of the putative
PDC E la  was poor following growth in media supplemented with non-fermentable 
carbon substrates (glycerol and succinate) and glucose, which may result in catabolite
repression. Phosphorylation of E la  was also observed following growth in YPL. This 
may be due to the conversion of lactate to pyruvate prior to entry to the citric acid cycle.
Under these conditions, PDC would be active and E la  non-phosphorylated prior to 
assaying.
Although the results obtained from these in situ experiments offer strong 
support to the presence of PDC kinase activity in yeast cells, they truly represent a pilot 
study leading ultimately to the elucidation of the regulatory mechanism for the yeast
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complex. Future experiments will determine the phosphorylation site (or sites) on the
E la  subunit, and also lead to the identification, purification and characterisation of the 
kinase.
The following experimental approach will be adopted to identify the in situ
phosphorylation site(s) on yeast PDC E la . In the process, it will also be possible to 
determine if this is identical to the single site identified in vitro by Uhlinger et al.
(1986) following phosphorylation of purified yeast PDC with a heterologous kinase
and subsequent sequencing of the E la  tryptic phosphopeptide:-
1) Purified yeast PDC in the presence of a heterologous kinase, and intact yeast
mitochondria will be radiolabelled with [y^PJATP;
2) Following autoradiography, the phosphorylated E la  bands will be removed from 
the gel and subjected to tryptic digestion;
3) In each case, the phosphopeptide(s) will be characterised by high voltage 
electrophoresis or high pressure liquid chromatography (HPLC);
4) The phosphorylation site(s) in each case will be identified by amino acid sequencing. 
It will thus be possible to compare the phosphorylation sites in situ and in vitro, as 
well as determining the number of these sites in situ .
The possibility that the phosphorylation sites are identical in situ and in vitro 
will be further investigated by preparing yeast mitochondrial extracts which can be 
tested for their viability as crude preparations of PDC kinase. If this is the case, it may 
be possible to determine if the two kinases (purified bovine heart and crude yeast)
compete for the same site on yeast PDC E la .
The preparation of crude mitochondrial extracts with yeast PDC kinase activity 
also represents the starting point for purification of the kinase. Separation of the protein 
components in the extracts will be achieved by FPLC and/or HPLC, with the peaks 
being analysed for PDC kinase activity, and by SDS-PAGE (to determine the level of 
purity). However, preliminary experiments have failed to detect kinase activity in these 
crude preparations. This may be due to the presence of a kinase- (or phosphatase-) 
regulating protein factor in yeast mitochondria.
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